{"name": "perturbation_10_d", "predictions": {"real": [0.0011198228791638285, 0.0014972881325903253, 0.00044033967731327403, 0.0015660411232317059, 0.00020720492504363615, 0.0014517324290084235, 0.0019492754397436377, 0.0008113210412134674, 0.000821097112881984, 9.260876629656783e-05, 0.007315754155672102, 0.0008230271031190004, 0.00037853980817130126, 0.0003190169177038651, -0.0005060369376106866, -0.00435716978254715, 0.0005738875109350919, 0.00014918964719045166, 0.002957710553861125, 0.0027510922962946703, 1.0683471580055868e-05, 0.0011155941849419477, -0.00014332730100150015, 0.0020220047761047933, 0.0002863325468745971, 0.0006525782923335012, 0.003925839764351594, 0.0029552377744581342, 0.006834362244098189, -0.0012234142947017152, 0.001345947203206562, 0.0010413191565576423, 0.006086278703278268, 0.00571442764128795, -0.0034688849979544207, 0.0022311347680470626, 0.00021900344896984498, -0.00033947001221257874, -0.0006520918940459287, -2.5554507680315084e-05, 0.0019789534538922834, -0.001340449138358001, 0.0012669128222830247, 0.005979739253040186, 0.00013444478824066773, 0.004043373102957838, 0.0035589324593294025, 0.0016912892329609918, -0.000542494812720385, 0.000627591195478098, 0.0011809218604955593, 0.00026594781873227284, 0.00016160461707650066, -0.0015910388338840004, 0.00042463620737243253, 0.006490817076934172, 0.016419678877321604, 0.000651579201236078, 0.00014773933985747693, -0.0003986818762794378, 0.000319699033670563, 0.007849562318686247, 0.000988903140566845, -0.0004678435659463843, 7.818577157384454e-05, 0.004083670568464655, 0.000983344322649261, 0.00038870520323444743, 0.014395459300286892, 0.00022986255117497396, 0.041019858934920335, 0.006786699442228072, -0.0002712615882840474, 0.0001066245077937511, 0.003873113329486633, 0.001800317051542993, 0.0012818498781371282, 0.0071915624246027664, -0.0009252620140263734, 0.0008159223081546845, 4.142187909016661e-05, 0.00539117021238631, 0.001153683087678218, 4.154011766444379e-05, 0.00011772323953582567, -0.0015068416127058115, 0.00021561711508700108, 0.009907899481308196, 0.00017165843832305872, -0.0009173600454178569, 0.0024891137576541697, -0.0005947959684411766, 0.0055058185059505965, -0.00016090488318620322, 0.001701075673904822, 0.0002466868975587018, 7.638444375969566e-05, 0.0011289018142557703, -0.00028288701472592805, 0.0006107000241178413, 0.006792782427673082, 0.004880915081416552, 0.015537831408746875, 0.002433129993215413, 0.0016224371200202565, -0.00014244614380490013, 2.618193078495806e-05, 0.00013676814567378006, 0.008952797949508302, -0.00028137718789161055, 0.006723843681336078, 0.0005144613400028194, 0.008669200757309765, 0.0003707687919752671, 0.0007799445876756177, 0.0018283243506409049, 0.0039703898227645374, -3.193401541853083e-05, 0.0014506188608733345, 0.0010097767607811282, 0.006308494099528227, -0.0015773164118012945, 0.0041341300170833215, 0.002740063834599781, 0.019855409946984984, 0.0013346705021631575, 0.002424282213484113, 0.000565037972388522, 0.0032204554584885883, 0.000866576703961196, 0.016480138588730944, 1.2043591277908572e-06, 0.0007139517333149165, 0.001488252600753863, 0.005740813104598076, 0.0003500012592468993, 0.005804269461561535, 0.007392328302480845, 0.0027519258570462505, 0.006133563528639476, 0.00012286244668886044, -0.0031294177180275326, -0.00019806075517447017, 0.008601001266327978, 0.007301427593138989, -0.002760382377468276, 0.00048093184022521057, -0.002190054015841998, 0.0004973523914216251, 0.00012441936399843807], "samples": [0.002030356941431044, 3.7941637341717266e-05, 0.028505255019229778, 0.006792904518887743, -0.11846168008892605, 0.003905677098821789, 0.0020351660952292764, 0.0017065891615301552, 0.003481107960641478, -0.000625105102197222, 0.006056125808764728, -0.0011173935401582505, 0.025418879465234866, 0.000974003127887231, 0.00011654797829893735, 0.007352842619406276, 0.003378482832613102, 0.0018409151779019742, 0.009912756862002721, 0.00747803947040569, -0.0004077949528460555, -0.00537992890874142, 0.0005116175127865498, 0.0053454090444634145, 0.00745173298318518, 0.02832571332842506, -0.0002528456232640697, 0.0026144949740155325, 0.007058694674506245, -0.008647429353756024, 0.011582419627580658, 0.00016760985100582396, 0.005850783068789299, 0.016164788840893427, -0.0006620922253355779, 0.01494774289376707, -0.0011286599892838282, -0.0002941864623403688, 0.0003365208771582142, 0.0008122743801416404, 0.00046814343832477217, 0.001957798063022, -0.0025318778332225067, 0.00427729005767438, -4.458266386790622e-05, 0.005214583202519156, 0.0052421766192242295, 0.0015824610251712438, 0.02201308071221447, -0.001388455689777592, 0.00097737740067152, 0.00018011624288786381, 0.00040778025074907206, -0.0015237935499950012, -0.0018615672729999245, -0.014362269616460782, 0.007748612511409264, 0.0008462427125086377, 0.017350722343420878, 0.0004456491985089998, -0.00029353047590856274, 0.0033415647766944674, 0.002511554123221636, -5.6580952471050466e-05, -0.001252390301088346, 0.004374769232005193, 0.0073461982841690684, 0.0007767372936052768, 0.010911552459259342, 0.005521196741467976, 0.010587840022151003, 0.0006582137867764447, -0.00042084025793495206, 0.0006734014243265996, 0.0022045477065276604, 0.03797751087393168, 0.0022575663549208036, 0.006614162476432072, 0.0009241196078494367, 0.0007599279546652103, -0.0009771371814699748, 0.03930449740095073, 0.002490631116448476, 1.4306822611611161e-05, 0.002778058514722081, 0.04622509893861201, 0.0017847664584011097, 0.00469701114821363, -0.0011731265778794709, -0.000138323459033571, 0.002569700684000762, -0.0009375387173311172, 0.0002272441165378095, 0.001020647307248464, 0.0011594365414170447, -5.994862608779683e-05, 0.0006286283709669386, 0.003666945798375786, 2.7243861249928508e-05, 0.00024337426565411088, 0.04603544068935975, 0.0016075853301258589, 0.012443238877758632, 0.005543321435626609, 0.0008545282326997263, -0.00018049992441110006, 0.00029489630688154427, 0.00044902905926607565, 0.008997275955245205, -0.001118465644990167, 0.009583884747833726, 0.002828823463709577, 0.011873339470294217, -0.0009570065852482659, 7.627488086630512e-05, 9.99861627215431e-05, -0.1992809282480526, 0.005649621499008309, -0.0015991510884200508, 0.0021879243436212902, 0.007257751199127504, 0.0014924350356125288, 0.003077633724835083, -0.0006940540610249971, 0.0016637817493133106, 0.001568939223487215, 0.004490737731600179, -0.001654607071889593, 0.002647295931219226, 0.00574056578271847, 0.006716131742332446, 0.001884920547848788, -0.0011814992228018906, 0.008674636588416582, 0.00839056288563824, 0.02077848102914582, 0.007406903326979878, 0.010493951681446456, 0.01087173063856503, 0.010331239608645999, 0.025156275021015063, 0.0016514284947559857, -0.00025651450831752935, -0.0007479192641479445, 0.004596227825480888, 0.00299739736603339, 0.0005043410830950002, 0.0001714511696786665, 0.00028798164572443777, 0.0005536682797812726]}, "info": {"pct_words_masked": 0.3, "span_length": 2, "n_perturbations": 10, "n_samples": 150}, "raw_results": [{"original": "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "sampled": "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and extent of care", "perturbed_sampled": [":Is implementing an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and timing of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their preferences for the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to state their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible and feasible to implement in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care, but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Introducing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to communicate their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to state their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and extent of care", ": Is implementing an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows individuals to express their wishes regarding the type and extent of care", "Question: Is an advance care planning model feasible in community palliative care? Answer:Yes, implementing an advance care planning model is not only feasible in community palliative care but also highly beneficial. Advance care planning (ACP) allows patients to express their wishes regarding the type and extent of care"], "perturbed_original": ["Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible for community palliative care? Answer: An advance care planning model is feasible for community palliative care . Answer: The survey and audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care services? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning decisions as an important outcome measure.", "Question: Is an advance care planning model feasible for implementation in community palliative care? Yes, the advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the model, with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible care palliative in community Quality audit processes are an essential component of the Model with documentation of in community planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in the context of community care? Answer: An advance care planning model is feasible for community health care services. Quality audit processes are an essential component of the model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with a documented advance care planning discussion established as the most important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are a critical component of the Model with documentation of advance care planning discussion established as an important outcome measure."], "original_ll": -0.00016619048357054546, "sampled_ll": -0.004998359434108794, "all_perturbed_sampled_ll": [-0.023934161528339652, -0.005295506578452241, -0.004822182944996896, -0.004352564174073493, -0.00020849931150727268, -0.00452428514196293, -0.006070378776751754, -0.0038929919809346553, -0.012107001930659828, -0.005079591387719656], "all_perturbed_original_ll": [-0.00014191926656945453, -0.0021525844055327588, -0.0002439538333483333, -0.00018341749195964287, -0.00012296855454907408, -0.00011449762197017241, -0.009189809999953398, -0.000492698795598, -0.00011063128728017859, -0.00010765237058272727], "perturbed_sampled_ll": -0.007028716375539838, "perturbed_original_ll": -0.001286013362734374, "perturbed_sampled_ll_std": 0.0062765871286428795, "perturbed_original_ll_std": 0.0027010374244520207}, {"original": "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "sampled": "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea", "perturbed_sampled": ["Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for clinical reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is an autoimmune disorder triggered by gluten consumption in certain individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals, which can lead to a wide range of symptoms, from digestive issues like diarrhea", ". Question:Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically susceptible people. It can cause a wide range of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide variety of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide range of complications, ranging from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten in genetically predisposed individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to symptoms which range s from digestive issues like diarrhea", "Question: Is coeliac disease screening in risk groups justified? Answer:Yes, coeliac disease screening in risk groups is justified for several reasons. Coeliac disease is a chronic autoimmune disorder triggered by gluten consumption in genetically predisposed individuals. It can lead to a wide range of symptoms, from digestive issues like diarrhea"], "perturbed_original": ["Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups was found to be useful rather than harmful.", "Question: Is active coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active coeliac disease screening in coeliac disease risk groups seems to be reasonable and not harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in coeliac disease patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease in high-risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? risk dietary compliance in screen-detected patients disease risk Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac \u00bb?1. groups seems to be reasonable rather than harmful.", "Question: Is active coeliac disease screening in risk groups justified? Answer: Long-term follow-up in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is active coeliac disease screening in risk groups justified? Answer: Long-term outcome in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects in the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Should we be encouraging coeliac disease screening in risk groups? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable and not harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone fracture rates were comparable with those in non-coeliac subjects and in the general population. Active screening in coeliac disease risk groups seems to be useful rather than harmful.", ". The effectiveness of coeliac disease screening in risk groups appears reasonable. Long-term dietary compliance in screen-detected patients was good. Quality of life, health related quality of life, fitness and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in controls and the population at risk. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful."], "original_ll": -6.863778426507937e-05, "sampled_ll": -0.006393659520444518, "all_perturbed_sampled_ll": [-0.006919585944909193, -0.006511412135041935, -0.0002585814211640351, -0.005670033634109032, -0.00980480441017183, -0.005613765469849195, -0.00617338327433254, -0.0064661087891285255, -0.009584436702318646, -0.007313899796837421], "all_perturbed_original_ll": [-7.282374893031745e-05, -0.0001179963480853731, -4.578020622292308e-05, -0.013812707459291402, -7.500413241937499e-05, -6.0052684459047606e-05, -9.73277632096923e-05, -7.065638339109374e-05, -0.0012343153098884282, -7.259513265639344e-05], "perturbed_sampled_ll": -0.006431601157786235, "perturbed_original_ll": -0.0015659259168554047, "perturbed_sampled_ll_std": 0.002485250534897114, "perturbed_original_ll_std": 0.004096870404947267}, {"original": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients.", "sampled": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" where patients exhibit higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or through self-measurement at home. The disparity in", "perturbed_sampled": ["Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" where patients exhibit higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or self-measurement at home. The disparity in", "Question: Does blood pressure often change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure often can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" where patients have higher or lower blood pressure readings in the presence of a physician compared to measurements made by a nurse or through self-measurement at home. The disparity in", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure does change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" where patients exhibit higher blood pressure measurements in the presence of a physician compared to measurements taken by a nurse or patient at home. The disparity in", "Question: Can blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" which occurs when individuals exhibit higher blood pressure readings in the presence of a physician in contrast with measurements taken by a nurse or through self-measurement at home. The disparity in", "pressure blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is referred to as \"dual-monitoring hypertension,\" where patients exhibit higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or through self-measurement at home. The disparity in", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure does change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon has been referred to as \"white coat hypertension,\" where patients exhibit higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or through self-measurement at home. The disparity in", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is often referred to as \"white coat hypertension,\" where patients ' blood pressure readings in the presence of a physician may be more high or lower compared to measurements by a nurse or even at home. The disparity in", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This is often referred to as \"white coat hypertension,\" where patients exhibit higher blood pressure readings in the office of a physician compared to measurements taken in the office by a nurse or through self-measurement at home. The disparity in", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer:Yes, blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or a nurse. This phenomenon is referred to as \"white coat hypertension,\" where patients have higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or through self-measurement at home. The disparity in", ". Why can blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Why blood pressure can change in treated hypertensive patients depending on whether it is measured by a physician or nurse. This phenomenon is referred to as \"reverse hypertension,\" where patients exhibit higher blood pressure readings in the presence of a physician compared to measurements taken by a nurse or through self-measurement at home. The disparity in"], "perturbed_original": ["Question: Does blood pressure change in treated hypertensive patients depending on whether the patient is measured by a physician or a nurse? Answer: The blood pressure measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during the therapy phase of treated hypertensive patients.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP obtained by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are more indicative of inadequate response to treatment than the readings obtained by the physician during home monitoring. Blood pressure monitoring by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients.", "or does the average blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory blood pressure readings. Blood pressure determination by the nurse is used not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients.", "Question: Does blood pressure change in hypertensive patients depending on whether it is measured by a physician or a nurse? Systolic BP measured by the nurse in hypertensive patients is significantly lower than those obtained by the physician, and are almost always lower than those obtained by ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during follow-up of treated hypertensive patients.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly higher than the readings obtained by the physician, and are almost as reliable as readings obtained by ambulatory BP monitoring. Therefore, BP determination by the nurse is desirable not only for diagnosis but also to evaluate the level and pattern of blood pressure during the follow-up of treated hypertensive patients.", "Question: Does blood pressure differ in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings by the physician, and are almost not correlated with those obtained using ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients.", "Question: Does blood pressure differ significantly in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician and are almost the same as those obtained by ambulatory BP monitoring. Blood pressure determination by the nurse is useful not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients.", "? Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for compliance evaluation but also to assess the level of control of blood pressure during the follow-up of treated hypertensive patients.", "Question: Does blood pressure vary in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than readings obtained by the physician, and are almost identical to normal BP readings acquired by intermittent monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the systolic control of blood pressure during the follow-up of treated hypertensive patients.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure monitoring by the nurse is appropriate not only for diagnosis but also to evaluate the level of control of blood pressure during the follow-up of treated hypertensive patients."], "original_ll": -0.00013816645761430109, "sampled_ll": -0.005901069822126021, "all_perturbed_sampled_ll": [-0.005232950430542284, -0.005354601404755155, -0.005098858401792223, -0.006611123661320418, -0.29729222561203467, -0.0047829802370650525, -0.007761886983961075, -0.005085473591678631, -0.004835523065094566, -0.002007625025313968], "all_perturbed_original_ll": [-0.00029496895091806445, -7.61390231138835e-05, -0.002894225003778527, -2.9452501116703297e-05, -0.00011074650423377552, -0.00014982464187885414, -0.0002652166722921649, -0.0017092559471913046, -8.338949670494738e-05, -0.00017184260804752684], "perturbed_sampled_ll": -0.0344063248413558, "perturbed_original_ll": -0.0005785061349275751, "perturbed_sampled_ll_std": 0.08763953162280934, "perturbed_original_ll_std": 0.0009047987539537645}, {"original": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "sampled": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "perturbed_sampled": ["Question: Metastatic carcinoma to the cervical nodes from  head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary Question: there a need for neck dissection? Answer:", "in situ. Answer: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma s of the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to ? Question::s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an unknown head : primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck  Is there a need for neck dissection? Answer:", "? Answer: Translation of carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an anterior head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from  head and neck primary site: Is there a need for neck dissection? Answer:"], "perturbed_original": ["Question: Metastatic carcinoma to the cervical nodes and an unknown head and neck primary site: Is there a need for neck dissection? Answer:", ": Radiation-induced carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "or carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: ????????????????????????????? to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary this significant? est-ce encore?!?!!?!?\u00e0!!!!!!!!!!!!?a!!!!!!!!!!!!!!!!!! there a need for neck dissection? Answer:", "tosis of squamous cell carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "-based breast carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma in situ of the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer:", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need  dissection? Answer:", "Question: Metastatic carcinoma to the cervical region with an unknown head and neck primary site: Is there a need for neck dissection? Answer:"], "original_ll": -0.0019846093840993327, "sampled_ll": -0.001239173480889667, "all_perturbed_sampled_ll": [-0.0053905663975957144, -0.018440960658355664, -0.002224627678549231, -0.008990182319681614, -0.006467244676269834, -0.022575427875222754, -0.008892562581312964, -0.00026746481064079996, -0.0027467749836176674, -0.0043249680165278566], "all_perturbed_original_ll": [-0.0018004570550633333, -0.0004893670284653846, -0.0007685249542692308, -0.0004596215667306061, -0.001726583009613913, -0.004452889827666129, -0.0005014170501477778, -0.00177554377542625, -0.02193226940115143, -0.0015998314047763339], "perturbed_sampled_ll": -0.00803207799977741, "perturbed_original_ll": -0.0035506505073310385, "perturbed_sampled_ll_std": 0.006831041925565604, "perturbed_original_ll_std": 0.006229036932824839}, {"original": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "sampled": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "perturbed_sampled": ["Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for the estimate of the basal metabolic rate are applicable to the Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether the current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Question: Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for basal metabolic rate (BMR) are applicable to the Chinese", "Question: Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) in Chinese are applicable to the Chinese", "Question: estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: The question of whether current prediction equations for estimating basal metabolic rate (BMR) are applicable to the Chinese", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer:Estimation of basal metabolic rate (BMR) in Chinese: are the current prediction equations applicable?\n\nAnswer: This study examined the question of whether current prediction equations for estimating basal metabolic rate (BMR) were applicable to the Chinese"], "perturbed_original": ["Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in individuals within the normal BMI range including those overweight and obese.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the 2010 Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for people with a large BMI range including those overweight and obese.", "Question: Estimation of BMI-based resting metabolic rate in Chinese: are the current methods applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "Question: Q: What is the most accurate basal metabolic rate prediction equation in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "Question: Estimation of basal metabolic rate in Chinese: Are the current prediction equations applicable? Answer: A Chinese based model using the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including overweight and obese.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the CGRF Singapore equation is the most accurate BMR equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "Question: How do you measure basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: We believe that the newly developed Singapore equation is the most accurate BMR prediction equation available in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "Question: Estimation of basal metabolic rate in Chinese: are the current BMR prediction equations still applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and can be adjusted for use in a large BMI range including overweight and obese.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese.", "\u2013 Prediction of basal metabolic rate in Chinese: are the Singapore or other English equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for use in a large BMI range including those overweight and obese."], "original_ll": -0.0001014670672601852, "sampled_ll": -0.4098408520084, "all_perturbed_sampled_ll": [-0.4762443075919643, -0.1062109836538125, -0.40162060039296, -0.3033206302742586, -0.29028473773716607, -0.20370470127006668, -0.4355473088310574, -0.20857533775905834, -0.17932715785611664, -0.3089559538282791], "all_perturbed_original_ll": [-0.00017231707166351858, -0.00012009868829418184, -0.00019983453130072726, -0.000109413552273, -0.00015391098951672723, -0.0001778418719871698, -8.007033613946427e-05, -0.0001338194338168421, -0.00017360790032111111, -0.0017658055477254714], "perturbed_sampled_ll": -0.29137917191947393, "perturbed_original_ll": -0.00030867199230382136, "perturbed_sampled_ll_std": 0.11355689396610401, "perturbed_original_ll_std": 0.00048693759397526194}, {"original": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "sampled": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating elements such as culture, attitudes, and faith is crucial. These", "perturbed_sampled": ["Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures incorporating factors contexts, including healthcare and rehabilitation, factors???????????????????????????????????? such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in healthcare and services, including addiction rehabilitation, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare settings, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome s: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating contexts such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating elements of culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a such as clinical treatment Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, s and rehabilitation, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare settings, incorporating elements such as culture, attitudes, and faith is crucial. These", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:Yes, when considering recovery outcome measures in various contexts, including healthcare and rehabilitation, incorporating elements such as culture, attitudes, and faith are crucial. These"], "perturbed_original": ["Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? more culturally sensitive paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop the RAQ in Australian settings????????????????????????????????????????????????????????????????????????????????????????????????????? recovery outcome measures.", "Question: Recovery Outcome Measures in Australia: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the limited application of the RAQ in Australian settings, and identifies areas for further research and development to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ -ROR in various settings, and identifies the need to develop culturally inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Geography, Language, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? The paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Assessment Questionnaires and Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Relationships, Attitudes, and Behaviours? This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Role for Culture, Sexuality and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of recovery outcome measures in Australian settings, and identifies the need to develop culturally inclusive recovery outcome measures."], "original_ll": -0.00015346981483160002, "sampled_ll": -0.005420194416120195, "all_perturbed_sampled_ll": [-0.0138774822808818, -0.004779155233050785, -0.0052337021220431375, -0.005768640371783798, -0.015796915126530982, -0.005826444509544704, -0.0055098706909732, -0.026590279236324607, -0.0046783613176080005, -0.005197864260678822], "all_perturbed_original_ll": [-0.013286390330154054, -0.0002999379290686274, -0.000218780107635, -0.0002651610469946154, -0.0004162896072941176, -0.00041139745733708333, -0.0001608364561479629, -0.000431392635497551, -0.000351498054917347, -0.00021033881335387754], "perturbed_sampled_ll": -0.009325871514941984, "perturbed_original_ll": -0.0016052022438400235, "perturbed_sampled_ll_std": 0.006900517076510252, "perturbed_original_ll_std": 0.0038947640444858887}, {"original": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "sampled": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "perturbed_sampled": ["Question: Thoracic after aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "treatment. Question: Spinal and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "postoperative pain and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: for thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question:  thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic : aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal cancer is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal  is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal ????????????????????????????????? a waste of time? Answer:", "Question: Thoracic and thoracoabdominal ? is reimplantation of spinal cord arteries a waste of time? Answer:"], "perturbed_original": ["Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of  arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is ?.???.?.?.?.??.?.??.??.?.?.?.?.?.?.??.??? spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal  a waste of time? Answer:", "Question: Thoracic and abdominal repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and re repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of thoracic arteries a waste of time? Answer:", "Question: Thoracic and thoracic repair: is reimplantation of spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is t spinal cord arteries a waste of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries .s:ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s??s?s? of time? Answer:", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord a waste of time???????????????????????????????????????????????????????????????????????????????????????? waste of time? Answer:"], "original_ll": -0.0024087418755515625, "sampled_ll": -0.0011846604470171875, "all_perturbed_sampled_ll": [-0.0015569381412403704, -0.008870803801589142, -0.0034207878312482757, -0.0020881127515336665, -0.001138219314953793, -0.0044099417826411105, -0.002755140101288889, -0.0043379339553365395, -0.0031190225671702634, -0.0005013651754625926], "all_perturbed_original_ll": [-0.0037256846241560007, -0.010232291129413333, -0.002496676596008667, -0.0014390725908020833, -0.0037611279607108333, -0.00121444860418375, -0.0009562817531627999, -0.005489086664194643, -0.008294082903109531, -0.005971420327210357], "perturbed_sampled_ll": -0.003219826542246464, "perturbed_original_ll": -0.0043580173152952, "perturbed_sampled_ll_std": 0.0022502368234791773, "perturbed_original_ll_std": 0.0029677747639209723}, {"original": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "sampled": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and applicable to both practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "perturbed_sampled": ["Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and applicable to both practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment protocols and rehabilitation methods that can", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Sport medicine journals are indeed relevant and applicable to both practitioners and athletes. These journals play an important role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Sports medicine journals are indeed relevant and applicable to practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment techniques, as well as diagnostic and prognostic methods that can", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are relevant and applicable to practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Are sports medicine journals relevant both to practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and valuable to both practitioners and athletes. These journals play a vital role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and applicable to both practitioners and athletes. These journals play a major role in disseminating the latest research findings, treatment techniques, and rehabilitation tips. Therefore, they can", "Question: Are sports medicine journals relevant and applicable to sports medicine practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and applicable to sports medicine practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Are sports medicine journals relevant and applicable to both practitioners and athletes? Answer:Answer: Sports medicine journals are indeed relevant and applicable to both practitioners and athletes. These publications play a pivotal role in providing practitioners with the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Why are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are relevant and applicable to both practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, treatment techniques, and rehabilitation methods that can", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer:Answer: Sports medicine journals are definitely relevant and applicable to practitioners and athletes. These journals play a pivotal role in disseminating the latest research findings, therapies and rehabilitation methods that can"], "perturbed_original": ["Are peer reviewed sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of systematic reviews addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of quantity and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and researchers? There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to grow both in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is currently a dearth of high quality systematic reviews addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of both quantity and quality.", "Question: Are sports medicine journals relevant and applicable to addressing medical problems in athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of both quantity and quality.", "Question: Are sports medicine treatment studies meaningful and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing performance related treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of quantity and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a great need to develop rigorous and systematic studies to validate diagnosis and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine clinical trials relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The need for sports medicine clinical trials continues to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners ? Answer: There is a dearth of studies addressing diagnostic and treatment decisions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of high quality and high impact evidence regarding diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine treatments must continue to increase in terms of quantity and quality.", "Question: Are articles published in sport medicine journals relevant and applicable to practitioners and athletes? There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for these interventions must continue to increase in terms of volume and quality."], "original_ll": -0.0001309485695962745, "sampled_ll": -0.005259666644062884, "all_perturbed_sampled_ll": [-0.011253563034486927, -0.00029045526087539996, -0.00029305396377654543, -0.008906095981768801, -0.008031054660012549, -0.006091705367017636, -0.004173553281794, -0.0058500303624, -0.007300965294477307, -0.017472080849321222], "all_perturbed_original_ll": [-0.003653026603278654, -8.454858138639999e-05, -0.0006641740320453572, -0.00014231417231407408, -0.0005521417439148077, -0.00011319766589160713, -0.00024291742749134613, -0.0035509673819185718, -0.00020186010493333334, -0.0002175483949232692], "perturbed_sampled_ll": -0.0069662558055930395, "perturbed_original_ll": -0.0009422696108097419, "perturbed_sampled_ll_std": 0.004823588818569974, "perturbed_original_ll_std": 0.0013419589914698607}, {"original": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "sampled": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "perturbed_sampled": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is , most often observed in newborns, characterized by respiratory depression with respiratory arrest during the first", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic (TTN) is encoding genes? Answer:Transient tachypnea of the newborn is a condition often observed in newborns, characterized by rapid breathing during the first", "? Question:Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of TTN (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? The newborn of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in ADP receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of the newborn (TTN): receptor for polymorphisms in the beta-adrenergic : encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "of transient tachypnea of the newborn: a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of the newborn (TTN): of for This disorder is commonly characterized by rapid breathing during the first weeks the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms : beta-adrenergic receptor : genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed in newborns, characterized by rapid breathing during the first", "Question: Transient tachypnea of in premature infants (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer:Transient tachypnea of the newborn (TTN) is a condition often observed days after birth and characterized by rapid breathing during the first"], "perturbed_original": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the associated with amino acid (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both to the ADRB2 gene variations, may predispose to TTN.", ". Question: The tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and amplification of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We in the ADP beta1Gly49 homozygosity and TACC haplotype re gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 in the beta1Der47Asp TACC haplotype Tet gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role /TACA mutations in the in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC : ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC variants, may ADRB2 gene, both loss-of-function genetic to predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a variant polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both n't be the same: TTN, an adverse effect of corticosteroids: can they be inherited? Question: est-ce que les variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding polymorphisms which are common We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both . variations, may predispose to TTN.", "Question: Time-transition of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, and possibly other genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) that CCG Answer: We conclude s? homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN."], "original_ll": -0.00014503942290545457, "sampled_ll": -0.0031231708102747763, "all_perturbed_sampled_ll": [-0.009785718425010997, -0.005367509897209682, -0.008348245816224266, -0.002438990675028197, -0.003337856981789207, -0.01142146200446661, -0.006834949073506614, -0.007004791023188242, -0.005932869660965482, -0.005570394151773235], "all_perturbed_original_ll": [-0.00010566414458499999, -0.0019509350045435615, -0.0005500628648124, -9.813647873078948e-05, -0.00021637882402407893, -0.0003906207658951351, -0.0007868784799530692, -0.002568152305918421, -0.0001731917676309722, -0.0028213447217809583], "perturbed_sampled_ll": -0.006604278770916254, "perturbed_original_ll": -0.0009661365357874386, "perturbed_sampled_ll_std": 0.0026009670039796374, "perturbed_original_ll_std": 0.0010099150451207447}, {"original": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "sampled": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of the condition often lies in its", "perturbed_sampled": ["Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer:Hepatorenal syndrome is a serious condition that occurs in patients with advanced liver disease, leading to kidney dysfunction. It is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of this disorder often lies in its", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in liver function and is associated with a poor prognosis. The complexity of HRS prognosis often lies in its", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline of renal function and is associated with a very poor prognosis. The cause of the condition often lies in its", "Question: What are the features of HRS and are we missing some prognostic factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, chronic infection, and kidney failure. It is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of the condition often lies in its", "Question: Hepatorenal syndrome: are we missing any important risk factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in kidney function and is associated with a poor prognosis. The complexity of the management of HRS lies in its", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer:Hepatorenal syndrome (HRS) is a serious condition found in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of the condition often hampers its", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Hepatorenal syndrome (HRS) is a multifactorial disease that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in kidney function and is associated with a poor prognosis. The significance of the condition often lies in its", "Question: Hepatorenal syndrome: are we missing important risk factors? Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, leading to kidney failure. It is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of the condition often lies in its", "Question: Hepatorenal syndrome: are we missing some important factors? Answer:Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease, but before onset of kidney failure. HRS is characterized by a rapid decline in kidney function and is associated with a very poor prognosis. The complexity of the condition often lies in its", "Question: Hepatorenal syndrome: are we missing some prognostic information? Hepatorenal syndrome (HRS) is a serious condition that occurs in patients with advanced liver disease leading to kidney failure. It is characterized by a rapid decline in renal function and is associated with a very poor prognosis. The complexity of the condition often lies in its"], "perturbed_original": ["Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. Low renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at time of diagnosis were found to be associated with survival, suggesting that early intervention may increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology and progression has been found to be independent prognostic factors of survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We have reported for the first time the value of renal function as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early renal replacement therapy may increase survival.", "Question: Hepatorenal syndrome: Are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as creatinine clearance and urinary Na +/K+ ratio) at the time of diagnosis were found to be positively associated with survival, suggesting that early treatment might increase survival.", "Question: ESLD: are we missing some prognostic factors? We report for the first time ESLD etiology as a prognostic factor for survival. The renal function parameters (serum sodium and serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as prognostic factor in ESLD. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) concentration at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and the serum ATP concentration (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are there some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as GFR <unk>40%) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: So are we missing other prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for NRF patients. Poor renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with poor outcome, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time the role of ESLD etiology as a prognostic factor for survival. Decreased renal function (expressed as serum creatinine) and low serum Na (<5 mEq/l) at the time of diagnosis were found to be associated with worse outcomes, suggesting that early treatment might increase survival."], "original_ll": -0.00016210947932291137, "sampled_ll": -0.004881712038319323, "all_perturbed_sampled_ll": [-0.006930863021942859, -0.005246440844082837, -0.004986425213363242, -0.0040965204530435916, -0.0061614627498828385, -0.0058615930092990555, -0.0002583684355995891, -0.00047984400868442877, -0.0080420154740392, -0.0005025361512833803], "all_perturbed_original_ll": [-0.0001370654090302564, -0.00024750785484988234, -0.00022242459289626503, -0.0002206107953891139, -0.0001327308671428947, -0.00040725138274274995, -0.0002482327495198766, -0.0005343011781041976, -0.00017205128481802634, -0.00022500634170152938], "perturbed_sampled_ll": -0.004256606936122101, "perturbed_original_ll": -0.0002547182456194792, "perturbed_sampled_ll_std": 0.0027123117394154982, "perturbed_original_ll_std": 0.00011839466108199812}, {"original": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "sampled": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "perturbed_sampled": ["Question: Does the increased hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "? Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in s more parities? Answer:", "Question: Does glomerular hyperfiltration ?u0027s damage the kidney in women with more parities? Answer:", "Question: Does glomerular ?sssss?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with ? Answer:", "Question: Does glomerular hyperfiltration in pregnancy ?c kidney in women with more parities? Answer:", "Question: Can hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:"], "perturbed_original": ["Question: Does hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Q: Can glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration ? damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney more with more parities? Answer:", "Question: Can hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:", "Question: Does glomerular hyperfiltration in pregnancy damage the question.tt?tt?t?t?t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t!t women with more parities? Answer:", "Question: Does glomerular ?????????????????????????????????????????\u201d? pregnancy damage the kidney in women with more parities? Answer:", "Question: Q: Will hyperfiltration in pregnancy damage the kidney in women with more parities? Answer:"], "original_ll": -0.0018798796029647826, "sampled_ll": -0.0019021051248969568, "all_perturbed_sampled_ll": [-0.0019053462969727273, -0.002098579077178261, -0.007519865045559168, -0.001338899188092, -0.02387256243465238, -0.021908010656496155, -0.0025473550319628003, -0.007500598917347499, -0.008930618460060871, -0.001960474228295], "all_perturbed_original_ll": [-0.00124440860209, -0.003504161208699565, -0.04658094197061652, -0.0011205193231625002, -0.012231682633680954, -0.004156956917305909, -0.003224088429797, -0.015905235251171275, -0.0026762846668046667, -0.0013120585830404543], "perturbed_sampled_ll": -0.007958230933661685, "perturbed_original_ll": -0.009195633758636884, "perturbed_sampled_ll_std": 0.00793251901502449, "perturbed_original_ll_std": 0.013335742264845992}, {"original": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "sampled": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "perturbed_sampled": ["Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:"], "perturbed_original": ["Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer:"], "original_ll": -0.0019740905145891664, "sampled_ll": -0.003881648110908334, "all_perturbed_sampled_ll": [-0.0023782948147604167, -0.0029236694464720835, -0.0019576880672999997, -0.003239918856930417, -0.002272773387841667, -0.00357752608409875, -0.0019677253865479165, -0.0021205418031870833, -0.004028469181762501, -0.0031759386786], "all_perturbed_original_ll": [-0.0023777515816316664, -0.002656585304441667, -0.0029765568419304164, -0.0034096610525875004, -0.002710446152720833, -0.002361522023495417, -0.0030684852695499996, -0.002681261978325833, -0.0026924123168866666, -0.003036493655511667], "perturbed_sampled_ll": -0.0027642545707500833, "perturbed_original_ll": -0.0027971176177081667, "perturbed_sampled_ll_std": 0.0006907022250449564, "perturbed_original_ll_std": 0.00030912903159811405}, {"original": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have added screw fixation of the acetabular component to the ischial tuberosity and the superior pubic ramus.", "sampled": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to better initial stability. Moreover, the addition of a cage further reinforces the construct, distributing the forces more evenly across the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "perturbed_sampled": ["Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for fixation to the host bone, leading to better initial stability. Moreover, the addition of a cage further stabilizes the construct, distributing forces more evenly across the acetabulum and reducing the risk of implant migration or failure.\n\nIn cases with osteoporotic acetabular fractures,", "Answer: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to greater stability. Moreover, the addition of a cage further reinforces the fixation system by distributing the forces more evenly across the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "Can cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable anchorage into osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to better initial stability. Moreover, the addition of a cage further reinforces the construct, distributing the forces of load across the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially providing better initial stability. Moreover, the addition of a cup-cage structure reinforces the construct, potentially distributing the loading forces more evenly across the compromised acetabulum and reducing the incidence of implant -related failure.\n\nIn cases of osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor bone quality and the difficulty of achieving stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to better initial stability. Moreover, the addition of a cage further reinforces the construct, distributing the forces more evenly across the compromised bone and potentially reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical approach is designed to address the challenges associated with the lack of host bone quality and the difficulty in achieving stable fixation in osteoporotic bone. The cups offer an increased surface area in contact with the host bone, potentially leading to better initial stability. Moreover, the addition of the cup-cage further reinforces the construct, distributing the forces more evenly across the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. The technique is designed to address the challenges associated with poor bone quality and the difficulty in achieving stable fixation to the host bone. The oversized cups offer an increased surface area for contact with the host bone, potentially providing better initial stability. Moreover, the addition of a cage further reinforces the fixation, distributing the forces more evenly within the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer:Yes, cup-cage reconstruction with oversized cups provides initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor -quality host bone, acetabular fusion, and the difficulty of stable fixation in osteoporotic bone. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to better fixation. Moreover, the addition of a cage further reinforces the construct, distributing the forces more evenly in the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of complicated acetabular fractures,", ". Does cup-cage reconstruction with oversized cups provide initial stability in total hip arthroplasty for osteoporotic acetabular fractures? In this series, we explore whether cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with poor fixation and the difficulty in achieving stable fixation in osteoporotic bone. The oversized cups provide an increased surface area for contact with the host bone, potentially leading to greater stability. Moreover, the addition of a cage further reinforces the construct, distributing the forces more evenly across the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn patients with osteoporotic acetabular fractures,", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Cup-cage reconstruction with oversized cups does provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. This surgical technique is designed to address the challenges associated with compromised bone quality and the difficulty in achieving stable fixation in osteoporotic fractures. The oversized cups offer an increased surface area for contact with the host bone, potentially leading to better initial stability. Moreover, the addition of a cage further reinforces the fixation by distributing the forces more evenly throughout the compromised acetabulum and reducing the risk of implant migration or failure.\n\nIn cases of osteoporotic acetabular fractures,"], "perturbed_original": ["Question: Does cup-cage reconstruction with oversized cup-cage components present a similar initial stability profile as primary THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface between the component and pelvic bone. Three components migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits were met in this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have added screw fixation of the acetabular component to the ischial tuberosity and the ischial ramus.", "Question: Does cup-cage repair with oversized cups provide increased stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be established whether these limits apply to our selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with an acetabular fracture for other indications, but since the publication of these data we have added screw fixation of the acetabular component to the ischial tuberosity and the subscapular ramus.", "Question: Does the new technique with oversized acetabular components provide adequate initial stability in patients with osteoporotic acetabular fractures? Answer: The majority of acetabular components in this study were stable despite the small contact area between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, and have modified the analysis of these data with the added screw fixation of the acetabular component to the ischial tuberosity and the superior pubic ramus.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular disorders? The majority of components in this cohort migrated to normal hip despite the contact point between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later mallocation in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have added secondary osteosynthesis of the acetabular component to the ischial tuberosity and the superior pubic ramus.", "Question: Does fixed acetabular fixation with oversized cups provide adequate stability in THA for osteoporotic men? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three components migrated in excess of previous findings that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have adopted fixed screw fixation of the acetabular component to the ischial tuberosity and the superior pubic ramus.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Only 1 of 10 migrated in excess of the limits that predict later failure in primary THA . It remains to be seen whether these limits apply to this group of osteoporotic acetabular fractures. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have added screw fixation of the acetabular component to the ischial tuberosity and the superior pubic ramus.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic patients? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in the first year following surgery, well within the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of young patients. We continue to use this technique routinely to treat these patients in the hip but following analysis of these results have added screw fixation of the acetabular component to the ischial tuberosity and the tibial ramus.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for acetabular fractures? Answer: The majority of acetabular components in this cohort demonstrated good initial stability despite the small contact surface between the component and the bone. Three of four components exhibited a thickness in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits can be surpassed in this selected group of frail osteoporotic patients. We continue to use this technique routinely to treat patients with the same indications, but since the analysis of these data we have added screw ing to secure the acetabular component to the pubic bone and the superior pubic ramus.", "Question: Does cup-cage reconstruction with oversized cups improve acetabular stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact area between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits were exceeded in this selected group of frail patients. We continue to use this technique routinely to treat patients for these same indications, but since the analysis of these data we have added screw fixation of the acetabular cup to the ischial tuberosity and superior pubic ramus.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA s with displaced acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the substantial migration of the internal contact surface between the component and pelvic bone. Three of 10 migrated in excess of the migration limits that predict later loosening in the osteotropic environment, but it remains to be determined whether these limits apply to this selected group of frail osteoporotic patients. We continue to use this technique to treat patients with the same indications, but since the analysis of these data we have added screw fixation of the acetabular component to the ischial tuberosity and the superior pubic ramus."], "original_ll": -0.00022264271308198585, "sampled_ll": -0.009312976161915423, "all_perturbed_sampled_ll": [-0.006569607330166643, -0.01215550748355662, -0.26792794729585306, -0.01059605934420064, -0.01006219748233631, -0.006872315087702639, -0.012406058500443096, -0.007935242498483847, -0.006211989757764622, -0.006581631490995435], "all_perturbed_original_ll": [-0.0007566766844138357, -0.00036268338914217685, -0.00032710404908, -7.39357747897826e-05, -0.000348920573842029, -0.001970245277646574, -0.0002175564532701449, -0.0011264962649710636, -0.0004953256768555396, -0.0003328810685217242], "perturbed_sampled_ll": -0.03473185562715029, "perturbed_original_ll": -0.0006011825212532871, "perturbed_sampled_ll_std": 0.07776427274082662, "perturbed_original_ll_std": 0.0005365120840049699}, {"original": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "sampled": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and clinical guidelines, and to monitor the patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "perturbed_sampled": ["Question: Are opioid dependence and methadone maintenance treatment documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals document this information to ensure the continuity of care, to satisfy legal and clinical guidelines, and to monitor the patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence and the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the patient's health record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record certain information to ensure the continuity of care, to comply with legal and regulatory requirements and to track a patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and clinical guidelines, and to monitor the patient's progress over time. This documentation includes details such as the diagnosis of opioid dependence, the diagnosis of MMT, and the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance therapy are typically documented in a patient's medical record. The goal is to record this information to ensure a consistent level of care, to comply with regulatory requirements and clinical guidelines, and to monitor the patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are documented in a patient's medical record. Medical professionals record information to ensure the continuity of care, to comply with legal and clinical guidelines, and to monitor the patient's progress over time. This documentation includes details such as the diagnosis of opioid dependence, dosage regimen, and duration of", "Question: Are opioid dependence and methadone maintenance treatment documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are documented in the medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and clinical guidelines, and to provide information about the patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in the medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and clinical guidelines, and to monitor the patient's progress over time. The documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and ethical requirements, and to monitor the patient's progress over time. This documentation includes details such as the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the patient's medical record? Answer:Yes, opioid dependence and methadone maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record this information to ensure the continuity of care, to maintain legal and clinical confidentiality, and to monitor the patient's progress over time. The documentation includes details regarding the diagnosis of opioid dependence, the dosage and duration of", "Question: Are opioid dependence and opioid maintenance treatment (MMT) documented in the medical record? Answer:Yes, opioid dependence and opioid maintenance treatment (MMT) are typically documented in a patient's medical record. Medical professionals record this information to ensure the continuity of care, to comply with legal and clinical guidelines, and to monitor the patient's progress over time. The documentation contains information such as the diagnosis of opioid dependence, prescription dosage s, and length of"], "perturbed_original": ["Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT in health care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that can interact with methadone. This study highlights the need for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients presenting and receiving MMT at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: What proportion of patients with documented opioid dependence and methadone maintenance therapy (MMT) was documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record is current for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that could potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with MMT. This data identifies opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: For patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is incomplete or missing for a substantial number of patients. Many of these patients are prescribed medications that potentially interact with methadone. This suggests opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? In a national survey of patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial portion of patients. Most of these patients are prescribed medications that potentially interact with methadone. This indicates opportunities for improved documentation and medical management in patients undergoing MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Among these patients are chronic pain medications that are administered along with methadone. This study highlights opportunities for improved documentation among patients receiving medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that may interact with opioids; therefore, this study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among clients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record is adequate for the majority of patients but is missing in a substantial number of patients. Some of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "or is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients take medications that potentially interact with MMT. The study highlights opportunities for improved coordination between medical care and MMT."], "original_ll": -4.341018877477778e-05, "sampled_ll": -0.0032264794593404264, "all_perturbed_sampled_ll": [-0.0038698705291570776, -0.009807893724333229, -0.0030483046926405933, -0.0030058739146173402, -0.003067219798027096, -0.00356965686680236, -0.004607648320694782, -0.003721757329462916, -0.003379328769366063, -0.003927271927175109], "all_perturbed_original_ll": [-7.594764169791208e-05, -4.31966748875862e-05, -5.086688515816327e-05, -5.149227145505618e-05, -0.00013971280251780222, -2.8240554378817206e-05, -2.5903483003296707e-05, -0.00010927882645433332, -8.555967101978262e-05, -0.003014072254213679], "perturbed_sampled_ll": -0.004200482587227657, "perturbed_original_ll": -0.00036242710647864287, "perturbed_sampled_ll_std": 0.0019269948852592114, "perturbed_original_ll_std": 0.0008845462608190132}, {"original": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "sampled": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "perturbed_sampled": ["Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:"], "perturbed_original": ["Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer:"], "original_ll": -0.0044866170180212495, "sampled_ll": -0.0034016823547125, "all_perturbed_sampled_ll": [-0.0037428209187837505, -0.00228631216229375, -0.0034461416960562498, -0.0037719674958962496, -0.00456723012688125, -0.0030606478485250004, -0.0046365355395, -0.0029635176565718747, -0.00339739843549375, -0.0033097314501124996], "all_perturbed_original_ll": [-0.0039413010759062495, -0.0032711191047981253, -0.004654036821001874, -0.003528213608865, -0.005974924062608749, -0.0033097314501124996, -0.0027136719021275, -0.0045792540200650005, -0.0031311280730050004, -0.004702420685615626], "perturbed_sampled_ll": -0.0035182303330114372, "perturbed_original_ll": -0.003980580080410563, "perturbed_sampled_ll_std": 0.0006755597492085022, "perturbed_original_ll_std": 0.0009379015042461118}, {"original": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "sampled": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "perturbed_sampled": ["Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment absolutely necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in the management Yes, expert breast pathology assessment is absolutely necessary for women? of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma", ". Question:Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer:Answer: Yes, expert breast pathology assessment is absolutely necessary for the management of ductal carcinoma"], "perturbed_original": ["Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast so for continue to be ? For the management of DCIS.", "Question: Does expert breast pathology assessment continue to be necessary in the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast ductal carcinoma continue to be necessary in the management of DCIS.", "Question: Is a pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert pathology assessments continue to be necessary in the management of DCIS.", "Is an expert breast pathology assessment necessary for the diagnosis and follow up of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management for the carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary for the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast management of patients with continue to be necessary in the of DCIS.", "Is an expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in breast pathology Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ breast pathology Expert ? assessments continue to be necessary in the management of DCIS."], "original_ll": -0.018982550239636284, "sampled_ll": -0.004064291246288888, "all_perturbed_sampled_ll": [-0.017157252227608204, -0.021490001037446922, -0.004632180060945945, -0.014415838658154413, -0.01039428250943128, -0.016976903367186668, -2.76452686078125e-05, -0.004096376932594, -0.02164979857544917, -0.003331060019527222], "all_perturbed_original_ll": [-0.04239801720654857, -0.00513281847305658, -0.014784841551658332, -0.01958093095447879, -0.015095253958756754, -0.014961079782351764, -0.007130023002427778, -0.014656267854393126, -0.005055697674575429, -0.007458874112644242], "perturbed_sampled_ll": -0.011417133865695164, "perturbed_original_ll": -0.014625380457089134, "perturbed_sampled_ll_std": 0.007581574059025001, "perturbed_original_ll_std": 0.010418557711616825}, {"original": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "sampled": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "perturbed_sampled": ["Question:Is endometrial polyp formation associated with increased secretion of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased secretion of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development transforming growth polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 endometrial polyps have shown that the pathological development of complex interaction involves a cell proliferation, vascular remodeling of . Studies and inflammatory factors, among which the role of VEGF", "Question:Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the development of endometrial polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased growth factor vascular endothelial polyps is controlled by (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial wide range a o of complex interactions of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "Question:Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the role of VEGF", "Question: Endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-<unk>1. Introduction: endometrial polyp formation associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial polyps involves a complex interplay of hormonal, vascular, and neural mechanisms, among which the role of VEGF", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of endometrial polyps involves a complex interplay of hormonal, vascular, and inflammatory factors, among which the production of VEGF", "Question: Is have shown formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies involves a that the pathological development of endometrial polyps between hormonal, complex interplay endometrial polyp vascular, and inflammatory factors, among which the role of VEGF", "Question: Is of vascular formation associated with increased expression endometrial polyps endothelial growth factor and transforming growth factor-beta1? Answer:Yes, endometrial polyp formation is associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-\u03b21). Studies have shown that the pathological development of cellular and involves a complex interplay of hormonal, is established.???????????????????????????????????? inflammatory factors, among which the role of VEGF"], "perturbed_original": ["Question: Was polyp formation associated with increased expression of vascular endothelial growth factor-beta1 and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid use and VEGF and TGF-\u03b21 expression.", "? Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in endometrial polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation factor and increased expression of vascular endothelial growth endometrial transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent role in tissue. It suggested that these cytokines might play a endometrial endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared with adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp development. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and -1 in polyp tissue factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF there was compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, , and VEGF-1 a significant correlation between steroid receptor expression and transforming growth and TGF-\u03b21 expression.", "in endometrial polyp formation with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in endometrial polyps compared to normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with factor and of vascular endothelial growth VEGF in transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and role in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a VEGF in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Why is polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Several recent studies report an increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these two factors might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp growth factor-<unk>1? with increased expression of vascular endothelial growth factor and transforming of TGF-<unk>1 Answer: There was increased expression may play and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines of TGF-<unk>1 a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression."], "original_ll": -0.0001531053698911458, "sampled_ll": -0.006205793175572323, "all_perturbed_sampled_ll": [-0.00752060252279818, -0.011748782289492166, -0.014034578415270869, -0.010741227414778332, -0.00868716921454559, -0.00889846399316384, -0.0017195490855234695, -0.005617458391893031, -0.01955553526920212, -0.007319393485186668], "all_perturbed_original_ll": [-9.291511758925532e-05, -0.00023134805346099999, -0.0006556996588817708, -0.00011860012749947918, -0.00019623607678182794, -0.001425395718362427, -0.0032548478313410003, -0.00011180094811428572, -0.000380513842541237, -0.0008025714336900935], "perturbed_sampled_ll": -0.009584276008185426, "perturbed_original_ll": -0.0007269928808262377, "perturbed_sampled_ll_std": 0.004620692352335796, "perturbed_original_ll_std": 0.000932023807935133}, {"original": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "sampled": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including evaluation of the", "perturbed_sampled": ["Question: Preparing patients at high risk of falls for discharge after rehabilitation: Does your approach meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the discharge plan align s with guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their own homes. This involves a comprehensive approach, including evaluation of the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention strategies are necessary to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including all levels of care in the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Before preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices follow established guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This is best achieved through a comprehensive approach, including evaluation of the", ": We are preparing patients at high risk of falls for discharge home after rehabilitation. Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including evaluation of the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to make sure that the care practices align with established guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a multidisciplinary approach, including evaluation of the", "? Question: When preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established clinical recommendations. Effective fall prevention planning is essential to minimize the risk of falls and ensure the safety of these patients in their home environment. Such planning requires a comprehensive approach, including evaluation of the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Are we meet our fall prevention goals? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including evaluation of the", "Question: Is there a need to prepare our patients at high risk of falls for discharge home after rehabilitation? Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether current practices align with current guidelines and recommendations. Effective fall prevention strategies are essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including evaluation of the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention is essential to minimize the risk of falls and ensure the safety of these patients in their home environment. This involves a comprehensive approach, including education of both the patient and caregiver of the", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer:Answer: When preparing patients at high risk of falls for discharge home after rehabilitation, it is crucial to assess whether the care practices align with established guidelines and recommendations. Effective fall prevention strategies are essential to reduce the risk of falls and ensure the safety of these patients in their home environment. This involves a multi-disciplinary approach, including evaluation of the"], "perturbed_original": ["Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There is little evidence that people at high risk of falls were offered a systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited the strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the highest standards? Answer: There was evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately assess patients' fall risk during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Risk assessment of older adults at high risk of falls for discharge home after rehabilitation: Do we need new guidelines? Answer: There was little evidence that older adults at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess all risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during rehabilitation may contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing persons at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. If risk was identified, generally a strategy was implemented. Most hospitals try to assess some risk but have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that patients at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during rehabilitation may contribute to worse falls outcomes. Geriatr Gerontol 2008; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge in adult rehabilitation: Do we need guidelines? Answer: There was little evidence that people at high risk for falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited the potential benefits of the strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2011; 14: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, a strategy was often implemented at discharge. The failure to assess fall risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. J Am Acad Orthop Int 2016; 16: 570-576.", "Question: Preparing older people at high risk of falls for independent living after rehabilitation: Do we meet the guidelines? Answer: There was little evidence of whether older people at high risk of falls received systematic falls risk assessment . When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls in later life. J Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk assessment was completed, generally a strategy was implemented. However, failure to assess some risk factors might affect the specific fall prevention strategies offered. Moreover, failure to adequately address risks during rehabilitation may contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the challenge? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy to minimise the risk was provided. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could result in an increased risk of falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576."], "original_ll": -0.00029731272657198106, "sampled_ll": -0.002827080158746591, "all_perturbed_sampled_ll": [-0.003403885091728523, -0.002104909029551319, -0.00031109415159965903, -0.014698468618175978, -0.002413499273484505, -0.00874645239110337, -0.003810760076804666, -0.003603186396880109, -0.0033312259108576347, -0.00425647242629989], "all_perturbed_original_ll": [-0.00023301838648420563, -0.00015269461248422017, -0.00023596480871962956, -0.0001750005912061765, -0.0003420677567445632, -0.00029792020195490746, -0.00018639522276698114, -0.002128446976014286, -0.0002637454563573393, -0.00044976972489201776], "perturbed_sampled_ll": -0.004667995336648565, "perturbed_original_ll": -0.0004465023737624327, "perturbed_sampled_ll_std": 0.0039153787394441576, "perturbed_original_ll_std": 0.0005668267010412922}, {"original": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "sampled": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "perturbed_sampled": ["Question: Could the extent of lymphadenectomy be modified by ? in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy ? by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: How can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be or neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the effectiveness of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be used before neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: ?x15d:x?x?x?x?x?x?xx?x?x?x?x?x?x?x?x??x?x?x?x?x?x?? extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:"], "perturbed_original": ["Question: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be modified by staging in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant therapy for cervical cancer? Answer:", "Question: Could the extent of the disease modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be modified with chemotherapy in cervical cancer? Answer:", "Answer: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be reduced by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer:", "Question: Could the extent of lymphadenectomy be modified by radiation therapy in cervical cancer? Answer:"], "original_ll": -0.0016992614005617388, "sampled_ll": -0.0011602723833226086, "all_perturbed_sampled_ll": [-0.005276219507944736, -0.04998462832449347, -0.015436943779021666, -0.027971880836360916, -0.0037754583991472727, -0.0029668629876369573, -0.0016350669647547827, -0.0015347725177934782, -0.0020653993886152176, -8.305974748477611e-05], "all_perturbed_original_ll": [-0.004274175515730435, -0.006109295961824783, -0.0063698855011815785, -0.003197922625677827, -0.01399274538019524, -0.0031704553170936846, -0.000806737223213913, -0.0013841254891104348, -0.0015984929848817388, -0.005665883545319], "perturbed_sampled_ll": -0.01107302924532533, "perturbed_original_ll": -0.004656971954422864, "perturbed_sampled_ll_std": 0.015340356095748154, "perturbed_original_ll_std": 0.0036413335571605114}, {"original": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "sampled": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "perturbed_sampled": ["Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with cel disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand ?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? colon cancer in patients with coronary artery disease? Answer:", "Question: : How can the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with ? disease? Answer:", "Question: Does the peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in s with coronary artery disease? Answer:", "Question: : Did the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary ? Answer:", "Question: Does the peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:"], "perturbed_original": ["Question: : Can the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated the drug bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the plasminogen proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer ?????????????????????????????????????????????????????????????????????????????????????????????????????? with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand ?.????????'?'''?'''?''?'''?''''?'''''''''''''''''''''''''''''''''''''' colon cancer in patients with coronary artery disease? Answer:", "Question: : Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent ? in patients with coronary artery disease? Answer:", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon ? patients with coronary artery disease? Answer:"], "original_ll": -0.001299017129407576, "sampled_ll": -0.0004612992426663637, "all_perturbed_sampled_ll": [-0.0063022533037096875, -0.01301354686865, -0.008242552417956765, -0.0007793912219234377, -0.0013086941042593334, -0.0013246952908306064, -0.01979765494704697, -0.008757660274076061, -0.017450942299599998, -0.002415996402667667], "all_perturbed_original_ll": [-0.008181454532850605, -0.00337190085702875, -0.0035827092950478116, -0.0005086334901356667, -0.00084536356789, -0.011096306810483228, -0.0009762513310357142, -0.008192947312458182, -0.000935967816186875, -0.0028095592439056254], "perturbed_sampled_ll": -0.007939338713072053, "perturbed_original_ll": -0.0040501094257022465, "perturbed_sampled_ll_std": 0.0065556891807773115, "perturbed_original_ll_std": 0.003578496047217753}, {"original": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "sampled": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "perturbed_sampled": ["Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:"], "perturbed_original": ["Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer:"], "original_ll": -0.002139243961079444, "sampled_ll": -0.0023439919194516664, "all_perturbed_sampled_ll": [-0.0023533058722377776, -0.0017231240980083331, -0.0024015557439866666, -0.0017240269897277776, -0.0024258093203388892, -0.001511394065261111, -0.0017344716744055555, -0.0017457650527816667, -0.0020142003647805554, -0.0017283164845277776], "all_perturbed_original_ll": [-0.002404104060896667, -0.001736853713483333, -0.0026005546868888897, -0.001639828740625, -0.0018562472256316665, -0.002664502299238889, -0.002104915410552222, -0.0034053656061244445, -0.0017831671869355556, -0.0013037353962183334], "perturbed_sampled_ll": -0.001936196966605611, "perturbed_original_ll": -0.0021499274326595, "perturbed_sampled_ll_std": 0.0003205290581919856, "perturbed_original_ll_std": 0.000589766202906533}, {"original": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "sampled": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "perturbed_sampled": ["Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:"], "perturbed_original": ["Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer:"], "original_ll": -0.002687586935760526, "sampled_ll": -0.0073410178580789465, "all_perturbed_sampled_ll": [-0.001089267085810526, -0.0009967532905368424, -0.0032105633172705263, -0.002003047787963158, -0.0015423914393973685, -0.001559992483081579, -0.0015453645889157896, -0.0015423914393973685, -0.0029040287720684213, -0.0032170892889336845], "all_perturbed_original_ll": [-0.005642815953331578, -0.007362481038810526, -0.003435840527305263, -0.002025762990273684, -0.0015792776412736846, -0.003322121054438947, -0.0014972136302278947, -0.007284909374821053, -0.0028897188035210534, -0.002991670193021053], "perturbed_sampled_ll": -0.0019610889493375267, "perturbed_original_ll": -0.0038031811207024737, "perturbed_sampled_ll_std": 0.0008002472152983293, "perturbed_original_ll_std": 0.002084636014101255}, {"original": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "sampled": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "perturbed_sampled": ["Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:"], "perturbed_original": ["Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer:"], "original_ll": -0.001747687137827, "sampled_ll": -0.001747687137827, "all_perturbed_sampled_ll": [-0.0020093725071645002, -0.0016510301423115002, -0.001364330020797, -0.0035973584751894994, -0.001340085802755, -0.0014863950962925, -0.0013156111856975, -0.0035153424427674996, -0.002772306196119, -0.0035412146370414994], "all_perturbed_original_ll": [-0.001341939075255, -0.001340085802755, -0.001448563520722, -0.0018035807387819995, -0.0014074692468875, -0.001422185400912, -0.001435522711125, -0.001340085802755, -0.001774130107645, -0.0027300359614165], "perturbed_sampled_ll": -0.0022593046506135498, "perturbed_original_ll": -0.0016043598368254998, "perturbed_sampled_ll_std": 0.0009402572062321465, "perturbed_original_ll_std": 0.000408526098677734}, {"original": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "sampled": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "perturbed_sampled": ["Question: Question: 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and other mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of unmet need for improvement? Answer:", "Question: 30-Day and 1-year results of emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and :?????????????????????????????????? improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an  concern and need for improvement? Answer:", "Question: 30-Day and 12-month mortality rates in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency : laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency ? laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 30-day mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:"], "perturbed_original": ["Question: 30-Day and 365-Day mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 60-Day mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "rate and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general medicine an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general .: an area of concern and need for improvement? Answer:", ". Question: 30 day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "? Question: In-hospital and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year survival rates following emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality following emergency general surgery laparotomies: an area of concern and need for improvement? Answer:", "Question: 30-Day and 1-year mortality in emergency general surgery ? What is the area of concern and need for improvement? Answer:"], "original_ll": -0.00350416120784, "sampled_ll": -0.004099820685999355, "all_perturbed_sampled_ll": [-0.009444661886293703, -0.005038403701222413, -0.003487094419810968, -0.003330140781409678, -0.015728577349643103, -0.015484318977187933, -0.005457410481042813, -0.012522186416910002, -0.021638223172539994, -0.0023212801185670965], "all_perturbed_original_ll": [-0.0034776926791354845, -0.0026644000657403233, -0.0031979790671295997, -0.0051335747892832006, -0.006799441436984231, -0.004836484635360968, -0.005028299444430624, -0.005806928962327188, -0.0017216516964177419, -0.016595207062638572], "perturbed_sampled_ll": -0.00944522973046277, "perturbed_original_ll": -0.005526165983944793, "perturbed_sampled_ll_std": 0.006269409648526394, "perturbed_original_ll_std": 0.0039671415183450565}, {"original": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "sampled": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has emerged as a potent diagnostic tool, offering detailed images of the body's structures, and it has made significant", "perturbed_sampled": ["Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has body, a potent diagnostic tool, offering detailed images of the strides in breast cancer diagnosis...................................................................................................................................................................... and it has made significant", ". Question:Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has emerged as a potent tool for offering detailed images of the body's structures, and it has made significant", "Question: Can computerised tomography replace bone scintigraphy in detecting allowing rapid generation of detailed from breast cancer? Answer:Computerized tomography (CT) has emerged as a potent diagnostic tool, ..?...??.?.???.??.?.??.?.??? eta??.???. images of the body's structures, and it has made significant", "Question: Can computerised tomography replace bone scintigraphy in as a metastases from breast cancer? Answer:Computerized tomography (CT) has emerged a potent diagnostic tool, offering detailed images of the body's structures, and it has made significant", "Question: Can computerised tomography replace bone scintigraphy in detecting providing from breast cancer? Answer:Computerized tomography (CT) has emerged as a potent diagnostic tool, use in cancer screening.?.???????.?.??????????????????????? images of the body's structures, and it has made significant", "Question: Can computerised tomography replace conventional bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has established itself as a potent diagnostic tool, offering detailed images of the body's structures, and it has made significant", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has emerged as a capturing detailed three-dimensional tool, .s images of the body's structures, and it has made significant", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has emerged as a cellular tool, offering detailed images of contributions to tumor imaging and treatment.?.?????????.??????????????...??????????? structures, and it has made significant", "Question: Should bone computed tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Question: Bone computed tomography (CT) has emerged as a potent diagnostic tool, offering detailed images of the body's structures, and it has made significant", "Question:Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:Computerized tomography (CT) has become a potent diagnostic tool, offering detailed images of the body's structures, and it has made significant"], "perturbed_original": ["Question: Can computerised tomography cancer? scintigraphy in detecting bone metastases from breast ? Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting osteoblastoma from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is no longer required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography cancer? scintigraphy in detecting bone metastases from . Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastasis from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is unnecessary if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting metastatic bone disease arising from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC may be required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography (CT) replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT abdomen, and even BS has been performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS only the spine (shoulder, presenting with MBC is not required if . abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our experience has shown that routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, pelvis) is performed."], "original_ll": -0.0004976132891077358, "sampled_ll": -0.008145258535590769, "all_perturbed_sampled_ll": [-0.021552468351512456, -0.01114955732881865, -0.027153776364210284, -0.01630432936722725, -0.047948707377537855, -0.005823911605271852, -0.009334498581359816, -0.009754748348785524, -0.00022436693878365388, -0.006723550924252156], "all_perturbed_original_ll": [-0.0021664465917302003, -0.0001785652447881818, -0.0018298792430072551, -0.0003833141140234615, -0.00026291862572509094, -0.0004041479484296227, -0.0008632866776634546, -0.0006641289516827083, -0.0007499588722411322, -0.00033681209053222215], "perturbed_sampled_ll": -0.015596991518775949, "perturbed_original_ll": -0.0007839458359823329, "perturbed_sampled_ll_std": 0.01311434232238503, "perturbed_original_ll_std": 0.0006457342342305361}, {"original": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "sampled": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules within tissue, has shown promise in the evaluation of various pathologies, including tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to the implications for treatment and prognosis.\n\nPrimary parotid", "perturbed_sampled": ["Question: Echo-planar MR imaging of primary parotid gland tumors: is differentiation of different histologic subtypes possible? Abstract: High-field echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules within tissues, has shown promise in the evaluation of various malignant tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to the implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of ionized water within tissue, has shown promise in the evaluation of various pathologies, including tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to its implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a distinction between different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a new MR imaging technique that measures the random Brownian motion of water molecules within tissue, has shown promise in the evaluation of various pathologies, including those of the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules in a sample, has shown promise in the evaluation of breast cancer, including tumors in the parotid gland. The question of whether this imaging method can identify different histologic subtypes of primary parotid gland tumors is significant due to the implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the Brownian motion of water molecules within tissue, has shown promise in the evaluation of various pathologies, including tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to the implications for management and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules within tissue, has shown promise in the evaluation of various histologies of tumors in the parotid gland. The question of whether this method can differentiate between different histologic subtypes of primary parotid gland tumors is of significant importance due to the implications for treatment and prognosis.\n\nPrimary parotid", "-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules within tissue, has shown to be useful in the evaluation of various pathologies, including tumors in the head and neck. The question of whether this imaging method can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a method that measures the random Brownian motion of water molecules , has shown its effectiveness in the evaluation of tumors, including tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of parotid gland tumors is significant due to the implications for treatment and prognosis.\n\nPrimary parotid", "Question: Diffusion-weighted echo-planar MR imaging of parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the dynamic motion of water molecules in tissue, has shown promise for the evaluation of various pathologies, including tumors in the parotid gland. The question of whether this imaging method can differentiate between different histologic subtypes of parotid gland tumors is significant due to the implications for treatment and prognosis.\n\nPrimary parotid", "q. Diffusion-weighted echo-planar MR imaging in primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer:Answer: Diffusion-weighted echo-planar MR imaging, a technique that measures the random Brownian motion of water molecules within tissue, has been used in the evaluation of various pathologies, including tumors in the parotid gland. The question of whether this imaging technique can differentiate between different histologic subtypes of primary parotid gland tumors is significant due to the implications for the prognosis.\n\nPrimary parotid"], "perturbed_original": ["Question: Using DWI in MR imaging of salivary gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas , among other examined entities. Due to an ambiguity that exists not only within the study population between benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, multidimensional assessment combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland : Is a prediction of clinical subtypes possible? Answer: epiDWI has the potential to differentiate mesenchymal and myoepithelial adenomas from all other entities. Due to an overlap not only within the group of benign and malignant lesions but also between the subgroups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining epiDWI, clinical criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of adrenal gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to the wide variation in ADC values not only within the group of benign and malignant entities but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and other MR imaging techniques seem warranted.", ". Question: On the basis of echo-planar MR imaging of primary parotid gland s, is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential of differentiation of pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap of histologic entities within the group of benign and malignant lesions and between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, multimodal diagnosis combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and benign congenital adenomas from all other examined entities. However, due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses cannot be addressed on the basis of ADC values solely. Therefore, further studies combining epiDWI with histological criteria, immunohistochemistry, and other MR imaging techniques seem warranted.", "diffusion-weighted imaging with echo-planar mapping (epidWI) of primary adrenal tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other adenomas. Due to overlap not only within the groups of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different outcomes possible? Answer: epiDWI has the potential to differentiate parotid and myoepithelial adenomas from all other examined entities. Nevertheless, due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be based on DWI alone and clinical assessments should not be made on the basis of ADC values solely. Therefore, strategies combining DWI, morphologic criteria, and other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: Is the prediction of different histologic subtypes possible? Answer: epiDWI has the potential to discriminate pleomorphic adenoma and myoepithelial adenomas from other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be made on the basis of ADC values solely. Therefore, further investigations of the relationship between epi DWI, morphologic criteria, and other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of histological subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to considerable overlap not only within the group of benign and malignant lesions but also with other groups, diagnoses cannot be addressed on the basis of DWI solely. Therefore, further studies combining DWI, epiDWI and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI showed potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only between the group of predominantly malignant lesions but also between groups of less malignant lesions, diagnoses should not be made on the basis of ADC values alone; further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted."], "original_ll": -0.0009969110378145534, "sampled_ll": -0.008370489277555175, "all_perturbed_sampled_ll": [-0.0013919071183402883, -0.010077612630634175, -0.012487046326549223, -0.007393125763991062, -0.007105253888396519, -0.005811232985547633, -0.2968224890726616, -0.006213458224962937, -0.004709350259063, -0.014950549789655944], "all_perturbed_original_ll": [-0.0014471367226105356, -0.0018329383447606303, -0.0006031859702997323, -0.004217003703599653, -0.0008390134734694017, -0.005017938372152053, -0.00025692204692529403, -0.0011425724596082609, -0.0003279477227081982, -0.0008102344853467856], "perturbed_sampled_ll": -0.036696202605980235, "perturbed_original_ll": -0.0016494893301480546, "perturbed_sampled_ll_std": 0.08678716294602638, "perturbed_original_ll_std": 0.0015624285656292915}, {"original": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "sampled": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "perturbed_sampled": ["Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Is radical cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is operative cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is was an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:"], "perturbed_original": ["Question: Is cholecystectomy really an indication for concomitant splenectomy in hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is bilateral cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is cholecystectomy really an indication for concomitant , mild hereditary spherocytosis? Answer:", "Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is cholecystectomy really an indication for concomitant splenectomy ?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? hereditary spherocytosis? Answer:", "Question: Is there really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer:", "Question: Is cholecystectomy really an indication of splenectomy in mild hereditary spherocytosis? Answer:"], "original_ll": -0.0010391749013931035, "sampled_ll": -0.0007261683010431035, "all_perturbed_sampled_ll": [-0.0003409891258088461, -0.00045579073269413797, -0.0006865961283023078, -0.00015772156985038462, -0.0003477289207857692, -0.000291291144776, -0.00035189258851192303, -0.00039858113950230767, -0.0010357576367151999, -0.0006668777908434615], "all_perturbed_original_ll": [-0.0014869692833699999, -0.00024024729711269232, -0.0005296093545896154, -0.00035442771962307693, -0.00021717722606966663, -0.008609030693555385, -3.724198809e-05, -0.03747628023407001, -0.00033652862576653847, -0.0003626342352], "perturbed_sampled_ll": -0.00047332267777903383, "perturbed_original_ll": -0.0049650146657446975, "perturbed_sampled_ll_std": 0.00024206335159474642, "perturbed_original_ll_std": 0.011113242069093011}, {"original": "Question: Does menopausal transition affect the quality of life? Answer:", "sampled": "Question: Does menopausal transition affect the quality of life? Answer:", "perturbed_sampled": ["Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:"], "perturbed_original": ["Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:", "Question: Does menopausal transition affect the quality of life? Answer:"], "original_ll": -0.007341248950666667, "sampled_ll": -0.007283405857660001, "all_perturbed_sampled_ll": [-0.00877004245404, -0.012601002580245999, -0.008505749634488666, -0.018651068436633333, -0.0076291397156653335, -0.012567118862140002, -0.007596711001326667, -0.007440770210048669, -0.007582129955573333, -0.007635275466593334], "all_perturbed_original_ll": [-0.007610030952636669, -0.014357300979856668, -0.011910035555309333, -0.012666900625846666, -0.011024408682473338, -0.015486991330673331, -0.007252149131059999, -0.007842061473685335, -0.007444788363193333, -0.007370200156513334], "perturbed_sampled_ll": -0.009897900831675533, "perturbed_original_ll": -0.010296486725124801, "perturbed_sampled_ll_std": 0.0034816962442962957, "perturbed_original_ll_std": 0.003023051416762916}, {"original": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "sampled": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "perturbed_sampled": [". Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the  80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients aged 80 or older after acute hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients aged 80 or older after the hemorrhage? Answer:", "Question: Is percutaneous repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm  for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients , or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is surgery justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm ?:ssss?ss.s.ss.s.ss.ss.s.ss.s.?s?s?s?ss?s?s?s?s?s?s?s?s?s?s? for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair ? Question:sss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:"], "perturbed_original": ["Question: Is it justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients aged 80 ? Question:s?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair s?suivresuivresuivre?suivre?suivre?suivre?suivre?suivre?suivre?suivre?suivre?suivre?suivre? the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is MRI guided repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients aged 80 .s.ss.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair mandatory for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", ". Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified ? patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair justified for the patients aged ? older after aneurysmal subarachnoid hemorrhage? Answer:", "Question: Is aneurysm repair ?suppression.suppression.suppression.suppression.suppressionsuppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression.suppression the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer:"], "original_ll": -0.0005211867056759375, "sampled_ll": -0.00035822836468937493, "all_perturbed_sampled_ll": [-0.002476957498531875, -0.002977635603604667, -0.0013147155900845831, -0.0012435738316379167, -0.0005620613230609676, -0.018221376699581, -0.02688467929416633, -0.001663657530025, -0.0008003678764891669, -0.018024205144774687], "all_perturbed_original_ll": [-0.008029023198774642, -0.012943110777140514, -0.007317218033390987, -0.0009450653009796666, -0.0037051589074374573, -0.0008165810844275, -0.0016939064945740627, -0.014631615865966775, -0.0071514284671763345, -0.016322381367873333], "perturbed_sampled_ll": -0.00741692303919562, "perturbed_original_ll": -0.0073555489497741265, "perturbed_sampled_ll_std": 0.00922805445490198, "perturbed_original_ll_std": 0.005424893793058764}, {"original": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "sampled": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "perturbed_sampled": ["Question: Sternal fractures in growing children : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are considered very rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fracture in growing children : A rare and frequently overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents or indirect trauma from a fracture of the thorax. Due to", ". Sternal fracture in growing children : A rare and often overlooked injury. Pediatric sternal fractures in growing children are considered rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle crashes, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fracture in growing children : A rare and potentially overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and can frequently be overlooked. These fractures typically result from direct trauma, such as motor vehicle accidents, or indirect trauma , such as compression of the thorax. Due to", "Question: Sternal fractures in growing children : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and can frequently be overlooked. These injuries result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are very rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the vertebral column due to", "Question: Sternal fracture in growing children : is it common and cause for concern? Does my child have a fracture? Answer:Yes, sternal fractures in children are considered rare and can frequently be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fracture in growing children : a common, common and often overlooked fracture? Answer:Yes, sternal fractures in children are considered rare and can frequently be missed. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fractures in growing children : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and can frequently be overlooked. These fractures typically result from high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to", "Question: Sternal fracture in growing child : A rare and often overlooked fracture? Answer:Yes, sternal fractures in growing children are considered rare and often be overlooked. These fractures typically result from direct high-energy trauma, such as motor vehicle accidents, or indirect trauma from severe compression of the thorax. Due to"], "perturbed_original": ["Question: Sternal fracture in children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related trauma. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the depth of the dislocation.", "Question: Sternal fractures in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to simple traumatic incidents. Physical examination is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and unusual fracture? Answer: Isolated sternal fractures in growing children are rare and are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children is a rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are uncommon and are usually due to typical age-related traumatic incidents. Ultrasonography is a good tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture s in children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in children are extremely rare and often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fractures in growing children: A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children: A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection , and MRI is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing infants: A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and should be the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children is a relatively rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to a traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", ". Title: Isolated sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful aid for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation."], "original_ll": -0.008302622118950782, "sampled_ll": -0.019976159832991565, "all_perturbed_sampled_ll": [-0.010774979717082, -0.011114385053914284, -0.010112033143898984, -0.009891433119612063, -0.008971074563581904, -0.012950135678579689, -0.006369326460080565, -0.010705771866213538, -0.014399128602768575, -0.017999036586623805], "all_perturbed_original_ll": [-0.011126809158346452, -0.00893948544066508, -0.009418554947411492, -0.0003238362958698484, -0.005465605061068636, -0.00017829159184096772, -0.0023442039310765626, -0.0005583618033180953, -0.009258616736916612, -0.023178313275976924], "perturbed_sampled_ll": -0.01132873047923554, "perturbed_original_ll": -0.007079207824249067, "perturbed_sampled_ll_std": 0.0030164606755736017, "perturbed_original_ll_std": 0.006708579371182738}, {"original": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "sampled": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "perturbed_sampled": ["Question: Emergency double-balloon enteroscopy combined in pericardial viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time video-guided capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure :,?????????????????????????????????.???????????????? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time ?ction:ction:ctionction?ction:ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction?ction capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "oscopic double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a :es?ssss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?? approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time ?:.??????????????\u00e0?regarder??????regarder???n???????????? capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time viewing dual-photon endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", ". Live double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy + real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:"], "perturbed_original": ["endoscope vs. double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "and double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy on real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "oscopic approach. Answer: Single- and double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy : real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", ", double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon ?..??.?.?.?.?.?.?.?.??.??.??.??.??.??.??.??.??.?????? with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon ??????????????cn??cn?cn?cn?cn?cn?cn??cn??cn???? with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach ?????????????????????????????????????????????????????? overt-obscure gastrointestinal bleeding? Answer:", "Question: Emergency .:.???????????????????????????????????? combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer:"], "original_ll": -0.005917846847916857, "sampled_ll": -0.004409905919453428, "all_perturbed_sampled_ll": [-0.004850844275541892, -0.006358115534542223, -0.11379309810705979, -0.004849270976090611, -0.0003406562577416129, -0.014205366858761904, -0.002779463305030926, -0.002125388444587778, -0.007437345843129678, -0.003183705867854412], "all_perturbed_original_ll": [-0.0022426956860638237, -0.0003464474859590322, -0.006698214296274117, -0.004531216540689394, -0.01260268183541853, -0.014405698784980001, -0.005856088198622903, -0.0016413128030433961, -0.023197954380674998, -0.001115630499508], "perturbed_sampled_ll": -0.015992325547034086, "perturbed_original_ll": -0.007263794051123419, "perturbed_sampled_ll_std": 0.032799996109666114, "perturbed_original_ll_std": 0.006968857942461181}, {"original": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "sampled": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "perturbed_sampled": ["Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a crucial and important aspect of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and necessary information, there are significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between primary care physicians and family caregivers of the frail elderly is a critical aspect of healthcare that warrants significant attention. While there are instances where physicians are meeting the needs of these caregivers, offering care and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of the caregiver experience and warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of family caregivers, offering support, guidance, and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a rapidly evolving segment of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers by providing support, guidance, and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? The relationship between physicians and family caregivers of the frail elderly is a critical component of family healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and assistance, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of healthcare that demands attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and necessary information, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical link in healthcare that warrants a thoughtful evaluation. While there are instances where physicians meet the needs of these caregivers, offering support, guidance, and educational sessions, there are also significant gaps that need to be addressed.\n\nMany", "Question: How are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and necessary referrals, there are also significant gaps that need to be addressed.\n\nMany", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer:Answer: The relationship between physicians and family caregivers of the frail elderly is a critical aspect of healthcare that warrants attention. While there are instances where physicians effectively meet the needs of these caregivers, offering support, guidance, and education, there are also significant barriers that need to be addressed.\n\nMany"], "perturbed_original": ["Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be reluctant to spend time helping caregivers; even if they were receptive to counseling , they could be poorly remunerated for the types of services that are usual for caregivers; and being a professional physician in a society of family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the many counseling sessions that are usual ; and the task of serving as professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses regarding the origin of caregiver discontent are presented. Physicians might be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling that are usual for caregivers; and being a professional caregiver to family caregivers is not considered a profession in itself.", "Question: Are physicians meeting the needs of family caregivers of the elderly? Answer: The results of a study are unsatisfactory, and three reasons for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they may be poorly prepared to provide the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to helping caregivers, they could be unprepared for the types of demands that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: I have no way of knowing this at the time this question was presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the kind of counseling and care that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were interested in counseling caregivers, they may be poorly remunerated for the types of counseling sessions that are usual for caregivers; and acting as a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were to provide counseling , physicians could be poorly remunerated for the types of counseling sessions that are often necessary for caregivers; and being a professional provider of care for family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are that physicians may be uninterested in counseling family caregivers; even if they were receptive to counseling caregivers, they could be unwilling to make time for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family members can be demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Hypotheses for this are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they may be poorly remunerated for the types of counseling sessions that would help in this regard. Family members may have no resources to look for caregivers; and being a professional caregiver to family caregivers is demanding in itself."], "original_ll": -4.583737331223684e-05, "sampled_ll": -0.0035754428648967114, "all_perturbed_sampled_ll": [-0.00355707595508446, -0.004924281235860686, -0.0035331741106107996, -0.006042072829546163, -0.0030142536630267565, -0.000688038236156479, -0.003529921528053013, -0.004721123663412163, -0.003313880996301217, -0.004106704940973611], "all_perturbed_original_ll": [-0.0031706668148458973, -0.005747811368927895, -6.631568959049383e-05, -5.835878463273809e-05, -6.0151079465205474e-05, -9.654665895385542e-05, -4.103106712285714e-05, -0.0015045200200592308, -5.5066588259090905e-05, -7.10972268415294e-05], "perturbed_sampled_ll": -0.0037430527159025354, "perturbed_original_ll": -0.001087156529869879, "perturbed_sampled_ll_std": 0.0013394839006892168, "perturbed_original_ll_std": 0.0018320880025625293}, {"original": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "sampled": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "perturbed_sampled": ["Question: Pap smears with glandular cell abnormalities: Are they detected by  Answer:", "with tumors versus smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they all detected by rapid prescreening? Answer:", "Question: Pap smears with abnormal abnormalities: Are they detected by rapid prescreening? Answer:", "on pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "or smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "follicle smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they detected by ? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they detected by ? Answer:", "Question: Pap smears with glandular cell abnormalities: Are ?sss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s by rapid prescreening? Answer:"], "perturbed_original": ["Question: Pap smears Are cell abnormalities: Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they ??s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?? rapid prescreening? Answer:", "Question: Pap smears with glandular  Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they detected by ? Answer:", "Question: Pap smears e cell abnormalities: Are they detected by rapid prescreening? Answer:", ": PSA smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer:", "Question: Pap smears with ?.s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?. abnormalities: Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell abnormalities: Are they detected by ? Answer:", "Question: Pap smears with glandular cell mutations? Are they detected by rapid prescreening? Answer:", "Question: Pap smears with glandular cell hyperplasia are they detected by rapid prescreening? Answer:"], "original_ll": -0.0025221662916045454, "sampled_ll": -0.0024358463392613636, "all_perturbed_sampled_ll": [-0.029710369118041174, -0.0019449514819727272, -0.0014263028771478263, -0.0017634915487865002, -0.01005911426082857, -0.0014563202031250002, -0.006268574407314999, -0.008074145627491112, -0.009650813346385, -0.012512211209413726], "all_perturbed_original_ll": [-0.00285248001222, -0.002314352638104, -0.024643810100610525, -0.007908956566594443, -0.0049542341076225, -0.018655848053716666, -0.006820414974180769, -0.009650813346385, -0.0030748815611672735, -0.005208658588226956], "perturbed_sampled_ll": -0.008286629408050663, "perturbed_original_ll": -0.008608444994882813, "perturbed_sampled_ll_std": 0.008139029246967588, "perturbed_original_ll_std": 0.007008102240042006}, {"original": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "sampled": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "perturbed_sampled": ["Question: Question: Does surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does airway resistance and serum lipid levels in obstructive sleep apnea patients? Answer:", "). Question: Does upper airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", ". Question: Can upper airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does  lower serum lipid levels in obstructive sleep apnea patients? Answer:", ". Question: Can airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does upper airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does airway surgery lower serum lipid levels in obstructive sleep  Answer:", "Question: Does airway . serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does airway surgery lower serum lipid s in obstructive sleep apnea patients? Answer:"], "perturbed_original": ["Question: Does surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does LES surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Can surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Does upper airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does airway surgery lower serum lipid levels in ? apnea patients? Answer:", ". Question: Can airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", ". Question: Does upper airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does not lower serum lipid levels in obstructive sleep apnea patients? Answer:", "Question: Does airway surgery lower serum lipid levels in obstructive . patients? Answer:"], "original_ll": -0.0036472567193159998, "sampled_ll": -0.0020681722720240006, "all_perturbed_sampled_ll": [-0.0070900166089555555, -0.04643005826282699, -0.0005499535711945454, -0.0045209506194614285, -0.03556309222886471, -0.005746956195623, -0.001688076598062381, -0.054450887881046864, -0.0034255963779763155, -0.022864022785162502], "all_perturbed_original_ll": [-0.0024625313857683335, -0.0014049110486778946, -0.0029371912735550003, -0.0009530092738529411, -0.022573548880787775, -0.003482386457029999, -0.011759644573361431, -0.02485424308689167, -0.0024953322863644446, -0.020694045339749997], "perturbed_sampled_ll": -0.018232961112917428, "perturbed_original_ll": -0.00936168436060395, "perturbed_sampled_ll_std": 0.019241516198784607, "perturbed_original_ll_std": 0.009237677059871906}, {"original": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "sampled": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "perturbed_sampled": ["Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:"], "perturbed_original": ["Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer:"], "original_ll": -0.00906005072992, "sampled_ll": -0.007403732378163158, "all_perturbed_sampled_ll": [-0.007123602471087896, -0.004103632176453684, -0.007123602471087896, -0.0039331270206273685, -0.007481644344404735, -0.005989250944627368, -0.007736830657036844, -0.008194389627760527, -0.006014732493236842, -0.00971558932195263], "all_perturbed_original_ll": [-0.005989433782012104, -0.00299293799252, -0.00397424632332579, -0.005954952960006842, -0.006748119896754738, -0.006914386850456841, -0.004035881773236843, -0.00822025854423316, -0.0031553527473157893, -0.007926086449793686], "perturbed_sampled_ll": -0.00674164015282758, "perturbed_original_ll": -0.005591165731965579, "perturbed_sampled_ll_std": 0.0016948737955718217, "perturbed_original_ll_std": 0.001829254172536064}, {"original": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "sampled": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "perturbed_sampled": ["Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and disc patients multiple sclerosis (MS)", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", ". Question:Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "Question: Is there any relation between cervical cord plaques and discopathy in patients between cervical sclerosis? Answer:Answer: The relationship ..?????????????????????.?.????????????? cord plaques and discopathy in patients with multiple sclerosis (MS)", "Answer:Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "Question: Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: cervical cord between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)", "Question: Is there any relation between cervical cord plaques and discopathy in patients with ?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s??s?s?s?? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients ? sclerosis (MS)", "Answer:Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer:Answer: The relationship between cervical cord plaques and discopathy in patients with multiple sclerosis (MS)"], "perturbed_original": ["Question: Is there any relationship between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between  plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: cervical cord data suggests a possible correlation between cervical discopathy and ???????????????.??.??????? plaque.", "Question: Is in patients relation between cervical cord plaques and discopathy there a with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord lesion and cervical discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy discopathy with multiple sclerosis? Answer: The study data suggests a possible correlation between MS and cervical MS plaque.", "multiple sclerosis? 3. Is there any relation between cervical cord plaques and discopathy in patients with MS? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any correlation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque."], "original_ll": -0.00028037717168473696, "sampled_ll": -0.0021017845344967504, "all_perturbed_sampled_ll": [-0.017432054317906762, -0.0025517363385429994, -0.020186829141111997, -0.00869526223399, -0.055656170865977996, -0.01501948187528477, -0.019467378522816665, -0.0019354505422992502, -0.01219303382193167, -0.017357876622776096], "all_perturbed_original_ll": [-0.0003553845481018421, -0.0015147660642402861, -0.019650301920467694, -0.00039494793261184207, -0.0003709431041760526, -0.0004470245601336111, -0.00132508986996875, -0.0004147177343549999, -0.0003248139337408107, -0.00031712972952210536], "perturbed_sampled_ll": -0.017049527428263822, "perturbed_original_ll": -0.0025115119397317994, "perturbed_sampled_ll_std": 0.014291692055717311, "perturbed_original_ll_std": 0.005728050284963812}, {"original": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "sampled": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to potential implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "perturbed_sampled": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: Is prevention of osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to potential implications on cancer prognosis. The question of whether prevention of osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is required for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Acute musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to potentially serious implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme Aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors undergoing adriamycin therapy. These symptoms can significantly impact the quality of life and response to treatment, leading to significant implications on physical activity and functional status. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms often negatively impact the quality of life and adherence to treatment, leading to potential implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms - Is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to increased risk of drug toxicity and further implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, the enzyme responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are the most common adverse side effect experienced by many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can negatively impact the quality of life and adherence to treatment, leading to potential implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors receiving aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to potentially adverse implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and investigation. Aromatase inhibitors work by inhibiting the enzyme aromatase, which is involved in converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect for many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can impact the quality of life and adherence to treatment, leading to potential implications on outcomes. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms \u2013 Is preventing osteoporosis the key to eliminating these symptoms? Answer:Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many breast cancer survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, with potential implications on outcomes. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens", "Question: Aromatase inhibitor-related musculoskeletal symptoms - is preventing osteoporosis the key to eliminating these symptoms? Aromatase inhibitor-related musculoskeletal symptoms are a common and challenging side effect experienced by many cancer patients and survivors undergoing aromatase inhibitor therapy. These symptoms can significantly impact the quality of life and adherence to treatment, leading to potential implications on cancer prognosis. The question of whether preventing osteoporosis is the key to eliminating these symptoms is an area of ongoing research and debate.\n\nAromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens"], "perturbed_original": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk for musculoskeletal symptoms and fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who had received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be given Ca/Bis to reduce the incidence of symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Prescription of Ca/Bis reduces the risk of osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if they are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients receiving AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients receive steroidal AI s and do not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: Is treatment of osteoporosis key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication of AIs reduces the incidence of osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered tamoxifen to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-associated musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the risk for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis as part of comedication to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to reducing these symptoms? Answer: Patients on AIs who have osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for AI-related musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal osteoporosis therapy or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the most important step in eliminating these symptoms? Answer: Patients on AIs who are receiving steroidal anti-inflammatory drugs (NSAIDs) are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if they are receiving steroidal agents or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and fracture. Comedication with Ca/Bis reduces the risk for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. It is recommended that patients on AIs be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen prior to being on AIs.", "and angiotensin-converting enzyme inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of fracture and bone loss. Treatment with Ca/Bis reduces the likelihood of fracture and musculoskeletal symptoms. Patients on AIs who had received tamoxifen before AIs were less likely to develop AI-related symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with calcium/bicarbonate decreased the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. These data suggest that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and bone fractures if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs."], "original_ll": -0.0006667594094834074, "sampled_ll": -0.00763566872631143, "all_perturbed_sampled_ll": [-0.008732155075549364, -0.005707040632787621, -0.006432575933228825, -0.006789622818410713, -0.006270187501322518, -0.006704996785035633, -0.006437640709423622, -0.006003129977027641, -0.006486477358499836, -0.005506260578990241], "all_perturbed_original_ll": [-0.0006414142333499243, -0.0006171838219054136, -0.004653223790719851, -0.0002629033804327612, -0.00044313219244630444, -0.0003269548945891852, -0.000749825811272837, -0.0003953734957270074, -0.00046674409349129766, -0.0003008728705979412], "perturbed_sampled_ll": -0.006507008737027602, "perturbed_original_ll": -0.0008857628584532524, "perturbed_sampled_ll_std": 0.0008386026391028458, "perturbed_original_ll_std": 0.001264846972289549}, {"original": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "sampled": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "perturbed_sampled": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:"], "perturbed_original": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer:"], "original_ll": -0.0021497432483452627, "sampled_ll": -0.0021035189553815794, "all_perturbed_sampled_ll": [-0.002704781765736842, -0.0017122007803631579, -0.001451732181778421, -0.0015743450764157897, -0.0014622038275394736, -0.0017896456612484213, -0.0017001667730052632, -0.0026109877879573686, -0.0015102667886263154, -0.001576994287741053], "all_perturbed_original_ll": [-0.0017371986224352632, -0.0020879002704999997, -0.0015516348993542105, -0.0021768168125042096, -0.002070741582334211, -0.0020165573909363154, -0.001557647530623158, -0.0014622449601736842, -0.0017418235194605262, -0.0017001667730052632], "perturbed_sampled_ll": -0.0018093324930412106, "perturbed_original_ll": -0.001810273236132684, "perturbed_sampled_ll_std": 0.0004374056039219033, "perturbed_original_ll_std": 0.0002440929717938427}, {"original": "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "sampled": "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "perturbed_sampled": ["Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:"], "perturbed_original": ["Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:", "Question: Does automatic transmission improve driving behavior in older drivers? Answer:"], "original_ll": -0.0017978118453964285, "sampled_ll": -0.0008206430731164287, "all_perturbed_sampled_ll": [-0.0008693386736964285, -0.0010961698379907145, -0.0008623634548528572, -0.001206548651952857, -0.001098735655957143, -0.00180970811025, -0.0015675357817250004, -0.0008559887215607141, -0.0010094303464, -0.0011958202683607143], "all_perturbed_original_ll": [-0.0008720134340714285, -0.0009661386888349998, -0.0010458287919892857, -0.0008514762714249999, -0.001200878225098571, -0.0008566528564178569, -0.0011605883011628572, -0.0016970791245728568, -0.002029052642239285, -0.0007774911776928572], "perturbed_sampled_ll": -0.001157163950274643, "perturbed_original_ll": -0.0011457199513504998, "perturbed_sampled_ll_std": 0.00029792090994201347, "perturbed_original_ll_std": 0.00038864013857845524}, {"original": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "sampled": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the understanding that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to a combination of the virus itself, antiretroviral therapy, and the", "perturbed_sampled": ["Question: Should HIV-infected patients be screened for silent myocardial ischaemia using myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using myocardial perfusion Single Photon Emission Computed Tomography. This recommendation stems from the understanding that individuals who are HIV-infected are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to a combination of the virus itself, antiretroviral therapy, and the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the understanding that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, caused by a combination of the virus , HIV therapy, and the", ". Question:Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the understanding that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to the combination of the virus itself, antiretroviral therapy, and the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the understanding that individuals with HIV are at increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to a combination of factors, including HIV itself, other infectious diseases, and the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should to a for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the understanding that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due of the HIV combination of the HIV virus itself, antiretroviral therapy, and the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the fact that individuals with HIV are at an increased risk of developing cardiovascular diseases, including ischaemia, due to a combination of the virus itself, antiretroviral therapy, and the", "Question:Can HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients can be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation came from the understanding that patients infected with HIV are at an increased risk of developing heart disease, including myocardial ischaemia, due to a combination of the virus itself, antiretroviral therapy, and the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computed Tomography). This recommendation stems from the evidence that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to a combination of the virus itself, antiretroviral therapy and alterations in the", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT (Single Photon Emission Computerized Tomography). This recommendation stems from the understanding that individuals with HIV are at an increased risk of cardiovascular diseases, including myocardial ischaemia, due to a combination of the virus itself, the AIDS drug, and the", "Question: Can HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer:Yes, HIV-infected patients should be screened for silent myocardial ischaemia using gated myocardial SPECT (Single Photon Emission Computed Tomography). This stems from the understanding that individuals with HIV are at an increased risk of developing cardiovascular diseases, including myocardial ischaemia, due to a combination of the virus itself, antiretroviral therapy, and the"], "perturbed_original": ["Question: Should HIV-infected patients be screened for silent myocardial ischaemia using myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 50 years and with at least two other CRFs, screening for SMI using myocardial SPECT was up to three times more likely to be positive than in the general population. This may justify further investigation to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should patients with CRF be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In a study of CRF patients older than 50 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may suggest that it is wise to advise these patients to undergo more frequent screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In HIV-infected patients older than 60 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients undergo more systematic screening for silent myocardial ischaemia using myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT is four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion imaging? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be helpful than in the general population. This may make it more rational to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This study provides guidelines to referring physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients with CRF undergo serial screening for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians and these patients to undergo periodic screening for SMI using this technique.", "Question: Should patients with HIV be screened for focal myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected males with CRFs be screened for ST-segmented myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise their patients to undergo systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least four other CRFs, screening for SMI using gated SPECT was about four times more likely to be positive than in the general population. This encourages physicians to advise these patients to undergo systematic screening for SMI using this technique."], "original_ll": -0.00016556747213054945, "sampled_ll": -0.00423222600997198, "all_perturbed_sampled_ll": [-0.0036138163886131735, -0.004418667639148911, -0.004922301930966321, -0.0041089808063635574, -0.010657099965429906, -0.0045415620516625, -0.004030942650985327, -0.006449278323938518, -0.003963094356203137, -0.0037392597878248557], "all_perturbed_original_ll": [-0.00027202739606228257, -0.00010415672604905262, -0.00010674802969651687, -0.00014026245073945059, -8.050335165108695e-05, -0.00011891095956311828, -0.0001490783247501075, -0.00018184422935211105, -0.00014747095965645835, -9.91272169821591e-05], "perturbed_sampled_ll": -0.005044500390113621, "perturbed_original_ll": -0.00014001296445023437, "perturbed_sampled_ll_std": 0.002023775334329409, "perturbed_original_ll_std": 5.2312606758456626e-05}, {"original": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "sampled": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the", "perturbed_sampled": ["Question:Can a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program does improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral education, prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and psychologically for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise instruction, and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and psychologically for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise and behavioral therapy, help prepare patients physically and mentally for the", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer:Yes, a preoperative medically supervised weight loss program can improve bariatric surgery outcomes. These programs, which often include dietary counseling, exercise regimens, and behavioral therapy, help prepare patients physically and mentally for the"], "perturbed_original": ["Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to provide additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss , metabolic and behavioral outcomes after LAGB in our patient population.", "Question: Does a medically supervised weight loss program improve postoperative outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB surgery in our patient population.", "Question: Does a preoperative medically guided weight loss program influence bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer a benefit as compared to the standard bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative intensive weight loss program improve bariatric surgery outcomes? Answer: An intensive weight loss program does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery program in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to provide a significant clinical benefit as compared to the standard preoperative bariatric program in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a medically supervised weight loss program improve bariatric surgery outcomes? Answer: A medically supervised weight loss program does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically -directed weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of final weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does participation in a preoperative medically -supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population."], "original_ll": -0.00016045747550898307, "sampled_ll": -0.00643442746873762, "all_perturbed_sampled_ll": [-0.0034467496514926986, -0.005403515485147258, -0.006435918909755716, -0.006219576025450159, -0.008522904105958065, -0.005378844435119049, -0.00698892629291629, -0.005378576044993492, -0.013382571983028033, -0.007868126136763173], "all_perturbed_original_ll": [-0.0030869136829126667, -0.0001570950766701818, -0.00015325753198813558, -0.00022428003722355932, -0.0001559582411877193, -0.00019998716380606558, -0.000188565998971, -0.0001298828080527869, -0.010118141563194833, -0.006980027190005715], "perturbed_sampled_ll": -0.0069025709070623924, "perturbed_original_ll": -0.0021394109294012665, "perturbed_sampled_ll_std": 0.0025509618632676666, "perturbed_original_ll_std": 0.003392212049551246}, {"original": "Question: Do Indigenous Australians age prematurely? Answer:", "sampled": "Question: Do Indigenous Australians age prematurely? Answer:", "perturbed_sampled": ["Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:"], "perturbed_original": ["Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:", "Question: Do Indigenous Australians age prematurely? Answer:"], "original_ll": -0.006178266137920001, "sampled_ll": -0.0024807763508999997, "all_perturbed_sampled_ll": [-0.005499842773820001, -0.00290816731956, -0.0024839754159, -0.0036807482521299993, -0.006178266137920001, -0.006342947736860001, -0.006171628507429999, -0.0024969966765299996, -0.0024848670612399996, -0.00613830425783], "all_perturbed_original_ll": [-0.0025207978145399997, -0.00617804957292, -0.00960233438875, -0.006621492231649999, -0.00580369760749, -0.0024953281889999995, -0.00257112470554, -0.00259998300307, -0.0038315491484199994, -0.0061538133342399996], "perturbed_sampled_ll": -0.004438574413922, "perturbed_original_ll": -0.004837816999562, "perturbed_sampled_ll_std": 0.001673188983706876, "perturbed_original_ll_std": 0.0022881721965147274}, {"original": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "sampled": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question touches on a complex and ethically charged issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the", "perturbed_sampled": ["Question: Do French lay people or professionals believe that it is ethically acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question touches on a complex and ethically charged issue that balances the principles of patient confidentiality against the imperative of avoiding harm to others. In the", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question touches on a complex and ethically charged issue that balances the principles of confidentiality against the obligation to prevent harm to others. In the", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife or child from harm from sexually transmitted diseases? Answer:Answer: The problem touches on a complex and ethically charged issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the", "Question: Do French lay people and health professionals find it ethical to withhold medical information in order to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question touches on an emotional and ethically charged issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This questionnaire aims to shed light on a complex and ethically charged issue : the conflict between the principles of patient confidentiality and the imperative to prevent harm to others. In the", "Question: Do lay people and health professionals generally agree it is acceptable to breach confidentiality to protect a patient's health against a sexually transmitted disease? Answer:Answer: This question touches on a complex and ethically charged issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the", "Question: Do French lay people and health professionals find it appropriate to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question touches on a complex and ethically charged issue , which pits the principles of patient confidentiality against the imperative to prevent sexually transmitted diseases in others. In the", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This situation touches on a complex and ethically fraught issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the", "Question: Do French lay people and health professionals find it acceptable to breach the privacy of a patient to protect a patient's wife from a sexually transmitted disease? Answer:Answer: This question involves a complex and ethically charged issue that balances the principles of patient confidentiality against the need to prevent harm to others. In the", "Question: Do French lay people and medical professionals find it acceptable to breach confidentiality in order to protect a patient's wife from a sexually transmitted disease? Answer:Answer: The question touches on a complex and ethically charged issue that balances the principles of patient confidentiality against the imperative to prevent harm to others. In the"], "perturbed_original": ["Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient from an STD.", "Question: Do French lay people and health practitioners find it acceptable to breach confidentiality to protect a spouse from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "that many French lay people and health professionals find that it is justified to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should violate patient confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people and health professionals say they are influenced by situational factors when deciding if a physician should breach confidentiality to protect a wife of a patient infected with STD.", "Question: Do French lay people and health professionals find it appropriate for physicians to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Health professionals in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: whether a in France are influenced by situational factors when deciding patient physician should breach confidentiality to protect the spouse of a People with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when determining whether a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: What influences do lay people and health professionals find relevant when deciding if a physician should have to breach confidentiality to protect a spouse from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD."], "original_ll": -0.00019053199118965517, "sampled_ll": -0.009792649000227584, "all_perturbed_sampled_ll": [-0.005317213460504426, -0.008168195527522982, -0.00351850718291, -0.008416654558647542, -0.007078043291662382, -0.005577749671087627, -0.011137822945954591, -0.005683583469770863, -0.00962143882121803, -0.008088502740772333], "all_perturbed_original_ll": [-0.0003098124674746552, -0.00023011824782965518, -0.0002467026988316072, -0.0006081007831286206, -0.0002767033230833898, -0.0002503351551444262, -0.0003958687623731667, -0.011605475183149108, -0.00020873319893534485, -0.0004425983147768253], "perturbed_sampled_ll": -0.007260771167005077, "perturbed_original_ll": -0.0014574448134726799, "perturbed_sampled_ll_std": 0.002158340458853931, "perturbed_original_ll_std": 0.003384680112699803}, {"original": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "sampled": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "perturbed_sampled": ["Question: Fragility ?:..????????????????????????????????????????????????????????????????????????????????????? esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic of the primary eosinophilic esophagitis? Answer:", "Question: : Eosinophil on the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility ????????????????????????????????????????????????????????????????????...???? esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: s the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the  a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic :.???????????????????????????????????????????????????????????????????????????????????????????????? of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic ?????????????????????????????????????????????????????????????????????????????????????????????????????????????? primary eosinophilic esophagitis? Answer:", "Answer: Blisters of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:"], "perturbed_original": ["Question: Fragility of the esophageal mucosa: a <unk> sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal ?????????????.?)??)? )?)!))!!)!)!!!!)!!!)!)!!)!)))!)!))!!))!!)!! pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic :????????????????????????????????????????????????????????????????????s?????????????????????????????????????? of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary ? Answer:", "Answer: Eczema of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Answer:", "Question: This page: Question:??????????????s??s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of the esophageal mucosa: : Question:s?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?ss?s?s?s?s?s?s?s?s?s?s? endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: :?.?????????????????????????????????????????????????????????????????????????????????????????????????? the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:", "Question: Fragility of esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer:"], "original_ll": -0.0013645527075348484, "sampled_ll": -0.000991715702252121, "all_perturbed_sampled_ll": [-0.0007801630931316366, -0.0034462180299542422, -0.018217075138311386, -0.00031521130035940003, -0.009241448190722258, -0.004185200410857408, -0.0028132427316260003, -0.003984797044678215, -0.009126112663670338, -0.0005805889959541175], "all_perturbed_original_ll": [-0.00035947565039633325, -0.0006563508205600001, -0.027661281621756448, -0.0124473854823996, -0.0007653520722241178, -0.003516992897519688, -0.007874169198143065, -0.014009330625445626, -0.005470966961801403, -0.0006816142755040624], "perturbed_sampled_ll": -0.0052690057599265, "perturbed_original_ll": -0.007344291960575034, "perturbed_sampled_ll_std": 0.0052645822832075835, "perturbed_original_ll_std": 0.008263610874878907}, {"original": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients' records of home BP monitoring to help guide treatment decisions.", "sampled": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the equipment and understand the importance of accurate", "perturbed_sampled": ["Question: Are stroke patients' reports of home blood pressure readings reliable? The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The results of various studies have shown that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the equipment and understand the importance of accurate", "Question: Is stroke patients' reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can reliably report blood pressure measurements taken at home, provided they have been properly trained in how to use a blood pressure device and understand the importance of accurate", "Question: Are the reports of home blood pressure readings accurate and reliable? The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can measure reliable blood pressure in their home, provided they have been properly trained on how to use the equipment and understand the importance of accurate", "Question: Are stroke patient reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the equipment and understand the importance of accurate", "Question: Are stroke patients' reported home blood pressure levels reliable? Answer:Answer: The reliability of home blood pressure levels reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the equipment and understand the importance of accurate", "Question: Are stroke patient reports of home blood pressure readings reliable? The reliability of home blood pressure readings reported by stroke patients is a subject that has garnered considerable attention in the field of medical research. The consensus from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the monitor, and understand the importance of accurate", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The evidence from various studies suggests that stroke patients can provide reliable blood pressure readings from home, provided they have been trained on how to use the equipment and understand the importance of accurate", "Question: Are stroke patients' reported home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. Evidence from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been adequately trained on how to use the equipment and on the importance of accurate", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is a topic that has garnered attention within medical research. The consensus from various scientific studies has been that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been properly trained on how to use the equipment and are aware of the importance of accurate", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer:Answer: The reliability of home blood pressure readings reported by stroke patients is an issue that has garnered attention within medical research. The consensus from various studies suggests that, generally, stroke patients can provide reliable blood pressure readings from home, provided they have been trained on how to use the equipment and understand the importance of accurate"], "perturbed_original": ["Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in the surgery are often a poor indication of true BP, GPs might consider using patients' records of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record blood pressure reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in the surgery may not provide a good estimate of true BP, GPs might consider using hypertensive patients' records of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure readings reliable? This group of elderly stroke patients were able to record BP reliably at home. Any differences between home and clinic BP were small and would be unlikely to affect management. Since BP readings in a GP surgery are often not a good indication of true BP, GPs might consider using hypertensive patients' reported home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure accurate? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. The bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using patients' records of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of stroke patients were able to record their BPs reliably at home. Any bias was small and therefore unlikely to affect management. Since BPs measured in a GP surgery are often a poor reflection of true BP, GPs might consider using hypertensive patients' records of home BP s as a means to help guide treatment decisions.", "Question: Are stroke patients' reports of blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect their management. Since BP readings in a GP surgery are often a poor indication of BP, GPs might consider using hypertensive stroke patients' reports of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their blood pressure fairly reliably at home. Any inaccuracy in BP measurements at hospital was small and would be unlikely to affect management. Since BP readings in a GP surgery are a poor indication of home BP, GPs might consider using hypertensive patients' records of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reported home blood pressure readings valid? This group of stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings obtained in a GP surgery are a poor indication of true BP, GPs might consider using hypertensive patients' records of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of blood pressure readings reliable? Answer: The majority of elderly stroke patients were able to record their BPs reliably at home. Any bias was in their report of home BP monitoring and would be unlikely to influence stroke management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive patients' reports of home BP monitoring to help guide treatment decisions.", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect clinical decisions. Since BP readings in a GP surgery are often a poor measure of true BP, GPs might consider using hypertensive patients' records of home BP to help them make BP management decisions."], "original_ll": -0.00010898652206839506, "sampled_ll": -0.0012744430651027273, "all_perturbed_sampled_ll": [-0.00016881464989276315, -0.002381485789707625, -0.00016796030841066665, -0.0014868575311671052, -0.0014862601998396055, -0.0004195791359054431, -0.0016088893514889038, -0.0013086800984836, -0.0015080185773000002, -0.0017620583701525006], "all_perturbed_original_ll": [-0.0001608342734774359, -0.0002282062701, -8.5599554182561e-05, -9.940836168384614e-05, -0.0003022814367790361, -0.0005374918451883951, -0.0001987871636480459, -9.860624439688313e-05, -0.0006224885171334485, -0.00010060943650097561], "perturbed_sampled_ll": -0.0012298604012348211, "perturbed_original_ll": -0.00024343131030906277, "perturbed_sampled_ll_std": 0.0006984638271417506, "perturbed_original_ll_std": 0.0001815743192485041}, {"original": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "sampled": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "perturbed_sampled": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic ation of maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary for the first urine ACR (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia ? Question:l?e factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first a ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio prognostic? Question:?-?se?s?s?s??s???s??s??s?'s?'s?''s?''s?''s?''s?''s?''s?''s?''s?''s?''s?''s? women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with not a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and infant outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic for maternal and neonatal adverse outcome? Answer:"], "perturbed_original": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary protein (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal ? Answer:", "Question: Is the first s ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic ? maternal and neonatal adverse outcome? Answer:", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected the question:s lequel?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s??s??s?? prognostic factor for maternal and neonatal adverse outcome? Answer:", "Is the measurement of the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer:"], "original_ll": -0.0006017533440643903, "sampled_ll": -0.0004941890403317073, "all_perturbed_sampled_ll": [-0.010998497658690237, -0.000744767125721, -0.01795354444395476, -0.001524345108643143, -0.00013472170968405404, -0.014875242290260741, -0.004312488680908333, -0.005575921669869761, -0.0005532462317746153, -0.000414947509002], "all_perturbed_original_ll": [-0.0007686734198985365, -0.002269161486656857, -0.0009688893942029268, -0.0005942105007997561, -0.008524943956563847, -0.0017947532560502859, -0.00036947502740846154, -0.023347864587294247, -0.007593794595992354, -0.00021949824535499998], "perturbed_sampled_ll": -0.0057087722428508635, "perturbed_original_ll": -0.004645126447022228, "perturbed_sampled_ll_std": 0.006258849069727875, "perturbed_original_ll_std": 0.006856593800927637}, {"original": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "sampled": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "perturbed_sampled": ["Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for  Answer:", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an tttttt?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux . there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is . optimal time of acid suppression for maximal healing? Answer:", ": A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of postsurgical grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there ??????????????????????????????????????????? time of acid suppression for maximal healing? Answer:", "Question: Time of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux st there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades ? D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:"], "perturbed_original": [". A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C . reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of chronic grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is :?????????????????????????????????????????? optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los , C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: Time course of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of No.s????????????????????????????????????????? for maximal healing? Answer:", "Question: A model is shown. Question:????????????????????????????????????????????????????????????????????????????????????????????????????? of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model of healing of Los . Question:????????????????n??n?n?n?n?n?n?n?n?n?n?n??n?n?n?n??n??n??n??nn?n?n???? C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:", "Question: A model  of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer:"], "original_ll": -0.0007117077649964706, "sampled_ll": -0.0008440411677191176, "all_perturbed_sampled_ll": [-0.014257274392125938, -0.004130750683566189, -0.015963752780034483, -0.01284476059268697, -0.00030514554109200003, -0.0016214655656329414, -0.006911973516010466, -0.0015120005442657574, -0.002124724248653572, -0.0011903300053651513], "all_perturbed_original_ll": [-0.0030477134012446656, -0.0037094424824075756, -0.0006289362537642423, -0.019121561363552954, -0.004935015839863031, -0.0005885012503229411, -0.0008237869031944445, -0.003770934092699524, -0.001108979285502169, -0.004971531370707187], "perturbed_sampled_ll": -0.006086217786943347, "perturbed_original_ll": -0.004270640224325873, "perturbed_sampled_ll_std": 0.005731116024604287, "perturbed_original_ll_std": 0.00521765995559142}, {"original": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "sampled": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is significantly influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative results. Experience contributes to a surgeon's proficiency in managing", "perturbed_sampled": ["Question: Is the ability to perform transurethral resection of the prostate (TURP) influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is influenced by the surgeon's previous experience. Studies show that surgeons with more experience in performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative results. Experience also impacts a surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing TURP tend to have better patient outcomes, shorter operation times, lower rates of complications, and improved postoperative outcomes. Additional training also contributes to a surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate is significantly influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience performing TURP tend to produce better patient outcomes, including shorter operative times, lower rates of complications, and improved postoperative results. Experience contributes to a surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate (TURP) influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative pain. This experience contributes to a surgeon's knowledge and skills in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is significantly influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of infection and improved postoperative results. Previous experience also contributes to a surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is significantly influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved satisfaction. Experience contributes to a surgeon's proficiency in managing", "is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is significantly influenced by the surgeon's previous experience. Studies demonstrate that surgeons with more experience performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative results. Experience contributes to the surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? The ability to perform transurethral resection of the prostate (TURP) is influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative results. Experience contributes to improved proficiency in managing", "Question: Is the ability to perform a transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform a transurethral resection of the prostate (TURP) is significantly influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience in performing the procedure tend to have better patient outcomes, including shorter operation times, a lower incidence of complications, and improved postoperative results. Experience contributes to a surgeon's proficiency in managing", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer:Yes, the ability to perform transurethral resection of the prostate (TURP) is influenced by the surgeon's previous experience. Studies have shown that surgeons with more experience performing TURP tend to have better patient outcomes, including shorter operation times, lower rates of complications, and improved postoperative care. Previous experience also contributes to a surgeon's proficiency in managing"], "perturbed_original": ["Was the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience is important for overall procedure efficiency. Experience did not reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of TURP infection was the same in the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? The senior urologist was capable of resecting four times more tissue per time unit than the two other surgeons. Therefore, a surgeon's previous experience may be important . Three groups had higher incidences of the need for secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more senior urologist. Therefore, surgical experience may be important to reduce the risk of secondary TURP s for recurring adenomas or adenomas that were not completely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per operation than the more junior surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. Overall, however, the incidence of complications was the same in all three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more per time unit than the more inexperienced urologist. Therefore, a surgeon's experience may be important in reducing the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the time required to perform TURP of the prostate influenced by the surgeon's experience? Answer: The senior urologist had an average of resecting four percent less tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "question is asked, \"Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per unit than the more inexperienced surgeons. The surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that cannot be completely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the decision to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was responsible for resecting four times more tissue in each male unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the likelihood of a secondary TURP due to recurring adenomas or adenomas that were incompletely removed. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior surgeons were capable of removing five times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that become encapsulated in the prostate during surgery and cannot be safely resected. However, the rate of complications was equal between the three groups.", "Question: Is the time needed to perform transurethral resection of the prostate affected by the surgeon's previous experience? Answer: A more experienced senior urologist was capable of resecting four times more tissue per time unit than were the two more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same among the three groups."], "original_ll": -0.0015386401675760604, "sampled_ll": -0.0037337776096571292, "all_perturbed_sampled_ll": [-0.003116775386552308, -0.0033821967598382185, -0.0043053030680824216, -0.005504644401092898, -0.010748562817410883, -0.004718407861939799, -0.013275766778645257, -0.0010697437920275535, -0.003029676545053495, -0.004011308937640892], "all_perturbed_original_ll": [-0.0057176198610894334, -0.0024795831412456728, -0.0008311177838763636, -0.0012197983642639, -0.00031990599944237624, -0.00018447601157237114, -0.009215613297540505, -0.007216019483142222, -0.0013834264952906864, -0.0037317335679069898], "perturbed_sampled_ll": -0.005316238634828373, "perturbed_original_ll": -0.003229929400537052, "perturbed_sampled_ll_std": 0.0035752091699987843, "perturbed_original_ll_std": 0.0029944661643406265}, {"original": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "sampled": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises", "perturbed_sampled": ["Question: Cervical spine fractures in clinical problem. trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms represent a significant ..tain???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical j in t trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures mechanism: are clinical predictors adequate? pose blunt trauma patients with low-energy , a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt low-energy mechanism with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with a significant diagnostic challenge.s:s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s???????? represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with low-energy ?? a : are clinical predictors adequate??????????????????????????????????????? challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are Cervical spine adequate? A. Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures patients with blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer:Cervical spine fractures in geriatric blunt trauma patients blunt trauma mechanisms represent a significant diagnostic challenge. The question arises", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy fractures in clinical predictors adequate? Answer:Cervical spine mechanisms: are geriatric blunt trauma patients with low-energy mechanisms represent a significant diagnostic challenge. The question arises"], "perturbed_original": ["Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: fractures of the cervical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of Clinical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with risk for cervical spine fracture are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the energy mechanism: in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are fractures adequate? Answer: Clinical predictors appear inadequate for not of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with geriatric blunt trauma are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in Question: patients with low-energy mechanism.", "Question: Cervical spine of the geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures with low-energy blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients .::?:?????????????????un.?\u2019.?\u2019.?\u2019.? \u2019\u2019un.\u2019????un.??un.?????un.? mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients to be adequate in mechanism: are clinical predictors adequate? Answer: Clinical predictors appear traumatic fractures requiring the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in patients with trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma . Question: How does this injury affect the spine? Answer: Question: How does this injury affect the spine?.?????????????????????????????????????????????????????????????????????????????????????? low-energy mechanism.", "Question: Cervical spine fractures in fractures in trauma trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in low-energy mechanism.:: Les donn\u00e9es m\u00e9dicales seraient-elles suffisantes?:::::!!...! :!!!!!!! :!!!!!!!!!!!!!!!!!!! patients with low-energy mechanism.", "Question: Cervical spine fractures in ? Question:s: Question:s: Question:s?s?s?s?s?s?s? Question:s?s? Question:s?s?s? Question:s?s?s?s?s?s?s?s?s?s??s?s?s? trauma patients ? mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism."], "original_ll": -0.005301058613258478, "sampled_ll": -0.005295974085922447, "all_perturbed_sampled_ll": [-0.15824216577, -0.021202125973118262, -0.006802292267956037, -0.02351174449157884, -0.02706792948819873, -0.001489797319528235, -0.0055532778963622445, -0.0065129060344675, -0.016534534719136667, -0.006173774021022653], "all_perturbed_original_ll": [-0.001272831656121915, -0.00176324522994125, -0.0012045362108331818, -0.013673828580237675, -0.0002628379288160869, -0.0016075009135672602, -0.0005851611564727082, -0.018577085700493635, -0.006582502077794658, -0.0020561085511025604], "perturbed_sampled_ll": -0.027309054798136917, "perturbed_original_ll": -0.004758563800538093, "perturbed_sampled_ll_std": 0.04444209402143429, "perturbed_original_ll_std": 0.006019758474368518}, {"original": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "sampled": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into colorectal cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which", "perturbed_sampled": ["Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into colorectal cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which", "Question: Can APC mutation analysis significantly contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to lead to colorectal cancer if not managed appropriately. The condition is primarily caused by mutations in the APC gene, which", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early development of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into malignant disease if not managed appropriately. The condition is caused by mutations in the APC gene, which", "Question:Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary condition marked by the early onset of hundreds to thousands of adenomatous polyps in the colon (colorectal polyps), which have a high potential to develop into colorectal cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which", "Question:Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a condition characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into colorectal cancer if not treated. The condition is caused by mutations in the APC gene, which", "Question: Can APC mutation analysis significantly contribute to therapeutic decisions in familial adenomatous polyposis? APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have the potential to develop into colorectal cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which", "Question: Does APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis significantly contributes to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into colon cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which", "Question: Can APC mutations contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutations can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into cancers if not managed early. This condition is caused by mutations in the APC gene, which", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can significantly contribute to therapeutic decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the prostate and rectum, which have a high potential to develop into cancer if not managed appropriately. The condition is caused by a gene mutation in the APC gene, which", "Question: Can APC mutation analysis contribute to treatment decisions in familial adenomatous polyposis? Answer:Yes, APC mutation analysis can significantly contribute to treatment decisions in familial adenomatous polyposis (FAP). FAP is a hereditary disorder characterized by the early onset of hundreds to thousands of adenomatous polyps in the colon and rectum, which have a high potential to develop into colorectal cancer if not managed appropriately. The condition is caused by mutations in the APC gene, which"], "perturbed_original": ["Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation s of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within exons 1445-1580, it may be advisable to postpone elective surgery since the appearance of desmoids may occur before surgical intervention.", "Question: Can APC mutation analysis predict therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in cases of identical germline mutations, therapeutic decisions should be based on clinical findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be safe to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of specific germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients and not on the specific type of mutation. However, in patients with APC mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis help make therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within the APC gene it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of disease may be variable, even in carriers of identical germline mutations, therapeutic decisions should be based on clinical findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within the Desmoplasin gene, it may be advisable to avoid elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the genotype of the mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to avoid colectomy because tumors tend to arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and the clinical course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective surgery as omophagoidal desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of disease may be rather variable, even among carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within gene 6 (APC6), it may be advisable to postpone elective surgery because only desmoids may need surgical intervention.", "Question: Can APC site contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As the clinical manifestation and course of the disease may be variable even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in the individual patient rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be prudent to postpone elective colectomy because desmoids may arise through surgical intervention."], "original_ll": -0.00010935348773920792, "sampled_ll": -0.004726653388647327, "all_perturbed_sampled_ll": [-0.004408761767703269, -0.004632855490001652, -0.0003151503299401041, -0.0022369046468684465, -0.002161350702436907, -0.0003985615038035052, -0.0038915487859182826, -0.005456975938510825, -0.005752663797744257, -0.004127204025770099], "all_perturbed_original_ll": [-0.0064804511013505945, -9.158983119676766e-05, -0.00010711581117815535, -0.00012015866528126315, -8.004267987257731e-05, -8.951157835858584e-05, -9.427237046898988e-05, -0.0001229277106676923, -8.230141701752576e-05, -0.00010107566678090908], "perturbed_sampled_ll": -0.003338197698869735, "perturbed_original_ll": -0.000736944683217306, "perturbed_sampled_ll_std": 0.0018560154631890506, "perturbed_original_ll_std": 0.0019145516416018222}, {"original": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "sampled": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "perturbed_sampled": ["Question: Can a geriatric oncology consultation modify the cancer treatment plan for older patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for older patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in the delicate", "Question:How might a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation might modify the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation modifies the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing this delicate", "Question: Does a geriatric oncology consultation often modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation often modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation does modify the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in how to handle patients at this delicate", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into consideration the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer:Yes, a geriatric oncology consultation often modifies the cancer treatment plan for elderly patients. This specialized approach takes into account the unique needs and health concerns of older adults. Geriatric oncologists are experts in managing the delicate"], "perturbed_original": ["Question: Does the geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation leads to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these changes improve the outcome of these older patients.", "Question: How does the geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of patients. Further studies are needed to assess whether these modifications improve the outcome of these older patients.", "Did a geriatric oncology consultation modify the cancer treatment plan for these older cancer patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does the geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to show whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the of patients. plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third the modification could Further studies are needed to determine whether cancer treatment improve the outcome of these older patients.", "Question: How did the geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the quality of life for these older patients.", "Question: Does a geriatric plan in modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for older patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: To what extent did the geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than a third of cases. Further studies are needed to determine whether these modifications improve the outcome of cancer treatment in these patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients."], "original_ll": -0.00021053893152000002, "sampled_ll": -0.005944707594357187, "all_perturbed_sampled_ll": [-0.006820220536607811, -0.005202727261039684, -0.008832361457000308, -0.0071905706105775, -0.006487185076793385, -0.0072253946216955574, -0.008625539618244464, -0.004782734679301176, -0.00843371578275047, -0.0056204003062767195], "all_perturbed_original_ll": [-0.0001367565145295, -0.00016849919285688523, -0.00037464011958383326, -0.00012972058443716666, -0.011804658285561806, -8.614206382936508e-05, -0.0008701546054989832, -0.00013063801362433333, -9.038702168938462e-05, -0.00012301151854433333], "perturbed_sampled_ll": -0.006922084995028707, "perturbed_original_ll": -0.0013914607920155592, "perturbed_sampled_ll_std": 0.0013574583174014874, "perturbed_original_ll_std": 0.003478470357554101}, {"original": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "sampled": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "perturbed_sampled": ["Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:"], "perturbed_original": ["Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:"], "original_ll": -0.0008888727133295454, "sampled_ll": -0.0010204627794590908, "all_perturbed_sampled_ll": [-0.0011378249603113636, -0.0015496603365440912, -0.0008882333480427273, -0.0012780987433904547, -0.001635534638265909, -0.0009965643974672725, -0.0012020642677090907, -0.001009752079269091, -0.0008881097636409093, -0.0014199476888286362], "all_perturbed_original_ll": [-0.0012459563695427273, -0.0010219079882513636, -0.0011993702677118182, -0.0012410733203454547, -0.0018383337982945459, -0.0014421535971927272, -0.0008698437967886362, -0.0009701618716022727, -0.0008293811608227272, -0.0008900231500659091], "perturbed_sampled_ll": -0.0012005790223469546, "perturbed_original_ll": -0.0011548205320618182, "perturbed_sampled_ll_std": 0.00025344626575341575, "perturbed_original_ll_std": 0.0002960549579784827}, {"original": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "sampled": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "perturbed_sampled": ["Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:"], "perturbed_original": ["Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer:"], "original_ll": -0.003614985236658571, "sampled_ll": -0.0035833304750592858, "all_perturbed_sampled_ll": [-0.0035833304750592858, -0.0036241857946364285, -0.0026950305399007146, -0.002946192073964286, -0.002739508443472143, -0.002946192073964286, -0.005713177180885716, -0.00363644043742, -0.008428893312094286, -0.003598156926686428], "all_perturbed_original_ll": [-0.0035851212932807132, -0.004024149789308571, -0.0029510811120107144, -0.006032905679892857, -0.002946192073964286, -0.003633242357196429, -0.0035902470443450003, -0.002946192073964286, -0.0035833304750592858, -0.004473436638328572], "perturbed_sampled_ll": -0.003991110725808358, "perturbed_original_ll": -0.0037765898537350717, "perturbed_sampled_ll_std": 0.0016932392506071473, "perturbed_original_ll_std": 0.0008847434454514639}, {"original": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "sampled": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "perturbed_sampled": ["Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:"], "perturbed_original": ["Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer:"], "original_ll": -0.005407894799620588, "sampled_ll": -0.005371986112175295, "all_perturbed_sampled_ll": [-0.005407894799620588, -0.003684142993773529, -0.003453817890417647, -0.003354377558423529, -0.005407894799620588, -0.0034015586260235293, -0.003440167299117647, -0.0033985826083235294, -0.003595615233352941, -0.0033378738131294118], "all_perturbed_original_ll": [-0.003569598849537059, -0.0037692374339882346, -0.003331343497835294, -0.002791826697422353, -0.006034746496311766, -0.0037000447998788238, -0.004229466715013529, -0.0021172447913117647, -0.0037757567519588232, -0.004849293624108235], "perturbed_sampled_ll": -0.0038481925621802935, "perturbed_original_ll": -0.003816855965736588, "perturbed_sampled_ll_std": 0.0007863825513712701, "perturbed_original_ll_std": 0.001020246865028037}, {"original": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "sampled": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer:Yes, early migraine treatment does indeed shorten the time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the headache phase. This early intervention approach is", "perturbed_sampled": ["Question: Does migraine treatment shorten time to headache peak and reduce its severity? Answer: Well, migraine treatment does indeed shorten time to headache peak and reduce its severity. This is, indeed, significant news. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the headache phase. This early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Early migraine treatment does indeed shorten time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the headache s. The best early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Our answer: early migraine treatment does indeed shorten the time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the symptoms and shorten the headache phase. This early intervention approach is", "Question: Does early migraine treatment indeed shorten the time to headache peak and reduce its severity? Answer:Yes, early migraine treatment does indeed shorten the time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the headache peak phase. This early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Yes, early migraine treatment does indeed shorten the time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of a headache . Therefore, an early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer:Yes, early migraine treatment can indeed shorten the time to headache peak and reduce its severity. By addressing migraines at their onset, patients can significantly mitigate the intensity and duration of the headache . A migraine early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its intensity? The early migraine treatment does indeed shorten the time to headache peak and reduce its intensity. In fact, by addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the headache phase. This early intervention approach is", "Question: Does early migraine intervention indeed shorten the time to headache peak and reduce its severity? Answer:Yes, early migraine intervention does indeed shorten the time to headache peak and reduce its severity. By addressing migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the acute headache phase. This early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer:Yes, early migraine treatment does indeed shorten the time to headache peak and reduce migraine severity. By treating migraines promptly at their onset, patients can significantly mitigate the intensity and duration of the symptoms. This early intervention approach is", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer:Yes, early migraine treatment does indeed shorten the time to headache peak and reduce its severity. By treating migraines promptly at their onset, patients can mitigate the intensity and duration of the headache phase. This early intervention approach is"], "perturbed_original": ["with triptans and early migraine treatment shorten time to headache peak and reduce total migraine headache duration? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not show significant reduction in headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to reduced total duration from migraine headache onset to headache peak but did not alleviate headache severity . This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce headache severity? Answer: Early treatment and use of triptans may result in shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. They could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early migraine treatment with the use of triptans was found to shorter en the time from migraine headache onset to its peak but did not reduce migraine headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment and use of triptans lead to shorter duration from migraine onset to headache peak and reduce its severity? Early migraine treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but do not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total headache duration.", "Question: How much can early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early migraine treatment through the use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine recurrence by reducing the headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may result in a shorter duration from migraine headache onset to its peak but did not alleviate migraine headache severity at peak. This could result in decreased annual migraine headache days by reducing total migraine headache duration.", "Question: Does migraine treatment shorten time to headache peak and /or reduce headache severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine onset to its peak but did not alleviate headache severity at all. Prompt treatment could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early diagnosis of migraine and use of triptans led to shorter duration from migraine start to its peak but did not reduce headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce severity at peak? Answer: Early therapeutic use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in lesser migraine burden by reducing peak migraine headache duration."], "original_ll": -8.217675265967213e-05, "sampled_ll": -0.00660438931618508, "all_perturbed_sampled_ll": [-0.0002266308270877941, -0.012260062474891722, -0.00042490726261475403, -0.006545963252938639, -0.0028650311187277426, -0.006521594289137419, -0.00024584815557539676, -0.004944183828467123, -0.007152779177269356, -0.006241220045141615], "all_perturbed_original_ll": [-0.0002997746836778261, -0.000495827443487, -7.45395245637705e-05, -0.002615943038684462, -3.5562947329428575e-05, -5.245596863640625e-05, -0.00013411089546030769, -0.0012022965060574193, -7.029923095409837e-05, -8.731936147032785e-05], "perturbed_sampled_ll": -0.004742822043185156, "perturbed_original_ll": -0.0005068129600321046, "perturbed_sampled_ll_std": 0.0036579657354432614, "perturbed_original_ll_std": 0.0007807634531582247}, {"original": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "sampled": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "perturbed_sampled": ["Question: Living in an urban environment and non-communicable disease ?????????????????????????????????????????????? Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", ". Schooling in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban environment and disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban environment and ?....................................... risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? ????????????????????????????????? text and extending it:\n\n", "Question: Living in an urban environment ????????????????????????????????????????? disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in a high-risk environment and non-communicable disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban ? non-communicable disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban environment and non-communicable disease ?............................. Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n", "Question: Living in an urban and non-communicable disease risk in Thailand: Does timing matter? Answer:Repeating the text and extending it:\n\n"], "perturbed_original": ["Question: Living in an urban - non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", ": Life expectancy in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an urban environment and cnc risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was  increases", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: \"\".?..?...?....?................. associated with increases", ". Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an communication and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an urban environment and non-communicable disease , Thailand: Does timing matter? Answer: Urbanicity was associated with increases", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases"], "original_ll": -0.0038145037438993092, "sampled_ll": -0.2336725231292934, "all_perturbed_sampled_ll": [-0.19296333838138457, -0.2698210842725636, -0.2328822115271188, -0.23098260998349998, -0.17894940643547252, -0.25144856889610634, -0.16181456688231935, -0.2104912726062585, -0.23213231220526903, -0.23161716393833312], "all_perturbed_original_ll": [-0.0026996107564374997, -0.01805349284505357, -0.010697509850276926, -0.005855295527665554, -0.02219952768475278, -0.02399952488041111, -0.004000711619853449, -0.003856380458221428, -0.007693343042282143, -0.0039978115433803455], "perturbed_sampled_ll": -0.21931025351283262, "perturbed_original_ll": -0.01030532082083348, "perturbed_sampled_ll_std": 0.03150747346592056, "perturbed_original_ll_std": 0.007712230186986647}, {"original": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer:", "sampled": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer:", "perturbed_sampled": ["Question: Marital status,  and mortality: does the association vary by gender? Answer:", ". Health status, living arrangement and mortality: does the association vary by gender? Answer:", "-related health status, living arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living arrangement and mortality: does it vary by gender? Answer:", "Question: Marital social arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living arrangement ? does the association vary by gender? Answer:", ". Social status, living arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living arrangement and membership in the association vary by gender? Answer:", "Question: Marital status, living arrangement and does the association vary by gender? Answer:", ", marital status, living arrangement and mortality: does the association vary by gender? Answer:"], "perturbed_original": ["Question: Marital status, living arrangement and mortality: does the ??????????????????????????????? by gender? Answer:", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer:", ", marital status, living arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living arrangement ? does the association vary by gender? Answer:", "Question: Marital status, living arrangement and mortality: of association vary by gender? Answer:", ". Answer: Health status, living arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living and mortality: does the association vary by gender? Answer:", "of education, health status, living arrangement and mortality: does the association vary by gender? Answer:", "Question: Marital status, living arrangement and mortality: does t vary by gender? Answer:", "Question: Marital status, living arrangement and mortality: does the association vary gender? Answer:"], "original_ll": -0.0027278688482799997, "sampled_ll": -0.0011439586728950002, "all_perturbed_sampled_ll": [-0.006029883076308333, -0.013476447307382003, -0.001453867718509375, -0.0011180139279442106, -0.0017936099138888889, -0.030082075227511107, -0.011874028096546667, -0.004587945013863159, -0.003823556936711111, -0.014686284624377778], "all_perturbed_original_ll": [-0.07837532952538999, -0.0009686205244994999, -0.01946795524712778, -0.02822815697066111, -0.008598681685310526, -0.005805627614756667, -0.002140597526001579, -0.0011498345967583337, -0.01409454629573158, -0.03264612726977895], "perturbed_sampled_ll": -0.008892571184304265, "perturbed_original_ll": -0.019147547725601604, "perturbed_sampled_ll_std": 0.008550182446419287, "perturbed_original_ll_std": 0.022430219725736895}, {"original": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "sampled": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns that can have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to more complex challenges and potentially poorer outcomes compared to", "perturbed_sampled": ["Question: Major depression and alcohol use disorder in adolescence: Does the interplay between them lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both serious mental health concerns that can have significant impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or occur together in adolescents, the interplay between them can lead to more complex challenges and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder in youth: Does comorbidity lead to increased likelihood of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are significant public health concerns that can have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to increased challenges and potentially poorer outcomes compared to", "Question: Depression and alcohol use disorder in adolescence: Does comorbidity mean poorer outcomes of depression? Answer:Major depressive disorder (MDD) and alcohol use disorder (AUD) in adolescence are both complex mental health concerns that can have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to more complex , interdependent issues and potentially poorer outcomes compared to", "Major depression and alcohol use disorder in adolescence: can the interplay between them lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are serious public health concerns that can have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to more severe outcomes and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to more severe symptoms of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns that can have profound impacts on an individual\u2019s health, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to more complex challenges and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder (AUD) in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns that can have profound impacts on an individual's well-being, social functioning, and recovery outcomes. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to more complex challenges and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder in adolescence are both significant health concerns that can have profound impacts on adolescent well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, overlapping features between them can lead to more serious symptoms and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder (AUD) in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns that can have profound impacts on an individual's psychological and physical health, social functioning, and developmental trajectory. When these conditions co-occur, or comorbidity occurs in adolescents, the interplay between them can lead to more complex challenges and potentially poorer outcomes compared to", ":Comorbidity between depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns and have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When these conditions co-occur, or are comorbid, in adolescents, the interplay between them can lead to significant challenges and potentially poorer outcomes compared to", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to worse outcomes? Does alcohol use disorder increase risk of depression? Answer:Major depression and alcohol use disorder (AUD) in adolescence are both significant public health concerns that can have profound impacts on an individual's well-being, social functioning, and developmental trajectory. When they co-occur, or are comorbid, in adolescents, the relationship between them can lead to more complex challenges and potentially poorer outcomes compared to"], "perturbed_original": ["Question: Major depression and alcohol use disorder in adolescence: Does this link to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by a prior history of exposure to adverse childhood circumstances amongst members of the comorbid group. This suggests that comorbidity is likely to act as a risk marker, rather than a causal factor in subsequent MD.", ", and substance misuse. Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of MD/AUD at age 35 amongst the comorbid group were explained by increased exposure to adverse childhood circumstances amongst those in the comorbid group. Adolescent MD/AUD comorbidity is likely to be an early risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use in adolescence: Does comorbidity lead to poorer outcomes in later life, notably to depression? Answer: The results of these analyses suggest that the higher rates of depression to age 35 amongst the comorbid MD/AUD group may be explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder among Australian adolescents: Does comorbidity lead to poorer outcomes of depression? The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by vulnerability to adverse experiences amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal risk factor, of subsequent MD.", ", depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression at the age of 35 in the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst MD/AUD in the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and substance use disorder in adolescence: Does comorbidity lead to poorer outcomes ? Answer: The results of these analyses suggest that marginally higher rates of depression to age 25 years amongst the comorbid group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggested that the marginally higher rates of MD from age 20 to age 35 amongst the comorbid MD/AUD group were explained by increased burden of adverse childhood circumstances amongst members of the comorbid group. Therefore, comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by greater exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depressive disorder and alcohol use disorder in adolescence: Does comorbidity in this age cohort predict poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression (MD) by age 35 amongst the comorbid group were explained by increased exposure to adverse childhood circumstances amongst those in the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depressive disorder and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of the present study suggest that marginally higher risks of subsequent depression to age 35 amongst the comorbid MD/AUD group were explained by an earlier exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD."], "original_ll": -7.342467480956521e-05, "sampled_ll": -0.002753152791357234, "all_perturbed_sampled_ll": [-0.002520440473649678, -0.002253794446337935, -0.0025122473982773005, -0.011733066551477536, -0.0021151106207245745, -0.0021225158158788655, -0.0035805982785314947, -0.003380581664072959, -0.0027058567683202936, -0.003069743021388081], "all_perturbed_original_ll": [-0.00013624349458172036, -0.00026560527129886594, -6.324859745989364e-05, -9.990920665461543e-05, -0.0006384027487921277, -0.005797029446855112, -5.2168499410631575e-05, -7.111255260377778e-05, -6.492200166572917e-05, -6.139694113395834e-05], "perturbed_sampled_ll": -0.003599395503865872, "perturbed_original_ll": -0.0007250038760456433, "perturbed_sampled_ll_std": 0.0027536291173809336, "perturbed_original_ll_std": 0.0016992838478994798}, {"original": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "sampled": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "perturbed_sampled": ["Question: Stretch-sensitive KCNQ1 mutation A potential link between genetic and environmental factors in the pathogenesis of atrial fibrillation, the stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and systemic infections. The pathogenesis of AF is complex and involves an interplay between genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, Stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Background:Atrial fibrillation (AF) is the most common cardiac arrhythmia and is characterized by an unsteady and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay of genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation provides a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation represents a potential link between genetic and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac rhythm and is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes such as stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Our research revealed that the stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac rhythm abnormality. It is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and embolism. The pathogenesis of AF is complex and involves interactions between genetic and", "Question: Stretch-sensitive mutation. A link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterized by rapid irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia , characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health consequences, including stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation is a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is characterised by a rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and pulmonary embolism. The pathogenesis of AF is complex and involves an interplay between genetic and", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental predispositions in the pathogenesis of atrial fibrillation? The stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation is the most common sustained cardiac rhythm disturbance and is characterized by rapid and irregular heartbeat, which can lead to a variety of adverse health outcomes including stroke, heart failure, and pulmonary embolism. The pathogenesis of atrial fibrillation is complex and involves an interplay between genetic and", "Question: Is KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer:Yes, the stretch-sensitive KCNQ1 mutation represents a potential link between genetic predispositions and environmental factors in the pathogenesis of atrial fibrillation. Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia . It is characterized by rapid and irregular heartbeat, which can lead to a range of adverse health outcomes including stroke, heart failure, and systemic embolism. The pathogenesis of AF is complex and involves an interplay between genetic and"], "perturbed_original": ["Question: Stretch-sensitive KCNQ1 mutation s have been isolated from patients with AF. Question: What is the relation between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Our findings suggest that a KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit,\" such as an environmental factor like hypertension, which promotes atrial stress and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related slowness of AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C mutation alone may not be sufficient to cause AF. Rather, they support a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks a defect in ion channel kinetics (the \"first hit\"), is necessary for AF to be manifested. Such a model would also account for the importance of dysrhythmia in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like age that promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a \"second hit\" mechanism would also account for the observed age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation in humans: role of the \"first hit\" between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a second hit, such as an environmental factor like hypertension, which induces atrial stretch and /or an inherited defect in ion channel kinetics (the \"first hit\"), is necessary for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, they suggest a model in which a \"second hit\", such as an environmental factor like chronic hypertension, that promotes atrial stretch and activates an inherited defect in ion channel kinetics (the R14C mutation), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A combination of genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Our results suggest that an R14C KCNQ1 mutation alone is insufficient to trigger AF. Rather, we would prefer to have a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit,\" such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ventricular contraction kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for our observation of a progressive increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: Our data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also explain the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the stretch-sensitive mutation alone is unlikely to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel activity that is an unexpected result of the \"first hit\" is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive potassium channels: A link between genetic and environmental factors in the development of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is not sufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development."], "original_ll": -0.00034113738484421046, "sampled_ll": -0.0036759214276905787, "all_perturbed_sampled_ll": [-0.0006776065343319829, -0.006046291921156341, -0.006341646802570167, -0.17162099000152312, -0.00047396113826915986, -0.005638540284867692, -0.004507409371977192, -0.00936321205758203, -0.0005974184992806837, -0.004999361099556198], "all_perturbed_original_ll": [-0.000851845663938254, -0.00028654908062833337, -0.00022760222288720344, -0.0014709884956508334, -0.0002944934982582456, -0.0003774320921058974, -0.00026660755799940165, -0.0003224504598097345, -0.0004614809010276315, -0.00032931727471133927], "perturbed_sampled_ll": -0.021026643771111457, "perturbed_original_ll": -0.0004888767247016874, "perturbed_sampled_ll_std": 0.050274401818782476, "perturbed_original_ll_std": 0.00036864706706380524}, {"original": "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "sampled": "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "perturbed_sampled": ["Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:"], "perturbed_original": ["Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:", "Question: Do we need imaging to diagnose appendicitis in children? Answer:"], "original_ll": -0.00180965933746125, "sampled_ll": -0.001049268205180625, "all_perturbed_sampled_ll": [-0.0015024947108312498, -0.001169644873634375, -0.0008829678795125, -0.002024453126916875, -0.001157684209870625, -0.001294546689371875, -0.001721098906336875, -0.0015033536526749998, -0.0014602762265875002, -0.0022326537611593754], "all_perturbed_original_ll": [-0.0012496603992218753, -0.001043098924293125, -0.001232523341853125, -0.001043098924293125, -0.001037628056168125, -0.0026494293589931247, -0.0021953464682806247, -0.000939936591005625, -0.0014875847965500001, -0.0012314677511593751], "perturbed_sampled_ll": -0.0014949174036896248, "perturbed_original_ll": -0.0014109774611818122, "perturbed_sampled_ll_std": 0.0003887555496191037, "perturbed_original_ll_std": 0.0005363672104916622}, {"original": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "sampled": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "perturbed_sampled": ["Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:"], "perturbed_original": ["Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer:"], "original_ll": -0.0027773172799812496, "sampled_ll": -0.0040782270129275005, "all_perturbed_sampled_ll": [-0.0036817816735125, -0.00417374556955875, -0.00408404725054, -0.0032652222465156247, -0.004142369992825, -0.0030768392160875, -0.004877497781037501, -0.00397178428, -0.00279191548676875, -0.0037817618733437496], "all_perturbed_original_ll": [-0.0038092484095624997, -0.0027773172799812496, -0.0015911696690743752, -0.0027644895819874996, -0.00467149323624375, -0.00276795840539375, -0.0031867412572749994, -0.0027773172799812496, -0.00273007925640625, -0.0038943487606125], "perturbed_sampled_ll": -0.0037846965370189377, "perturbed_original_ll": -0.0030970163136518126, "perturbed_sampled_ll_std": 0.0005801074472288479, "perturbed_original_ll_std": 0.0008034629259765427}, {"original": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer:", "sampled": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer:", "perturbed_sampled": ["Question: Are higher rates  in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by  reporting? Answer:", "Question: Are higher rates of depression in women accounted for by  reporting? Answer:", "Question: Are higher rates of depression in women accounted for by increased symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for their symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted  differential symptom reporting? Answer:", "Question: Are higher rates of  women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by symptom reporting? Answer:"], "perturbed_original": ["Question: Is the higher rates of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are depression?!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!? of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for ?sssssssssssssss?s?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s symptom reporting? Answer:", ". Is the higher rates of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by ? reporting? Answer:", "Question: Are higher rates of depression s accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in women accounted for by ? reporting? Answer:", "Are higher rates of depression in women accounted for by differential symptom reporting? Answer:", "Question: Are higher rates of depression in older individuals accounted for by differential symptom reporting? Answer:"], "original_ll": -0.0013471655379805557, "sampled_ll": -0.0016782959927455555, "all_perturbed_sampled_ll": [-0.0022385606112875003, -0.0013355261581911113, -0.002056367744191667, -0.00237321835536875, -0.00242383211413125, -0.001560488791423889, -0.003719746736637647, -0.02830465949439445, -0.0050242302599875005, -0.0011619774287864708], "all_perturbed_original_ll": [-0.0031497873295989473, -0.0011448005919746154, -0.019482394867635294, -0.01891813123642105, -0.026680405823101765, -0.005729479675705883, -0.0103557030337625, -0.005007997882325294, -0.000563306191212143, -0.000935271934930526], "perturbed_sampled_ll": -0.005019860769440023, "perturbed_original_ll": -0.009196727856666802, "perturbed_sampled_ll_std": 0.007839381413478865, "perturbed_original_ll_std": 0.008837854733972472}, {"original": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "sampled": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer:Answer: Profound hypotensive events can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "perturbed_sampled": ["Question: Hypotension in patients with coronary disease: can profound hypotensive events cause ischemic events? Answer:Answer: Profound hypotensive events can indeed result in ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial perfusion, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotensive events Profound ischaemic events? induce myocardial hypotensive events can indeed disease. ischemic events in patients with coronary artery . This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer:Answer: patients with events can indeed precipitate myocardial ischemic events in coronary perfusion coronary artery disease (CAD). This is primarily because adequate adequate coronary blood pressure is essential to maintain Polymorphous hypotensive supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotensive episodes precipitate myocardial ischaemic events? Answer:Answer: Profound hypotension can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of coronary artery obstructions. Hypotension can reduce coronary artery pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotension cause myocardial ischaemic events? Answer:Answer: Profound hypotensive events can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because a constant myocardial perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Profound hypotensive events can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of CAD with persistent angiographic obstructions. Hypotension can reduce coronary artery perfusion pressure to levels where", "Question: Hypotension in patients with coronary artery disease: can profound hypotensive events cause myocardial ischaemic events? Answer:Answer: Profound hypotensive events can indeed precipitate myocardial ischaemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is required to maintain myocardial oxygen supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer:Answer: Profound hypotensive events can indeed precipitate myocardial pressure is in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion presence of essential to maintain myocardial oxygen supply, especially in the Hypotension may fixed atherosclerotic obstructions. ischaemic events reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary disease: can hypotensive events cause myocardial ischaemic events? We believe that hypotensive events can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to maintain myocardial oxygen supply, especially in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where", "Question: Hypotension in patients with coronary events?\u201d profound hypotensive events cause myocardial ischaemic maintain cardiac Profound hypotensive events can indeed precipitate myocardial ischemic events in patients with coronary artery disease (CAD). This is primarily because adequate coronary perfusion pressure is essential to ation oxygen artery disease (CAD): can in the context of fixed atherosclerotic obstructions. Hypotension can reduce coronary artery perfusion pressure to a point where"], "perturbed_original": ["Question: Hypotension in patients with disease undergoing treatment for can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart more frequently and hypotension, symptomatic and silent ischaemia occurred in patients temporally treated with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease and severe profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart myocardial hypotension, symptomatic patients with severe ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that ischemic coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial a Answer: In patients with ischaemic heart disease and hypotension, both active and silent ischaemia occurred in a causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can as events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events blood pressure a result of low chronic caused by these drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent hypotension and with normal values in a temporally causal relation with patients with for diastolic pressures, suggesting that as a coronary disease may be susceptible to ischaemic events incurred of result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension. Especially for diastolic pressures, heart failure patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease have symptomatic and silent ischaemia , a temporally causal relation symptomatic ischaemia, particularly for , suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound and spatially correlated manner cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally susceptible to myocardial with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be or ischaemic events incurred as a result of low blood pressure to excessive hypotensive drug treatment.", "Question: Hypotension disease susceptible to hypotension? Can with coronary myocardial profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic to low blood pressure, ischaemia occurred in a temporally causal relation , particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic cardiomyopathy and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment."], "original_ll": -0.00013154974731536078, "sampled_ll": -0.002802110787236598, "all_perturbed_sampled_ll": [-0.003456640273483913, -0.006837285427881557, -0.021570208479883224, -0.0034302510852990105, -0.002314928445317959, -0.0002582840280469893, -0.0027590205209181828, -0.008759773356841225, -0.00024890803333747373, -0.0035013494535728134], "all_perturbed_original_ll": [-0.00031019467930979593, -0.00015989303809377554, -0.0008550276670679124, -0.0003350513714822222, -0.0007265715573093748, -0.00013259798641453608, -0.0021940633470220222, -0.00012659656195653063, -0.0024996180867629704, -0.003864914583402917], "perturbed_sampled_ll": -0.005313664910458234, "perturbed_original_ll": -0.0011204528878822058, "perturbed_sampled_ll_std": 0.0059622129584518905, "perturbed_original_ll_std": 0.0012236035283890326}, {"original": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product inserts' lack of information on the specificity of each method to the various forms of hCG.", "sampled": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that contribute to the accuracy and reliability of these results. These factors include the adherence to standardized testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories must use well-established and validated assays for measuring hCG levels. The assays should be specific to the", "perturbed_sampled": ["Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider all factors that contribute to the accuracy and reliability of these results. These factors include the adherence to standardized testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in testing and reporting results.\n\nFirstly, laboratories must use reliable and validated assays for measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that relate to the accuracy and reliability of these results. These factors include the adherence to standardized laboratory practices, the calibration of the equipment, the specificity and sensitivity of the assays used, and the proficiency of personnel in interpreting and reporting results.\n\nFirstly, laboratories must use well-established and validated assays in measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that contribute to the accuracy and reliability of these results. These factors include the adherence to assay protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories must use approved and validated assays for measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that contribute to the accuracy and reliability of these results. These factors include the adherence to standardized testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories should use well-established and validated assays for measuring serum hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider several factors that contribute to the accuracy and reliability of these results. These factors include the adherence to well-established testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories must use well-established , sensitive and specific assays for measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine whether laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to investigate the various factors that influence the accuracy and reliability of these results. These factors include the adherence to standardized testing protocols, the calibration of assay devices, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories must use well-established and validated assays for measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that may contribute to the accuracy and reliability of these results. These factors include adherence to standardized testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting the results. Laboratories must use well-established and validated assays for analyzing serum hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to understand the various factors that contribute to the accuracy and reliability of these results. These factors include the quality of the equipment, the adherence to standardized testing protocols, the calibration of the equipment, the specificity and sensitivity of the assays used, and the proficiency of the laboratory staff in interpreting and reporting results.\n\nFirstly, laboratories must use well-established and validated assays for measuring hCG levels. The assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that contribute to the accuracy and reliability of these results. These factors include the adherence to standardized testing protocols, the calibration of assay equipment, the specificity and sensitivity of the laboratory assay used, and the proficiency of laboratory personnel in interpreting and reporting results.\n\nFirstly, laboratories must use well-established laboratory assays for measuring hCG . These assays should be specific to the", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer:Answer: To determine if laboratories are reporting serum quantitative hCG (human chorionic gonadotropin) results correctly, it is essential to consider various factors that contribute to the accuracy and reliability of these results. These factors include adherence to testing protocols, the calibration of assay equipment, the specificity and sensitivity of the assays used, and the proficiency of laboratory personnel in interpreting and reporting results. First, laboratories must use well-established and validated methods for measuring hCG. The assays should be specific to the"], "perturbed_original": ["Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG measurement techniques and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the different measurement methods for the various forms of hCG and failure to recognize the specificity of the reagents used for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product inserts' lack of information on the specificity of each reagent for measuring the various forms of hCG.", "Question: Are all serum hCG assays reporting hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of the compound; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product inserts' lack of information on the specificity of each assay for the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and the consequent lack of nomenclature on the various forms ; (b) laboratory personnel's lack of awareness of the distinctions between the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' instructions and instructions for use of their products; and (d) most significantly, lack of information on the specificity of each method to measure the different forms of hCG.", "Question: Are laboratories reporting serum hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of the hCG molecule and confusion of nomenclature on the various forms of hCG; (b) a lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product labeling lacking the important additional piece of information on the specificity of each method to the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors are contributing to the confusion and error in reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) method inserts' lack of information on the specificity of each method to the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of serum quantitative hCG results, including (a) complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory lack of awareness of the distinctions of the forms of hCG and failure to assess the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' product inserts; and (d) most product inserts' lack of information on the specificity of each method to the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to inaccurate reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product inserts' lack of information on the specificity of each assay for the measurement of the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) a lack of awareness of the distinctions between the various forms of hCG and a failure to recognize the specificity of assays for their measurement; (c) lack of clarity and direction in manufacturers' reagent labeling; and (d) most product labels do not include a sufficient amount of information on the specificity of each method to the various forms of hCG.", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) complexity of hCG molecule and confusion of nomenclature on the identification of various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize differences in the performance of assays for their measurement; (c) lack of clarity or specificity in manufacturers' reagent labeling; and (d) most product inserts' lack of information on the specificity of each method to the various forms of hCG.", "prevent laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to laboratory error in the reporting of hCG results, including (a) the complexity of the molecule and confusion on the literature on the various forms of hCG; (b) laboratory personnel's lack of awareness of the distinctions of the forms of hCG and failure to recognize the specificity of assays for their measurement; (c) lack of clarity and uniformity in manufacturers' reagent labeling; and (d) most product labels' absence of information on the specificity of each method to the various forms of hCG."], "original_ll": -0.0023057697721790924, "sampled_ll": -0.003007043896245517, "all_perturbed_sampled_ll": [-0.0029849815757579997, -0.00043754570625513284, -0.0027986486371199115, -0.0003211934460933044, -0.008188900069836916, -0.003870543107310948, -8.990961859681418e-05, -0.003541278740410163, -0.0043272520822835656, -0.0029443764540799107], "all_perturbed_original_ll": [-0.0001601829424619231, -0.0029708582662929034, -0.0060936393212149605, -3.181876888163934e-05, -0.0010866885585825, -0.0009947435249390757, -0.0012379345039430075, -0.0008153466993519353, -0.001887276357381138, -0.0031007731192779996], "perturbed_sampled_ll": -0.0029504629437744666, "perturbed_original_ll": -0.0018379262062327081, "perturbed_sampled_ll_std": 0.0022796323232875237, "perturbed_original_ll_std": 0.0017248091893111892}, {"original": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "sampled": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "perturbed_sampled": ["Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has been proposed as a measure of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Antral follicle assessment has emerged as a useful tool for prediction of outcome and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves the assessment of visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment may serve as a significant predictor of success and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle assessment, which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of ovarian reserve and pregnancy outcomes in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. Antral follicle count (AFC), which involves counting the visible", "Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Antral follicle assessment has been proposed as a significant predictor of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has emerged as a significant predictor of pregnancy and response in IVF treatments, and is thought to have advantages over more traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC), which involves counting the visible", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer:Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment has been proposed as a significant predictor of ovarian reserve and response in IVF treatments, potentially offering advantages over traditional predictors such as age and follicle-stimulating hormone (FSH) levels. The antral follicle count (AFC) involves counting the visible"], "perturbed_original": ["Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is correlated with both maternal ages, basal cycle, day 12, follicle stimulated hormone, and antral follicle assessment. Antral follicle assessment is a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool in predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with ovarian ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological and hormonal markers.", "Question: Antral follicle assessment as a tool for ovarian age in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly related to both maternal age and cycle, day of last menstrual period, follicle stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a marker for ovarian age and in predicting outcome of IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly influenced by both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is associated with both maternal age and ovarian cycle, day 3 follicle, stimulated hormone and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological and hormonal markers.", "Question: The value of antral follicle assessment as a tool for predicting successful IVF--is it a better predictor than age or follicle stimulated hormone? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro pregnancy outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological and hormonal markers.", "Question: Antral follicle assessment a useful tool for predicting outcome in IVF. Is it a better predictor than age and FSH? Answer: In vitro fertilization outcome was strongly associated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day and night cycle, follicle stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age and follicle stimulated hormone. Antral assessment may provide a marker of maternal age that is distinct from the use of age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization (IVF) outcomes were strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker independent of age that could inform the ability to have a pregnancy independently from physical or hormonal markers.", "Question: Antral follicle assessment is a tool for predicting outcome in in vitro fertilization. Is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with ovarian ages, basal cycle, day 3 follicle, FSH, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age and other markers."], "original_ll": -0.00021141025798169645, "sampled_ll": -0.01178584354159133, "all_perturbed_sampled_ll": [-0.008643480582400168, -0.006010718506586917, -0.009262943674964465, -0.014580591434478598, -0.010106045620388426, -0.014578780020261795, -0.012108418685303166, -0.005173110841848487, -0.017543576539304127, -0.007326866499493667], "all_perturbed_original_ll": [-0.0002659894027811711, -0.00021435870554669718, -0.00014259049682654865, -0.0003205115475692035, -0.00022899941094266054, -0.0002528874304094737, -0.0005084447017201819, -0.00029800401366081097, -0.0002115474024990164, -0.00045262718359964595], "perturbed_sampled_ll": -0.010533453240502984, "perturbed_original_ll": -0.000289596029555541, "perturbed_sampled_ll_std": 0.003862716767288445, "perturbed_original_ll_std": 0.00010697662173416567}, {"original": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "sampled": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain conditions are at a higher risk", "perturbed_sampled": ["Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have shown that individuals suffering from chronic pain conditions are at a higher risk", "Question: Is pain a clinically relevant problem in acute or psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is individual\u2019s mental chronic, has a significant impact on an deteriorating............................................... health. Studies have shown that patients suffering from chronic pain conditions are at a higher risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain conditions are at a greater risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, psychiatry, a clinically relevant problem in general adult and can have a whether it is acute or chronic, . significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain conditions are at a higher risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, psychiatry. Pain, a clinically relevant problem in general adult are whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain of depression.................???? at a higher risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, clinically relevant a is acute problem in general adult psychiatry. Pain, whether it is a clinically relevant or chronic, has a significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain conditions are at a higher risk", "Question: Is pain a on an problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact pain individual's mental health. Studies have shown that patients suffering from of suicide.?.?????????????????????????????????????????? conditions are at a higher risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant shown that general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have are patients suffering from chronic pain for mental health problems.....???????????????????????????????????????? at a higher risk", "Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. Pain, whether it is acute or chronic, has a significant impact on an individual's mental health. Studies have shown that patients suffering from chronic pain conditions are at a higher risk", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer:Yes, pain is a clinically relevant problem in general adult psychiatry. patients' it is acute or chronic, has a significant impact on those who suffer mental health. Studies have shown that developing mental health disorders................................. from chronic pain conditions are at a higher risk"], "perturbed_original": ["Question: Is pain a clinically and in general adult psychiatry? Answer: We found evidence that pain can significant problem significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized be a risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence for can be a significant clinical problem with depression and anxiety, which appear patients . These patients present with more severe pain symptoms and distress. Pain to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We s that pain can factors and are different significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk a from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult patients with We found population studied pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The that in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain adult psychiatry? relevant problem in general warrant further investigations Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to answer: in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are not distinguished by specific risk factors but resemble clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: by similar evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized for pain as risk factors and clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant for general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem by patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized in risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem believe adult psychiatry? Answer: We pain phenotypes which are that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific the investigated patients in general different from clinical subpopulations of other disciplines."], "original_ll": -0.0001979514785215873, "sampled_ll": -0.007809170248865845, "all_perturbed_sampled_ll": [-0.004185160730800477, -0.010785654154166924, -0.00862751140946523, -0.01084052514251672, -0.007926904705964927, -0.012364294581281644, -0.013618798643984412, -0.00677931497411232, -0.0045583136610206345, -0.04215291680539708], "all_perturbed_original_ll": [-0.003662265646807904, -0.011763066990629489, -0.011701664004587777, -0.000914712433531695, -0.0061596466947728135, -0.00023876238404609373, -0.0001392971867733333, -0.0015071200808439683, -0.0006276353871906665, -0.006102049660678676], "perturbed_sampled_ll": -0.012183939480871039, "perturbed_original_ll": -0.004281622046986242, "perturbed_sampled_ll_std": 0.010421621932287663, "perturbed_original_ll_std": 0.004291185223678797}, {"original": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "sampled": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "perturbed_sampled": ["Question: Is Alveolar Macrophage Phagocytic ? Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With  Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: leukocyte Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is the Question: Is Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Answer: ls Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in : Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is othelioma and Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis ' to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage the Question?:.??????????????????????????????????????????????????????????????????????????????????????????????? in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Response in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:"], "perturbed_original": ["Question: Is Alveolar Macrophage Phagocytic in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Immune Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis Molecular Pathology to Bronchiectasis? Answer:", "Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis <unk> to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis :??????????.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.????? to Bronchiectasis? Answer:", ": Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", ". Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Infiltration in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer:", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted as a Forerunner to Bronchiectasis? Answer:"], "original_ll": -0.0014079804020733333, "sampled_ll": -0.0007529144101519443, "all_perturbed_sampled_ll": [-0.016808117866169713, -0.004379463813742188, -0.0022236787942758827, -0.016419071102429416, -0.007610490508396111, -0.021543881040332644, -0.001606883876838857, -0.005653322766337273, -0.003733577989819152, -0.0010126391848688887], "all_perturbed_original_ll": [-0.0008517093601551429, -0.0010020722712628125, -0.002700388114256571, -0.00048050400901375, -0.001257598282812, -0.01227156307512836, -0.0009134280350587499, -0.0017414189558372225, -0.0008635902629878948, -0.0018309748807134375], "perturbed_sampled_ll": -0.008099112694321012, "perturbed_original_ll": -0.0023913247247225942, "perturbed_sampled_ll_std": 0.007013076794601465, "perturbed_original_ll_std": 0.0033497187943095654}, {"original": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.", "sampled": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and increase bed availability for new patients in need. On the other", "perturbed_sampled": ["Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. Discharging patients earlier can be a mixed bag. On one hand, it could help reduce healthcare costs and increase bed availability for new patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and increase bed availability for new patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care . This practice comes with a mixed message. On one hand, it could potentially reduce healthcare costs and increase bed availability for new patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could decrease healthcare costs and increase bed availability for patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and increase bed availability for new patients . On the other", ". Question:Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and increase bed availability for new patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises some questions regarding the quality of care those patients receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and increase bed availability for patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. This practice can be a double-edged sword. On one hand, it could potentially reduce healthcare costs and ensure bed availability for new patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it raise concerns regarding the quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns regarding the quality of care they receive. It also highlights that this practice can be a double-edged sword. On one hand, this may potentially reduce healthcare costs and increase bed availability for patients in need. On the other", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer:Discharging patients earlier from Winnipeg hospitals raises critical concerns about the quality of care they receive. This practice can be a double-edged sword. On one hand, it can help reduce healthcare costs and increase bed availability for new patients in need. On the other"], "perturbed_original": ["Question: Discharging patients earlier from hospitals: does it adversely affect quality of care? Answer: Improving quality of patient care by shortening length of stay does not appear to result in greater risk of readmission or numbers of physician visits within 180 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from hospital does not seem to affect quality of care? Answer: Improvement in hospital cost efficiency by shortening hospital stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: Does this adversely affect quality of care? Answer: Improving hospital efficiency by shortening hospital length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify relationship between length of stay and expected readmission rates.", "Question: Discharging earlier from Winnipeg hospitals: does it adversely affect quality of care? In hospital wards, shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Long-term research is needed to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect hospital efficiency and quality of care? Answer: Improving hospital efficiency by shortening the length of stay doesn\u2019t appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Further research is needed to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in an increased likelihood of readmission or numbers of physician visits within 30 days after discharge from hospital. Further research is needed to identify relationships between shorter length of stay and expected readmission rates.", "to patients earlier from hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits in the first 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by decreasing the average length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Further study is needed to identify optimal duration of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased risk of readmission or numbers of deaths within 30 days after discharge from hospital. Research is ongoing to identify optimal lengths of stay and expected readmission rates.", "Question: Discharging patients earlier from Winnipeg hospitals: does it affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Additional research is needed to identify optimal lengths of stay and expected readmission rates."], "original_ll": -0.00015430797807585716, "sampled_ll": -0.003005863334206338, "all_perturbed_sampled_ll": [-0.004135285743762395, -0.004304474483698873, -0.003373328394781045, -0.0030630083874080886, -0.004236837352723914, -0.0063274286366314094, -0.0035262355672885906, -0.0032902593658490136, -0.0024574356466339473, -0.003111712699338874], "all_perturbed_original_ll": [-0.00022989144233492956, -0.0004317910358160869, -0.0006792932112366667, -0.00020568828999426467, -0.00025529033653733335, -0.00015351286741986488, -0.0029101003164479413, -0.0002719559379841666, -0.00010363625669536231, -0.0001889721186364286], "perturbed_sampled_ll": -0.003782600627811615, "perturbed_original_ll": -0.0005430131813103046, "perturbed_sampled_ll_std": 0.001013844774350658, "perturbed_original_ll_std": 0.0008045024262416747}, {"original": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "sampled": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "perturbed_sampled": ["Health optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict better ?????????????????????????????????????a advanced ages? Answer:", "positive outlook and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "outlook on life and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "coping and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict better more advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict ?t?t?t??t??t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t??t?? at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic individual have a better survival at advanced ages? Answer:", "optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict better :..?????????????????????????????????????\u2019 advanced ages? Answer:"], "perturbed_original": ["Question: Optimism and survival: older optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and age an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict : at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic .:?????.??.?.?.???.?.??.???.??.??.??.??.?.?????? better survival at advanced ages? Answer:", "depression, health and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: does an optimistic outlook predict better :s.sssssss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s??s?s?s??s??? advanced ages? Answer:", "Question: Optimism and /or an optimistic outlook predict better survival at advanced ages? Answer:", "optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism  does an optimistic outlook predict better survival at advanced ages? Answer:", "Question: Optimism and survival: Does an optimistic outlook predict better survival at advanced ages? Answer:"], "original_ll": -0.0036627784432045002, "sampled_ll": -0.004852377233071499, "all_perturbed_sampled_ll": [-0.00060931366125875, -0.0224697171108315, -0.007417924256875, -0.009253258410012, -0.016238119095444998, -0.004110827951494737, -0.013830482942411777, -0.008393902945497144, -0.0344186424702575, -0.040897108079225], "all_perturbed_original_ll": [-0.02003542755752105, -0.01896890223392778, -0.03222310133306842, -0.01619338585904273, -0.014357784101088887, -0.009174046675437843, -0.0230098283291, -0.03441812840434187, -0.009972106876582355, -0.002229666064803], "perturbed_sampled_ll": -0.01576392969233084, "perturbed_original_ll": -0.01805823774349139, "perturbed_sampled_ll_std": 0.0124916961627992, "perturbed_original_ll_std": 0.00953716570096682}, {"original": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "sampled": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", "perturbed_sampled": ["Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization was based on various", ". Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", ". Question:Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", "Question: Is multiparity considered an independent risk factor for adverse perinatal outcomes? Answer:Yes, multiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This is based on various", ":Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This conclusion is based on various", "Question: Is grandmultiparity considered an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", "Question: Is grandmultiparity considered an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth six or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", ". Question:Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various", "Question: Is grandmultiparity considered an independent risk factor for adverse perinatal outcomes? Answer:Yes, grandmultiparity, which refers to a woman who has given birth five or more times, is considered an independent risk factor for adverse perinatal outcomes. This categorization is based on various"], "perturbed_original": ["Question: Is geriatric a distinct and independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular antenatal care during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality, even after controlling for confounders, suggesting a need for closer observation compared with regular multiparous patients during labor and delivery.", ". Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparity had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous patients presented with increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer monitoring and differential management with regular multiparous patients during labor and delivery.", "Question: Is multiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, such as prematurity and smoking. This suggests the need for closer observation of multiparous patients during labor and delivery.", "? Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous patients had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for age. This suggests a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Was grandmultiparity an independent risk factor for adverse birth outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labour and delivery.", "Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: We have had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for other factors. There may be a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Can gestational diabetes be an independent risk factor for adverse perinatal outcomes? Adherent women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "a. Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery."], "original_ll": -0.0002062943326017742, "sampled_ll": -0.006089064866925932, "all_perturbed_sampled_ll": [-0.008953530587364407, -0.0177345284923907, -0.016079383258454916, -0.006113787283416781, -0.007566361948739285, -0.019373866867665002, -0.008456171898826166, -0.009571446240472995, -0.015676258214478985, -0.006577281292129833], "all_perturbed_original_ll": [-0.00019063588648, -0.0002796622191282813, -0.0013818431779878332, -0.00014623840573348485, -8.186003770558824e-05, -0.00017256511285283332, -0.00032243664100733326, -5.584554176000001e-05, -0.00013408356790101694, -0.0015963982472111111], "perturbed_sampled_ll": -0.011610261608393908, "perturbed_original_ll": -0.00043615688377674817, "perturbed_sampled_ll_std": 0.0047680614850996025, "perturbed_original_ll_std": 0.0005341470423068655}, {"original": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "sampled": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "perturbed_sampled": ["Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania ? generalize? Answer:", "of child depression in general? The characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "? Answer: Q: The characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: reference \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "and symptom characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", ": is the group sample generalizable? Answer: Clinical characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar disorder does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I : the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "of juvenile bipolar disorder. Question: Clinical characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: ? \"Treatment of Early Age Mania (team)\" sample generalize? Answer:"], "perturbed_original": ["Question: Diagnostic characteristics of child bipolar I disorder in the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does the ?????<unk>?respect?? redress??redress??redress??redress??redress??redress??redress?>?redress?>redress?<unk>?rder??report?rder?rder?rder??re Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania \" generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age e sample generalize? Answer:", "for all pediatric subtypes. Question: Clinical characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does .?????????.?..?.?.?.?.?.???.??.?.?.?.?..?.? of Early Age Mania (team)\" sample generalize? Answer:", "in the present report? Case characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age  sample generalize? Answer:", "Question: Diagnostic characteristics of child o disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer:", "Question: Diagnostic characteristics of child bipolar I disorder: does the the Early Age Mania (team)\" sample generalize? Answer:"], "original_ll": -0.008355510001374073, "sampled_ll": -0.009174584270434815, "all_perturbed_sampled_ll": [-0.028756716772497085, -0.013197183424843224, -0.040691810036735186, -0.003460814310715384, -0.028997832771993335, -0.015778583701676573, -0.013830905484656, -0.03809617558101, -0.010458412479312187, -0.004355808362419231], "all_perturbed_original_ll": [-0.03239760668883077, -0.0014675366128177332, -0.013264227624155417, -0.01115097522518261, -0.008013795640147574, -0.0009290827183969565, -0.35992675923, -0.008647503264913635, -0.017187344795657693, -0.04076885756284167], "perturbed_sampled_ll": -0.019762424292585817, "perturbed_original_ll": -0.049375368936294406, "perturbed_sampled_ll_std": 0.012744343521912746, "perturbed_original_ll_std": 0.10421967760252915}, {"original": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "sampled": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "perturbed_sampled": ["Question: Do provider care result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or ?'s's...'s...'s....s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s. case management in Florida's Medicaid program? Answer:", "Question: Do provider organizations result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care  in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management within Medicaid program? Answer:", "Question: How do Medicaid-based provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower cost with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs for primary care case management in Florida's Medicaid program? Answer:"], "perturbed_original": ["Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in ? program? Answer:", "Question: Do provider service networks ?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Does the implementation of provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures . HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in efficiencies compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider -management result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management ?????.???.?.???.??????.????.?.?.??.????? Medicaid program? Answer:", "Question: Do provider service networks result in the state compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do t orgs networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer:", "Question: Do provider service networks result in lower expenditures ? d'assurance??????.??.?.?.?.?.?.??.??.??.??.??.?.?.????? HMOs or primary care case management in Florida's Medicaid program? Answer:"], "original_ll": -0.001438833505069643, "sampled_ll": -0.0011579461421525, "all_perturbed_sampled_ll": [-0.0008050239855662964, -0.0010764922341303447, -0.001385733670914074, -0.0015655822365874996, -0.0014357618672576921, -0.0018944695829460714, -0.0020979149672307688, -0.005303029839325484, -0.000658154118524074, -0.001939436786807143], "all_perturbed_original_ll": [-0.005213520331190384, -0.014170112747901923, -0.009109566602905185, -0.027855229471385176, -0.0009498124660777777, -0.004999376425050358, -0.0020761567946656814, -0.0009500188931589286, -0.0014247647750079311, -0.015506770965633819], "perturbed_sampled_ll": -0.0018161599289289447, "perturbed_original_ll": -0.008225532947297715, "perturbed_sampled_ll_std": 0.001247486173858008, "perturbed_original_ll_std": 0.008269678054166712}, {"original": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "sampled": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "perturbed_sampled": ["Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:"], "perturbed_original": ["Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer:"], "original_ll": -0.002704938953254286, "sampled_ll": -0.0026924292349366666, "all_perturbed_sampled_ll": [-0.0028438406815485717, -0.0027099275129652384, -0.0021718850939761907, -0.0028333732435752382, -0.002757235800914286, -0.0024914856793499993, -0.001197922806945238, -0.0022947280661114286, -0.002216635235114286, -0.0011988556495166666], "all_perturbed_original_ll": [-0.002697346104852381, -0.0021559578892676188, -0.00254875117875, -0.00224666844905, -0.002456740328778571, -0.0014858901747266664, -0.002681424293408096, -0.002764369104291429, -0.0027499816716423813, -0.002549644454935238], "perturbed_sampled_ll": -0.0022715889770017145, "perturbed_original_ll": -0.0024336773649702385, "perturbed_sampled_ll_std": 0.0005862110265954155, "perturbed_original_ll_std": 0.00037120458435968285}, {"original": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "sampled": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "perturbed_sampled": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:"], "perturbed_original": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer:"], "original_ll": -0.003013916241042999, "sampled_ll": -0.00252785515893, "all_perturbed_sampled_ll": [-0.0031940426610250006, -0.004022497956887, -0.004779602896704999, -0.002420667427584, -0.0025495350128250005, -0.003163717040525001, -0.0027585576874339995, -0.0025635877148740003, -0.0030492172268919994, -0.0035111402078149994], "all_perturbed_original_ll": [-0.003884876343515, -0.0028092539744485, -0.0041452784546025, -0.0026169869583725002, -0.0028455546564335006, -0.0031299825341925005, -0.00271094408248, -0.0040272789061275, -0.0025031566977400006, -0.0025320948804555005], "perturbed_sampled_ll": -0.0032012565832565997, "perturbed_original_ll": -0.00312054074883675, "perturbed_sampled_ll_std": 0.0007016326600807976, "perturbed_original_ll_std": 0.0006146416649217053}, {"original": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "sampled": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "perturbed_sampled": ["Question: Does the radiographic transition zone correlate with the level of aganglionosis on the question.????????????????????????????????? Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of ?t.tt?nt!n!n!n!n!n!n!n!n!n!n!..!n!n!n!n!n!n!n!!n!n!n!n!n!!!! the specimen in Hirschsprung's disease? Answer:", "Question: Does the green zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of aganglionosis  specimen in Hirschsprung's disease? Answer:", "Question: How does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition . Question:s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of  the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition ??????????????n?n?n?n?n?n?n?n?n?n?n?nn?-?n?n??n?? with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the is it true that the zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:"], "perturbed_original": ["Question: Does the radiographic transition zone correlate with the level of aganglionosis e:?.???<unk>??????<unk>???<unk>!???<unk>!?!?<unk>!!!?!!!!!!!!!!!!!!!! specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition ?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?? with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with  of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic changes correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the  zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the location of the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer:", "Question: Does the radiographic transition zone correlate with the level of aganglionosis per specimen in Hirschsprung's disease? Answer:"], "original_ll": -0.001051026238237, "sampled_ll": -0.0008732400637660001, "all_perturbed_sampled_ll": [-0.002753795437053077, -0.008432845536371605, -0.0013794002734221426, -0.0022885885223642858, -0.0008174690100809676, -0.004334814814529474, -0.0013433721755040005, -0.00024252475379222226, -0.0008710428991513333, -0.0083140242806675], "all_perturbed_original_ll": [-0.004948090130248275, -0.013679526160668773, -0.014598532422393931, -0.001662097146636207, -0.001044889267924, -0.00936446140564222, -0.0011574868843117858, -0.0005856184222156666, -0.0008640442311303028, -0.0013366496060651725], "perturbed_sampled_ll": -0.0030777877702936607, "perturbed_original_ll": -0.004924139567723633, "perturbed_sampled_ll_std": 0.0028690231384092602, "perturbed_original_ll_std": 0.0052727801332155995}, {"original": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.", "sampled": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has consistently shown that males and females respond differently to trauma and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating these responses. Estrogen, in particular, has been identified as a protective agent in females, potentially explaining why women often exhibit better outcomes after such", "perturbed_sampled": ["Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the existence of hormonal differences. Research has shown that males and females respond differently to trauma and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating these responses. Estrogen, in particular, has been identified as a protective agent in females, potentially explaining why women often have better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the possibility of hormonal differences. Research has shown that males and females respond differently to trauma and hemorrhagic shock, suggesting a significant role for sex hormones in modulating these responses. Estrogen, in particular, has been identified as a positive factor in females, potentially explaining why women often exhibit better outcomes after such", "characterisation of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has consistently shown that males and females react differently to trauma and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating healing processes. Estrogen, in particular, has been identified as a protective agent in females, potentially explaining why women often exhibit better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has consistently shown that males and females respond differently to injury and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating these responses. Estrogen, for instance, has been identified as a protective factor for females, potentially explaining why women often exhibit better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of gender differences in protective mechanisms. Research has consistently shown that males and females respond differently to trauma and subsequent physiologic changes, suggesting a significant role of sex hormones in modulating these responses. Estrogen, in particular, has been suggested as a protective agent in females, potentially explaining why women often exhibit better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has consistently shown that males and females react differently to injury and subsequent hemorrhagic shock, which strongly suggests a significant role for hormonal differences in modulating these responses. Estrogen, in particular, has been identified as a protective agent in females, potentially explaining why females often exhibit better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: Are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards a role of hormonal differences. Research has consistently shown that males and females respond differently to trauma and subsequent hemorrhagic shock, suggesting a role for sex hormones in modulating these responses. Estrogen, in particular, has been identified as a protective agent in females, potentially explaining why women often exhibit better outcomes after such", "Question: Characterization of gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the female male differences after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has consistently shown that males and females respond differently to trauma and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating these differences. Estrogen, in particular, has been identified as a protective agent , potentially explaining why women often exhibit better outcomes when facing such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has shown that males and females respond differently to injury and subsequent hemorrhaging, suggesting a significant role for sex hormones in modulating these responses. Estrogen, in particular, has been identified as a protective agent in females, explaining why women often have better outcomes after such", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer:Characterization of the gender dimorphism after injury and hemorrhagic shock indeed points towards the influence of hormonal differences. Research has shown that males and females respond differently to trauma and subsequent hemorrhagic shock, suggesting a significant role for sex hormones in modulating these responses. LH, in particular, has been identified as a protective agent in females, potentially explaining why women often exhibit better outcomes after such"], "perturbed_original": ["may be the origin of the gender dimorphism after injury . Female gender and shock: are hormonal differences responsible? Answer: The adverse effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than hormonal differences may be responsible for gender-based differences in outcomes after injury.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of the female gender on multiple organ failure and nosocomial mortality remains significant in both premenopausal and postmenopausal women in comparison with similarly aged men. This is contrary to prior studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on the risk of wound failure and nosocomial infection was observed only in female gender and was not significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex -specific changes that occur after menopause in women. These results suggest that factors other than sex ism may be responsible for gender-based differences after injury.", "the nature of the gender dimorphism after injury and how well are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the observational evidence supporting the hypothesis that the sex hormone changes that occur in older age may be protective only in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.", "Question: Characterization of gender dimorphism after injury and shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known and well studied hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for female and male gender differences after injury.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The protective effect of female gender on multiple organ failure and mortality rates remains significant in both premenopausal and postmenopausal women compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes observed after menopause in women. These results suggest that factors other than sex hormones may be responsible for the observed gender differences after injury.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? The independent protective effect of female gender on multiple organ failure and nosocomial death remains significant in both premenopausal and postmenopausal women when compared to similarly aged men. This is contrary to previous studies in men and in younger women and the known physiologic hormonal changes that occur after menopause in women. These results suggest that factors other than sex hormones may be responsible for gender-based differences after injury.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock. Question: Are hormonal differences responsible? Answer: The independent protective effect of gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. These results are contrary to previous experimental studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than sex hormones are responsible for gender-based differences after injury.", "? Question: Remaining strength of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women when compared with similarly injured men. This is contrary to most previous studies and the known physiologic sex hormone changes that occur after menopause in women. These results suggest that factors other than hormones may be responsible for gender-based differences after injury.", "Question: Characterization of the gender dimorphism after injury and shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and death rates remains significant in both premenopausal and postmenopausal women compared with similarly aged men. This is contrary to previous experimental studies and the known physiologic sex hormone changes occurring before and after menopause in women. These results suggest that other mechanisms than the sex hormone differences may be responsible for gender-based differences after injury."], "original_ll": -0.0001179728202360577, "sampled_ll": -0.004066501006109019, "all_perturbed_sampled_ll": [-0.004598027521899109, -0.004226589703527401, -0.3807161945594526, -0.004956455097154606, -0.003977420896184812, -0.004659966372048462, -0.00418652833122495, -0.0039785693211272, -0.0040029044203040405, -0.0051374625774838], "all_perturbed_original_ll": [-0.0038886374068357547, -0.00014970737072145628, -0.008507160961583158, -0.005198901786454773, -0.00041786388069205876, -0.00014171253544727276, -9.959614636657142e-05, -3.6898659257999996e-05, -0.0005921178602509709, -0.00015030211018049502], "perturbed_sampled_ll": -0.0420440118800407, "perturbed_original_ll": -0.0019182898717790507, "perturbed_sampled_ll_std": 0.11289141321522354, "perturbed_original_ll_std": 0.002798661968193833}, {"original": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "sampled": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk can vary based on a combination of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of genetic risk coupled with recent deterioration in functioning, and the individual's response to stress or environmental triggers. The UHR criteria are", "perturbed_sampled": ["Question: Ultra high risk for psychosis criteria: are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk can vary based on a combination of factors, including the intensity and frequency of subthreshold psychotic symptoms, the presence of psychotic symptoms coupled with recent deterioration in functioning, and the individual's response to stress or environmental triggers. The UHR criteria are", "Question: Ultra high risk (UHR) for psychosis criteria: Are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk can vary based on a variety of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of genetic risk , recent deterioration in the symptoms of subsyndromal schizophrenia, and the individual's response to stress or environmental triggers. The UHR criteria are", "Question: Ultra high risk for psychosis , are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for Psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk vary based on a combination of factors including the intensity and frequency of psychotic symptoms, the presence of personality features suggestive of psychological risk coupled with recent deterioration in functioning, and the individual's response to stress or environmental triggers. The UHR criteria are", "Question: Ultra high risk (UHR) for psychosis criteria, are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk can vary according to a combination of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of recent severe distress coupled with recent deterioration in functioning, and an individual's response to stress or environmental triggers. The UHR criteria are", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Although there is a certain commonality within the Ultra High Risk (UHR) for psychosis criteria, there may be different levels of risk for transition to psychosis. These levels of risk can vary depending on a combination of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of genetic risk coupled with recent deterioration in functioning, and the individual's response to stress or environmental triggers. The UHR criteria are", "Question: Within the ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk vary based on a variety of factors including the intensity and frequency of current psychotic symptoms, the presence of genetic risk coupled with recent abnormalities of cognitive functioning, and the individual's response to stress or environmental exposure. The UHR criteria are", "Question: Ultra high risk (UHR) for psychosis : are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk vary based on a combination of several factors including: the intensity and frequency of subthreshold psychotic symptoms, the presence of genetic risk factors, recent deterioration in functioning, and the individual's response to stress or environmental triggers. The UHR criteria are", ": Are there different levels of risk for transition to psychosis? Question: Ultra high risk for psychosis criteria: are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk are based on a combination of factors including the intensity and duration of subthreshold psychotic symptoms, the presence of genetic risk coupled with recent deterioration in functioning, and the individual's response to biological or environmental triggers. The UHR criteria are", "Question: Ultra high risk for psychosis - are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are indeed different levels of risk for transition to psychosis. These levels of risk can vary based on a combination of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of genetic risk coupled with recent deterioration in functioning, and the individual's response to stress or environmental stimuli. UHR criteria are", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer:Yes, within the Ultra High Risk (UHR) for psychosis criteria, there are different levels of risk for transition to psychosis. These levels of risk can vary depending on a combination of factors including the intensity and frequency of subthreshold psychotic symptoms, the presence of acute psychotic symptoms coupled with recent deterioration in functioning, and the individual's response to stress or changes in environment. The UHR criteria are"], "perturbed_original": ["Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk of transition to psychosis? Answer: Our data suggest that UHR intake criteria predict higher rates of conversion over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" phase of the prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "at high risk (UHR) for psychosis criteria: are there different cohorts at risk for transition to psychosis? Answer: Our study shows that UHR intake criteria predict transition over 6 months on the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that more clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) intake criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition by 3 months in the course of Trait Disorder Treatment. The fact that the UHR patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high threshold for psychosis criteria: are there different levels of risk of transition to psychosis? Answer: Our data suggest that higher intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, whose risk of transition has been most clearly demonstrated in the course of treatment.", "Question: Ultra high risk for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria increase the risk of transition over 6 months in the order of Trait alone<APS<BLIPS. Our finding that BLIPS patients are at the highest risk of transition over the full course of treatment is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra sound intake (UHR) for psychosis criteria: are there different levels of risk of transition to psychosis? Answer: The results suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term in this study is in line with the \"early\" onset of prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially during the course of treatment.", "Question: Ultra high risk (UHR) for psychosis is defined as >1 year. Are there different levels of risk for transition ? Answer: Our data suggest that UHR intake s are at the greatest risk of transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention needs to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. However, it is clear that BLIPS patients are at the highest risk of transition over the course of treatment. This is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "for psychosis/unacceptably high risk (UHR) for psychosis criteria: are there different levels of BLIPS that predict transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS predicts transition at the highest level is notable because BLIPS can predict transition over the short term consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Upper threshold risk (UHR) intake criteria: are there patterns of risk for transition to psychosis? Question: Do UHR intake criteria predict transition risk? Answer: These data suggest that UHR intake criteria predict the order of risk over 6 months, in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment."], "original_ll": -0.00012921825949825688, "sampled_ll": -0.0032126303628002882, "all_perturbed_sampled_ll": [-0.005134441644678556, -0.003889315852424866, -0.003913748667257524, -0.005345813378842177, -0.0005725366664166355, -0.004211350484476571, -0.011472142479987497, -0.012040931925312182, -0.004455589065440715, -0.00366609701237419], "all_perturbed_original_ll": [-8.854542736522524e-05, -0.0030627841298402807, -0.00010316957137990476, -6.22603987545946e-05, -8.924809125590908e-05, -6.222259027300001e-05, -0.008288078051442157, -7.86475327017699e-05, -0.0020151135055432204, -0.0002606120777977869], "perturbed_sampled_ll": -0.005470196717721092, "perturbed_original_ll": -0.001411068137635385, "perturbed_sampled_ll_std": 0.003377925456276041, "perturbed_original_ll_std": 0.0024966124155537195}, {"original": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "sampled": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "perturbed_sampled": ["Question: Does angiotensin-converting enzyme-1 polymorphism polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead ?r :rr?r.r.rr.r.r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r?r kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene their to chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 q polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "? Question: How can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism ?e chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism ?:?????????n?n??n?n?n?n?n?n?nn?n?nn?n?nn?nn?n?nn?n?n?n?n?nn?n?n? chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene the disease to chronic kidney disease among hypertensive patients? Answer:", "Question: -1 enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", ". Q: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:"], "perturbed_original": ["Question: Does angiotensin-converting enzyme-1 (ACE-1) gene up regulation in relation to chronic kidney disease among hypertensive patients? Answer:", "Question: Does the (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", ". Question: Does an angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does ? (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among . Answer:", "? Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does ACE-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: s enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene ACE-1 mutations to chronic kidney disease among hypertensive patients? Answer:", "what angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer:"], "original_ll": -0.0008426167945971876, "sampled_ll": -0.00142388984574875, "all_perturbed_sampled_ll": [-0.008112889304416787, -0.035310419857357715, -0.0025718793019196664, -0.001936584213003704, -0.003381347007626176, -0.01278454651679781, -0.006155680483403374, -0.00312730979663129, -0.002941473863454815, -0.004058392877196875], "all_perturbed_original_ll": [-0.005439195187009393, -0.0009668985705491667, -0.001650438387312424, -0.0036840031301187503, -0.007257810853399655, -0.00971771273131879, -0.0009883428311223076, -0.018173912557938845, -0.005848758299674849, -0.02661471964355536], "perturbed_sampled_ll": -0.008038052322180822, "perturbed_original_ll": -0.008034179219199954, "perturbed_sampled_ll_std": 0.009615509455167804, "perturbed_original_ll_std": 0.007888372198873337}, {"original": "Question: Is there a first night effect on sleep bruxism? Answer:", "sampled": "Question: Is there a first night effect on sleep bruxism? Answer:", "perturbed_sampled": ["Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:"], "perturbed_original": ["Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:", "Question: Is there a first night effect on sleep bruxism? Answer:"], "original_ll": -0.006096912918561249, "sampled_ll": -0.004146444575705, "all_perturbed_sampled_ll": [-0.006094470391061249, -0.0056156129872375, -0.005591542776748125, -0.0056156129872375, -0.004169675200155625, -0.006096912918561249, -0.004409116935509375, -0.00379572569943125, -0.006103375698653124, -0.003213596240949375], "all_perturbed_original_ll": [-0.006313234942905625, -0.004166044518905626, -0.006256113878760625, -0.0045170189367625, -0.006167643897311249, -0.005954494075715624, -0.0028437104665343747, -0.00422444906708125, -0.004294458560784375, -0.006979340700587499], "perturbed_sampled_ll": -0.005070564183554437, "perturbed_original_ll": -0.005171650904534876, "perturbed_sampled_ll_std": 0.0010176790696246225, "perturbed_original_ll_std": 0.0012600640284502215}, {"original": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "sampled": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "perturbed_sampled": ["Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:"], "perturbed_original": ["Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:"], "original_ll": -0.0014883439064657894, "sampled_ll": -0.0016878135047421051, "all_perturbed_sampled_ll": [-0.0020842719060710523, -0.002992377994457894, -0.0026091413374842104, -0.0014839590078473683, -0.0019749022127489475, -0.002935601261348947, -0.0014459199843842106, -0.0035558860983263157, -0.003855689145783158, -0.0015396656456210522], "all_perturbed_original_ll": [-0.0014886470698342105, -0.0028976533614568424, -0.004070295342220001, -0.0028976533614568424, -0.001720226930806316, -0.0024962411870578945, -0.0011810692444473682, -0.0018709758946489476, -0.0029891027110026318, -0.0014307970432736843], "perturbed_sampled_ll": -0.0024477414594073154, "perturbed_original_ll": -0.002304266214620474, "perturbed_sampled_ll_std": 0.0008296866230909442, "perturbed_original_ll_std": 0.0008687650839709689}, {"original": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "sampled": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining how readily a new IT system is adopted. For instance, larger practices with more resources may", "perturbed_sampled": ["Question: Do general practice characteristics influence the uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in how readily a new IT system is adopted. For instance, larger practices with more resources may", "Question: Do general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, play crucial roles in determining how readily a new IT system is adopted. For example, larger practices with more resources may", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT systems, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining whether a new IT system is adopted. For instance, larger practices with more resources may", "Question: Do general practice characteristics significantly influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, such as the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, play crucial roles in how readily a new IT system is adopted. For instance, larger practices with extensive IT infrastructure and fewer new IT users may", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing use of IT, the level of IT literacy among staff, and the organizational culture, can play a role in determining how readily a new IT system is adopted by a practice. For instance, larger practices with more resources may", "Question: Do general practice characteristics influence the uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics can significantly influence the uptake of an information technology (IT) innovation in primary care. Practice characteristics, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining how readily a new IT system is adopted. For instance, larger practices with more resources may", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Several factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining how readily a new IT system is adopted. For instance, larger practices with existing IT infrastructure may", "Question: Do general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining how readily a new IT innovation is adopted. For instance, larger practices with more resources may", "Question: Do general practice characteristics influence the uptake of an information technology (IT) innovation in primary care? We examined whether general practice characteristics influence the uptake of an information technology (IT) innovation in primary care. Various factors, including the size of the practice, the existing IT infrastructure, the level of IT literacy among staff, and the organizational culture, can play crucial roles in determining how readily a new IT system is adopted. For example, larger practices with more resources may", "Question: Do general practice characteristics significantly influence uptake of an information technology (IT) innovation in primary care? Answer:Yes, general practice characteristics significantly influence the uptake of an information technology (IT) innovation in primary care. Various practice characteristics, including the size of the practice, the existing IT infrastructure, the level of IT literacy of the medical staff, and the organizational culture, can play crucial roles in determining how readily a new IT system is adopted. For instance, practices with more resources may"], "perturbed_original": ["Question: What general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use is influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial enthusiasts and for sustained and enduring use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that characteristic characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, increased nurse use was critical in extending the system beyond initial GP enthusiasts and for sustained and rising use over four years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in general practice? Answer: The analyses show that structural characteristics of a practice are not important for the uptake of a new IT innovation, but that its use may be influenced by post-graduate education in the relevant clinical condition. For the British healthcare system at least, practice nurse champions of the service have proved critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Data analyses indicate that structural characteristics of general practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts , resulting in sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of information technology (IT) innovation in primary care? Answer: The research shows that structural characteristics of general practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the appropriate clinical condition. For this diabetes system at least, practice nurse use was critical in spreading the knowledge of the system beyond the initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology innovation in primary care? The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate training of practice nurses in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for maintaining rising use in subsequent years.", "Question: Do general practice attributes influence uptake of information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and in encouraging sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical area, practice nurse role, and practice staff education. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond an early group of enthusiasts and for sustained and rising rates over subsequent years.", "Question: Do general practice characteristics influence the uptake of an information technology (IT) innovation in primary care? Answer: The evidence suggests that structural characteristics of a practice are not associated with uptake of a new IT innovation, but that its uptake could be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for its rising use in subsequent years.", "Question: Do general practice characteristics influence the uptake of an information technology (IT) innovation in primary care? Answer: The findings suggest that structural characteristics of a practice are not associated with uptake of a new IT facility, but that use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in extending uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years."], "original_ll": -0.00020837855999707863, "sampled_ll": -0.005087746850425264, "all_perturbed_sampled_ll": [-0.0051853310544059585, -0.004023764775542188, -0.004637535655782341, -0.004776936804329703, -0.0040320765826, -0.004234853572502785, -0.0047103601895681245, -0.003515634229519381, -9.028755880648936e-05, -0.005899316266495918], "all_perturbed_original_ll": [-0.0002024284114070115, -0.00017737502490433336, -0.0001800500483355789, -0.0011091371549393182, -0.00012998508066763443, -0.0001411235967884884, -0.00019267234494761367, -0.0001099453693418, -0.00012630973323235955, -0.00012897762630831463], "perturbed_sampled_ll": -0.004110609668955289, "perturbed_original_ll": -0.00024980043908724524, "perturbed_sampled_ll_std": 0.0014826318677929485, "perturbed_original_ll_std": 0.00028803676852212265}, {"original": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "sampled": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "perturbed_sampled": ["using high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are negative flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than  for preterm infants? Answer:", "Question: Are high ?s:?ssssssssss?ss.ss.ss.s????sss?s?sss?sss?ssssssss?ss?s cannulae noisier than bubble CPAP for preterm infants? Answer:", "? Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than bubble CPAP in infants? Answer:", "Question: Are high flow nasal cannulae n bubble CPAP for preterm infants? Answer:", "Question: Are s nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than normal for preterm infants? Answer:"], "perturbed_original": ["Question: Are pressure flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae acceptable when used with a bubble CPAP for preterm infants? Answer:", "Question: Are negative flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier versus CPAP for preterm infants? Answer:", "Question: Is high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than ? for preterm infants? Answer:", "p high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high flow nasal cannulae noisier than bubble CPAP for ? Answer:", "CPAP with high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer:", "Question: Are high -efficiency cannulae noisier than bubble CPAP for preterm infants? Answer:"], "original_ll": -0.0015270509518669562, "sampled_ll": -0.0012586055670600002, "all_perturbed_sampled_ll": [-0.34661250945, -0.0013985527911652173, -0.0040789070708049996, -0.0003077387155495918, -0.010873112035118752, -0.001801416192922857, -0.018293201038085, -0.019610890699699998, -0.0012596416440165217, -0.0013950600427442858], "all_perturbed_original_ll": [-0.0009541152572230435, -0.002441031195341667, -0.0007493653560195652, -0.0024612345177150003, -0.0012834436978613043, -0.0021464517071333334, -0.012248259843110954, -0.0085578867551765, -0.01578299465419913, -0.022557428658752175], "perturbed_sampled_ll": -0.04056310296801073, "perturbed_original_ll": -0.006918221164253266, "perturbed_sampled_ll_std": 0.1022494486110751, "perturbed_original_ll_std": 0.007227189202851065}, {"original": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "sampled": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "perturbed_sampled": ["Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible  assays? Answer:", "based RT-PCR? Response: RNA transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "? Question: Long transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR ? Are correlated results possible from homebrew assays? Answer:", ". Q: DNA transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "s. DNA transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time the transcript are correlated results possible from homebrew assays? Answer:", "versus transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "by real-time PCR? Question: Target gene transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR: are correlated results possible from homebrew assays? Answer:"], "perturbed_original": ["of transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR : are  possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time ? are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR : correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR : are  possible from homebrew assays? Answer:", "and transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", ". Y2S transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "based on sequence amplification? Question: DNA transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR using correlated results possible from homebrew assays? Answer:", "Question: BCRABL transcript detection by quantitative real-time PCR with correlated results possible from homebrew assays? Answer:"], "original_ll": -0.02527053879096833, "sampled_ll": -0.02446224143884167, "all_perturbed_sampled_ll": [-0.037661339200685706, -0.05864139012692519, -0.052978079841476074, -0.0182943466485875, -0.02946402628387954, -0.0208038556492035, -0.0132213833421125, -0.012232005794022104, -0.02355692872522643, -0.0026753699407829168], "all_perturbed_original_ll": [-0.002749920826644445, -0.06792050088122727, -0.003407781926997826, -0.022180856160530428, -0.0357583070261, -0.046505832570702774, -0.038836929538837495, -0.03392493192870179, -0.006568682185247826, -0.006388475741475654], "perturbed_sampled_ll": -0.026952872555290146, "perturbed_original_ll": -0.02642422187864655, "perturbed_sampled_ll_std": 0.017092157478850584, "perturbed_original_ll_std": 0.0208004378272556}, {"original": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "sampled": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "perturbed_sampled": ["Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:"], "perturbed_original": ["Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer:"], "original_ll": -0.001938292626185, "sampled_ll": -0.0016556415339527776, "all_perturbed_sampled_ll": [-0.0017719495590355554, -0.0015107717572361112, -0.0016075774460488886, -0.0014701346721022219, -0.001886913650327222, -0.0019434016652500003, -0.0019217194576722223, -0.0019295954059416664, -0.0009427986544883332, -0.0017146212975416668], "all_perturbed_original_ll": [-0.001485709470085555, -0.001970981396953333, -0.0014126692335155553, -0.0016071532738327777, -0.0017427175785533335, -0.003956095519782777, -0.0016417001866099999, -0.0018461477930483336, -0.0017058118590966664, -0.002429341127016111], "perturbed_sampled_ll": -0.0016699483565643888, "perturbed_original_ll": -0.001979832743849444, "perturbed_sampled_ll_std": 0.00029376101907385396, "perturbed_original_ll_std": 0.0007124597726293109}, {"original": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "sampled": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,", "perturbed_sampled": ["Question: Is fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degenerative changes in the intervertebral disks of the spine, can lead to neck pain,", ". Question:Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the complex (FN-AC) has been identified in the context of cervical disk disease. This complex may play a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often results in degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex present in cervical neck, Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified role in context of cervical disk disease. This complex plays a significant disk disease? the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degenerative changes in the intervertebral disks of the disk disease? can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex involved in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degeneration in the intervertebral discs of the cervical spine, can lead to neck pain,", "Question: Is fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified as an important biological marker in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of cervical disc degeneration. Cervical disk disease, which often manifests as degenerative changes in the discs of the cervical spine, can lead to neck pain,", "Question:Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which manifests as degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of cervical disc degeneration. Cervical disk disease, which has been characterized as degenerative changes in the disks of the cervical spine, can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays a significant role in the pathophysiology of disk degeneration. Cervical disk disease, which often manifests as degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer:Yes, the fibronectin-aggrecan complex (FN-AC) has been identified in the context of cervical disk disease. This complex plays an important role in the pathophysiology of disk degeneration. Cervical disc disease (CDD), which often manifests as degenerative changes in the intervertebral disks of the cervical spine, can lead to neck pain,"], "perturbed_original": ["Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins including the FAC, and a correlation with pH. Further study of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical evaluation of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential biomarker or therapeutic target in disk injury is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of injury markers such as MCP, fragments of structural matrix proteins such as FAC, and a shift in cytoskeleton pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further analysis would identify the FAC fragment as a potential diagnostic biomarker or therapeutic target for chronic disk disease in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks revealed the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as fibrillar actin and a correlation with pH. Further evaluation of the fibronectin-aggrecan complex as a potential diagnostic biomarker or therapeutic target is warranted in cervical spine.", "Question: Is the fibronectin-aggrecan complex (FAC) associated with cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, FIL-5, and IL-6, structural matrix proteins such as FAC, and a correlation with pH. Future investigation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the FAC present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural proteins such as collagen, and a lowered pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the FAC present in cervical disk injuries? Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as sphingomyelinase, increased levels of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker and therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in patients with cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers including MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibre optic complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with cervical spine injury. An evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine."], "original_ll": -7.981600845337663e-05, "sampled_ll": -0.003967956430149895, "all_perturbed_sampled_ll": [-0.0054582189287393544, -0.010232256167585977, -0.010329975744548633, -0.005959271657520664, -0.004236703535618511, -0.0059547183694445335, -0.007393511818539361, -0.005894746609394254, -0.005907565737229682, -0.006093180880098776], "all_perturbed_original_ll": [-0.00013711668897285718, -0.00014204945174873417, -0.00010604927387374999, -0.0001458827302639506, -0.0007250796335163218, -0.00013843319240295455, -5.892068413208954e-05, -9.10699897238889e-05, -0.00022406990987884615, -0.00020672092537863014], "perturbed_sampled_ll": -0.006746014944871976, "perturbed_original_ll": -0.0001975392479892023, "perturbed_sampled_ll_std": 0.001909762546630913, "perturbed_original_ll_std": 0.00018190662079827245}, {"original": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and", "sampled": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer:Given the current text, an extended version could resemble the following:\n\n", "perturbed_sampled": ["Question: Prostate bed target motion using RTOG -A and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer:Given the current text, an extended version could include the following:\n\n", "Question: Prostate bed and inferior motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior prostate? portions of the clinical : Answer:Given the current text, an extended version could resemble the following:\n\n", "Question: Prostate ? [ ] This is interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target the next the current text, : Reusing version could resemble the following:\n\n", ". Measurement of bed target motion using clinical target volume definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer:Given the current text, an extended version could resemble the following:\n\n", "Question: Prostate bed target interfractional motion using RTOG consensus inferior corners daily CT on rails : Does target motion differ between superior and question could of the clinical target volume? Answer:Given the current text, an extended ... resemble the following:\n\n", "Question: Prostate bed target interfractional : RTOG consensus definitions inferior apexes CT on rails : Does target motion differ between superior and . of the clinical target volume? Answer:Given the current text, an extended version could resemble the following:\n\n", "Question: Can CT target interfractional motion be described from intraradiographic data? The consensus on daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer:Given the current text, an extended version could resemble the following:\n\n", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : the motion differ between superior and inferior portions of above discussion target volume? Answer:Given the questions, an extended version could resemble the following:\n\n", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and success of this trial, on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer:Given the explore the an extended version could ........................................... following:\n\n", "Question: Prostate bed target motion using RTOG fMRI and daily CT on rails : Does target motion differ between superior and inferior portions of the prostate volume? Answer:Given the current text, an extended version could resemble the following:\n\n"], "perturbed_original": ["Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails the target motion differ between superior and inferior portions of differences between the target volume? Answer: There are no statistically apparent motion .............................................. SUP-CTV and", "Question: Prostate bed motion differ motion using RTOG consensus definitions and daily CT on rails : Does target There between superior and inferior portions of the clinical target volume? and are no statistically apparent motion differences between SUP-CTV and", "Question: Prostate bed target interfractional inferior portions RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and There of the clinical target volume? IP-CTV using are no statistically apparent motion differences between SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG consensus scanners daily CT interfractional : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no . motion differences between SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails no significant differences in target motion differ between superior and inferior portions of the clinical target volume? Answer: There are between the apparent motion the SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target target volume? (S) between superior and inferior portions of the clinical differences Answer: There are no statistically apparent s between SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG inferior prostatic area and daily CT on rails : Does target motion differ between superior and target volume? of the clinical : no. Source Answer: There are no statistically apparent motion differences between SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between ? inferior portions of the clinical target volume? Answer: superior no statistically apparent There between SUP-CTV and", "for a bed target interfractional motion using RTOG consensus and daily trend data and standardized RTOG rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and", "Question: Prostate bed target interfractional motion using RTOG inferior planes and daily CT on rails : Does target motion differ between superior and There of the clinical target volume? . There are no..re are no statistically apparent motion differences between SUP-CTV and"], "original_ll": -0.014042042199012696, "sampled_ll": -0.014673645070406728, "all_perturbed_sampled_ll": [-0.02113694157487714, -0.03519755085357659, -0.01532525222009245, -0.23383384166442311, -0.08744435779172, -0.0765020945051203, -0.027821320583335085, -0.05467531555980566, -0.04085975544329364, -0.016191009893943332], "all_perturbed_original_ll": [-0.007416266722642454, -0.009991727285903192, -0.012932940335960373, -0.011779467718535688, -0.00279292003710717, -0.009788609280544149, -0.012133812010799818, -0.037175898136123584, -0.0028077084868616663, -0.018532655848590738], "perturbed_sampled_ll": -0.060898744009018735, "perturbed_original_ll": -0.012535200586306885, "perturbed_sampled_ll_std": 0.06221444135386506, "perturbed_original_ll_std": 0.009347601426058363}, {"original": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.", "sampled": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic oncology, with Thai women being no exception. Second-look laparotomy, a surgical procedure performed after the initial treatment", "perturbed_sampled": ["Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic oncology, with Thai women being no exception. Second-look laparotomy, a second surgery to assess cancer status, is performed for this condition after initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a challenging problem in gynecologic oncology, with Thailand being no exception. Second-look laparotomy, a surgical procedure performed at 2-year follow-up, has been increasingly used as initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic oncology, with Thailand being no exception. Second-look laparotomy, a surgery performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma is prevalent in Thai women. Should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic cancer, with Thai women being no exception. Second-look laparotomy, a surgical procedure performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we try to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic oncology, with Thai women being no exception. Second-look laparotomy, a procedure performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we still offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in many regions of the world with Thai women being no exception. Second-look laparotomy, a procedure performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in clinical oncology, with Thai women being no exception. A second-look laparotomy, a surgical procedure performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in oncology, with Thai women being no exception. Second-look laparotomy, a surgical procedure performed after the initial treatment", ". Question:Advanced epithelial ovarian carcinoma in Thai women: should we still offer second-look laparotomy? Answer:Advanced epithelial ovarian carcinoma remains a significant challenge in gynecologic oncology, with Thai women being no different. Second-look laparotomy, a surgical procedure performed after the initial treatment", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer:Advanced ovarian carcinoma remains a recurrent problem in gynecologic oncology, with Thai women being no exception. Second-look laparotomy, a surgical procedure performed after chemotherapy, is the initial treatment"], "perturbed_original": ["Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a significant impact on overall and disease-free survival. Tumor grade is the only independent prognostic factor for predicting overall survival among patients.", "Question: Advanced ovarian carcinoma in Thai women: should we continue to recommend second-look laparotomy? A second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.", "Question: Advanced epithelial ovarian cancer (ECO) with high grading for Thai patients. Question: Should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the independent prognostic variable for survival of the patients.", "Question: Advanced ovarian carcinoma in Thai women: should we continue to perform second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for the progression-free survival of the patients.", "Question: Advanced epithelial ovarian carcinoma in women over 75 years: should we continue to use second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. The resection status is the only independent prognostic variable for survival of the patients.", "Question: Advanced epithelial ovarian carcinoma in postmenopausal women: should we continue to offer second-look laparotomy? Answer: The presence of second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the best prognostic variable for survival of the patients.", "Question: Advanced epithelial ovarian carcinoma in Thai population. Question: Should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall patient survival. Tumor grade is the only independent prognostic variable in the majority of the patients.", "Question: Advanced epithelial ovarian carcinoma in younger women: should we try to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Age is the only independent prognostic variable for survival of the patients.", "Question: Advanced epithelial ovarian cancer in a Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent risk variable for survival in these patients.", "Question: Second-look laparotomy for ovarian carcinoma in Thai women: should we continue to offer it? Answer: The second-look laparotomy doesn't have a favorable impact on overall survival and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients."], "original_ll": -5.786035640903226e-05, "sampled_ll": -0.0021098694592671424, "all_perturbed_sampled_ll": [-0.003079678281084305, -0.0022244456194084727, -0.0024308837354678685, -0.0022552077679025, -0.0019160063130067744, -0.005305820635106834, -0.0026521440477159665, -0.0024454183396088337, -0.014167759208622063, -0.0024689952287589062], "all_perturbed_original_ll": [-4.5418659221904764e-05, -0.00011682761433379312, -9.623290942785714e-05, -8.533401534920637e-05, -7.008747289212121e-05, -8.200015135878789e-05, -5.6729401354603176e-05, -6.262046552499998e-05, -0.002053895018387705, -6.562900710935484e-05], "perturbed_sampled_ll": -0.003894635917668252, "perturbed_original_ll": -0.00027347747149603335, "perturbed_sampled_ll_std": 0.0035412418057880323, "perturbed_original_ll_std": 0.000593794802810049}, {"original": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "sampled": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "perturbed_sampled": ["Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in ? birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth ?\" in the first week of life? Answer:", "Question: Does gastric carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon week?chchchchchchchchchchchchchchchchchchchchchchchchccccccccccchcccccchccccchcccchccccc extremely low birth weight infants in the first week of life? Answer:", "Question: Does skin carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose respiratory carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: How does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal concentration measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate  carbon dioxide in extremely low birth weight infants in the first week of life? Answer:"], "perturbed_original": ["Question: Does respiratory carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate ?!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Does fetal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate ?t:tt?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate or carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Does end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer:", "Question: Dose end-tidal carbon dioxide measurement correlate with ? dioxide in extremely low birth weight infants in the first week of life? Answer:"], "original_ll": -0.010321043591654668, "sampled_ll": -0.010266812054042333, "all_perturbed_sampled_ll": [-0.025040599389110345, -0.019055224106134482, -0.0014361661493296296, -0.03448045820634667, -0.002273015200408148, -0.013082073570411428, -0.0034165561711180003, -0.015340291449802758, -0.01425419273332138, -0.02125965504657679], "all_perturbed_original_ll": [-0.0032991898771685185, -0.03377582092160714, -0.002606556630379259, -0.012826004505582762, -0.012033088251311382, -0.058218387255281674, -0.028797302530679313, -0.002905720031732759, -0.01596096935841, -0.031866391367475856], "perturbed_sampled_ll": -0.014963823202255963, "perturbed_original_ll": -0.020228943072962864, "perturbed_sampled_ll_std": 0.01010147164804036, "perturbed_original_ll_std": 0.016949964585179174}, {"original": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "sampled": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "perturbed_sampled": ["Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:"], "perturbed_original": ["Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer:"], "original_ll": -0.0021490091893758825, "sampled_ll": -0.003348890301385294, "all_perturbed_sampled_ll": [-0.0029176747649429413, -0.00216584431671647, -0.002165722042767059, -0.0028492696643635292, -0.002276854586475882, -0.0022151380134976468, -0.001832239750507647, -0.0015040816202135294, -0.0022521434925129413, -0.0015786689830605879], "all_perturbed_original_ll": [-0.0024739665369935297, -0.0020255747803735293, -0.002222967830760588, -0.002213834548783529, -0.0020823906293352943, -0.002488802601502941, -0.0016962145436899998, -0.0027600401176364705, -0.0027600401176364705, -0.0024828445702770588], "perturbed_sampled_ll": -0.0021757637235058232, "perturbed_original_ll": -0.0023206676276989412, "perturbed_sampled_ll_std": 0.0004413085926125834, "perturbed_original_ll_std": 0.0003192058243878399}, {"original": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "sampled": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "perturbed_sampled": ["Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:"], "perturbed_original": ["Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer:"], "original_ll": -0.0029060867522964283, "sampled_ll": -0.0014712452146035712, "all_perturbed_sampled_ll": [-0.0014712452146035712, -0.0013641668543857139, -0.001068197795267857, -0.0013773237882428574, -0.001629298959210714, -0.0014264525383178572, -0.0018710545968678573, -0.001037714813817857, -0.0010574481121107143, -0.001026314882875], "all_perturbed_original_ll": [-0.002889255976267857, -0.0010468425421464285, -0.0021954255622535714, -0.0010332829104249999, -0.003582503733375001, -0.0010292364175535714, -0.0008729588913535716, -0.0033258430521678566, -0.0010443769885035714, -0.0028675409947392858], "perturbed_sampled_ll": -0.0013329217555700002, "perturbed_original_ll": -0.0019887267068785714, "perturbed_sampled_ll_std": 0.0002711779860734207, "perturbed_original_ll_std": 0.0010397774626061083}, {"original": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "sampled": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", "perturbed_sampled": ["Question:Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", ":Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy is generally considered less invasive than retropubic radical prostatectomy", "Question: Are robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less sede retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is generally considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive prostatectomy radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical surgery is generally considered less invasive than retropubic radical prostatectomy", "Question:Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is considered less invasive than retropubic radical prostatectomy", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive indeed radical prostatectomy? Answer:Yes, robotically assisted laparoscopic radical prostatectomy (RALP) is much less invasive than retropubic radical prostatectomy"], "perturbed_original": ["Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This time, that for the first ? RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than robotically assisted radical prostatectomy? Answer: This study showed for the first time than induces lower tissue trauma than RRP.", ". Question: Does robotically assisted laparoscopic radical prostatectomy less en the tissue trauma than open retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue damage than RRP.", "Question: Is robotic assisted radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RP had lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study shows for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the significantly that first time lower tissue trauma than RRP.", "Question: Is robotic assisted laparoscopic radical prostatectomy less traumatic than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is laparoscopic vs. laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that LRP causes lower tissue trauma than RRP."], "original_ll": -0.0002608525136644445, "sampled_ll": -0.003752119092933393, "all_perturbed_sampled_ll": [-0.007077363228255357, -0.00410120653039875, -0.013215837101186852, -0.0035856507799600004, -0.0036005730180405458, -0.0037955037155189284, -0.008857119458811962, -0.004707611560193673, -0.00789309823108164, -0.006384234145893846], "all_perturbed_original_ll": [-0.0016686009035288888, -0.01409039304286095, -0.009286751431300208, -0.0002081657902068889, -0.0003525752870682927, -0.00021812716593425002, -0.0002749057457368182, -0.0007609984864828572, -0.00031725753682068175, -0.0003218873232463044], "perturbed_sampled_ll": -0.006321819776934155, "perturbed_original_ll": -0.0027499662713186142, "perturbed_sampled_ll_std": 0.002929330054592998, "perturbed_original_ll_std": 0.004615389363197919}, {"original": "Question: Globulomaxillary cysts--do they really exist? Answer:", "sampled": "Question: Globulomaxillary cysts--do they really exist? Answer:", "perturbed_sampled": ["Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:"], "perturbed_original": ["Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:", "Question: Globulomaxillary cysts--do they really exist? Answer:"], "original_ll": -0.0031725099017164706, "sampled_ll": -0.0031610639714576465, "all_perturbed_sampled_ll": [-0.0026543240539811767, -0.0021344222939164706, -0.0031740860779941177, -0.003152705153261765, -0.0011283301795735295, -0.0016805304571323532, -0.003173533972132353, -0.0012825170972323528, -0.0012397608842411767, -0.0026150423718000007], "all_perturbed_original_ll": [-0.0025822611177429415, -0.0026239947075088234, -0.0032731308959058824, -0.0020649425618458825, -0.0032307917776694117, -0.00396795175301353, -0.0024607334847058823, -0.0020418917970164707, -0.0017867938513617648, -0.001744647385982353], "perturbed_sampled_ll": -0.0022235252541265293, "perturbed_original_ll": -0.002577713933275294, "perturbed_sampled_ll_std": 0.0007977377146472896, "perturbed_original_ll_std": 0.0006876276550384182}, {"original": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "sampled": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic procedures for", "perturbed_sampled": ["Question: Question: Is advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic procedures for", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: No, the advanced age in and of itself is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic procedures for", "Question: Is the advanced age a contraindication to laparoscopic surgery? Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic surgery has been demonstrated for", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an effectiveness of to GERD has increased........................................... Disease) laparoscopic surgery. Over the past few decades, the safety and dication laparoscopic procedures for", "Question: Is advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the last several decades, the safety and efficacy of laparoscopic procedures for", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic surgery for", "Question: Is the aging process a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of GERD surgery for", "Question: Is advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of laparoscopic procedures for", "Question: Is the presence of advanced cancer a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced cancer, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few years, advances have been made in the safety and efficacy of laparoscopic procedures for", "Is the advanced age a contraindication to GERD laparoscopic surgery? Answer:Answer: Advanced age, in and of itself, is not an automatic contraindication to GERD (Gastroesophageal Reflux Disease) laparoscopic surgery. Over the past few decades, the safety and efficacy of procedures for"], "perturbed_original": ["Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment option for GERD even in elderly patients, warranting low morbidity and mortality rates and a long-term improvement of symptoms comparable to younger patients.", "Question: Is the advanced age of patients a factor in the acceptance of elderly patients to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? is a antireflux surgery , and safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality Laparoscopic a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux mortality after laparoscopic surgery a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and resolution and a , of symptoms comparable to younger patients.", "Question: Is the age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rate, and a significant improvement of symptoms comparable to younger patients.", "Question: Is the presence of severe GERD or elderly patients a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a rapid improvement of symptoms comparable to younger patients.", "Question: Is advancing age a contraindication to laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients with low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to antireflux surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low postoperative mortality rates and a significant improvement in functional status comparable to younger patients.", "Question: Is advanced age a contraindication to GERD surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, with very low morbidity and mortality rates and a significant improvement of symptoms compared to younger patients."], "original_ll": -0.0002188513502852459, "sampled_ll": -0.004159906307044226, "all_perturbed_sampled_ll": [-0.004134843549602432, -0.0027883399805962495, -0.0004425191417945714, -0.016046458315683382, -0.0031438660667317147, -0.0034208730959540837, -0.002972963415106714, -0.00414442123743257, -0.00309427218677423, -0.003682947246144394], "all_perturbed_original_ll": [-1.1015156822786882e-05, -0.0002456494004813636, -0.024337341042525162, -0.03173293879627894, -0.0002517920660078689, -0.0002468836304560606, -0.00015065577297660715, -0.0001621022603159322, -9.070234849929824e-05, -1.761808799440678e-05], "perturbed_sampled_ll": -0.004387150423582035, "perturbed_original_ll": -0.005724669856235843, "perturbed_sampled_ll_std": 0.0040103011923330765, "perturbed_original_ll_std": 0.011277452954415366}, {"original": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "sampled": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "perturbed_sampled": ["Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic fitness, characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, including activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and promote the body\u2019s utilization of oxygen, plays a significant role", ". Question:Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by physical activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and force the use of the muscles, may play a significant role", "Question: Does aerobic exercise influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes? Answer:Yes, aerobic exercise does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, which is characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic fitness, which is defined by activities that increase the heart rate and promote the use of oxygen, plays a significant role", "Question:Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer:Yes, aerobic fitness does influence microvascular function in healthy adults who are at risk of developing Type 2 diabetes. Aerobic exercise, characterized by activities that increase the heart rate and promote the use of oxygen, plays a significant role"], "perturbed_original": ["Question: Does aerobic fitness influence microvascular responsiveness in healthy individuals at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. In the 'at-risk' group alone, individuals with higher levels of fitness also had better microvascular and endothelial responsiveness.", "Question: Did physical fitness influence maximal oxygen uptake in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. But, in the 'at-risk' group individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does physical activity level influence microvascular function in healthy controls with a high risk of developing type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction, skin oxygen uptake was not reduced compared with healthy controls. However, in the control group with diabetes alone, individuals with higher levels of aerobic fitness also had better microvascular oxygen responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin folds, maximal oxygen uptake was not reduced compared with controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular oxygen responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group, skin erythrocyte maximal oxygen uptake was not reduced compared to healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had higher levels of microvascular function and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in adults at risk of developing Type 2 diabetes? Answer: In this trial of 94 individuals with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "? Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the high aerobic group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence glucose uptake in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction , blood glucose uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with lower levels of aerobic fitness also had lower levels of microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular responsiveness in healthy adults at risk of developing Type 2 diabetes? Answer: In the at-risk group with skin microvascular hyperresponsiveness, oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness."], "original_ll": -0.0006866916788904055, "sampled_ll": -0.006368043024916087, "all_perturbed_sampled_ll": [-0.006414804114725215, -0.006676207715294649, -0.005248939442256666, -0.014789658884551407, -0.006490884763597323, -0.010917698087643717, -0.00637410401981817, -0.006806448766763288, -0.00032101706707250005, -0.009847140459922571], "all_perturbed_original_ll": [-0.0003876178720674648, -0.00035667589692166664, -0.0005505317396384417, -9.842664516277778e-05, -9.801542992042859e-05, -6.523763720102565e-05, -0.001071627059070274, -0.0014661972256781693, -0.0011102884258393422, -5.325002554243243e-05], "perturbed_sampled_ll": -0.007388690332164551, "perturbed_original_ll": -0.0005257867957042023, "perturbed_sampled_ll_std": 0.0036253727924694195, "perturbed_original_ll_std": 0.000487163068340621}, {"original": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "sampled": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "perturbed_sampled": ["Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide For In Vitro Fertilization. Does It Improve Fertility Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment with Microdose Leuprolide in In Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Use of Leuprolide in in Vitro Fertilization. Does It Improve Fertility Rate in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist s Used in Addition to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Infertile Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Fertility Compared to the Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in it Improve Does ? IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "duction and Antagonist Pretreatment Prior to Microdose Leuprolide in in fertile Women: Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Q1: Agonist Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Did it Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol Estreme as Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in Does It Fertilization. ? Does it Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:"], "perturbed_original": ["Question: Estradiol and Antagonist Pretreatment Prior to Microdose Micropills for in Vitro Fertilization. Does It Improve IVF Success Rate of Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Affect Outcomes in Poor Quality Women Compared to Oral Contraceptive Pill? Answer:", "Question: Estrogen Receptor Antagonist Pretreatment Prior to Use of IVF in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist ic to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Treatments? Answer:", "Question: Testosterone Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders to Microdose Leuprolide, Similar to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Pretreatment?..?.?.?.????????????????????????????????????? Outcomes in Poor Responders as Compared to Oral ? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Response Does It Improve to Microdose Leuprolide in Poor Responders as Compared to Oral Contraceptive Pill? Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in In Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Leuprolide alone? Best Answer:", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in to Antagonists or Does It Improve IVF Outcomes in Poor Responders ? or to Oral Contraceptive Pill? Answer:"], "original_ll": -0.001423112887169, "sampled_ll": -0.0014849857952922, "all_perturbed_sampled_ll": [-0.0016443703332426002, -0.0006335658362022449, -0.0005740051750116667, -0.004993382820266226, -0.0012654193428894, -0.011553682126706443, -0.0033035682770197567, -0.0009586504590096154, -0.0010545999646382979, -0.00046297903210619994], "all_perturbed_original_ll": [-0.0012386515653963264, -0.002267611498606875, -0.00048356966457361694, -0.0011294169833078722, -0.0006080760536191304, -0.0003704410406805357, -0.0027235111726185, -0.007342392698576124, -0.0022315555442525, -0.012846659389106735], "perturbed_sampled_ll": -0.0026444223367092447, "perturbed_original_ll": -0.003124188561073822, "perturbed_sampled_ll_std": 0.0032662972916570766, "perturbed_original_ll_std": 0.0037740154293034282}, {"original": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.", "sampled": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and ethical aspects of the vaccines, urging their followers to avoid participating", "perturbed_sampled": ["Question: Did the call for boycott by the Catholic bishops have a significant impact on polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised serious questions about the safety and ethical aspects of the vaccines, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. Catholic clerics expressed concerns over the safety and ethical aspects of the vaccines, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Mexico in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Mexico in 2015. The bishops raised concerns over the safety, security and ethical aspects of the vaccines, urging their followers to avoid participating", "call for boycott by the Catholic bishops affect the vaccination coverage in 2015. Will the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops will indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and ethical aspects of the vaccines, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and ethical aspects of the vaccines, urging their followers to boycott the vaccine and to abstain from participating", "Question: Did the call for a boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised serious concerns about the safety and ethical aspects of the vaccines, urging people to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and ethical aspects of the vaccination campaign, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did not have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and quality of the vaccines, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops have a significant impact on polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns about safety and ethical aspects of the vaccines, urging their followers to avoid participating", "Question: Did the call for boycott by the Catholic bishops affect polio vaccination coverage in Kenya in 2015? Answer:Answer: The call for a boycott by the Catholic bishops did indeed have a significant impact on the polio vaccination coverage in Kenya in 2015. The Catholic bishops raised concerns over the safety and ethical aspects of vaccination programmes that use live vaccines, urging their followers to refrain from participating"], "perturbed_original": ["Question: Did the call for boycott by the Catholic bishops affect the polio eradication campaign in Kenya in 2014? The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination campaign coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott of vaccines by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott of vaccines is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the polio eradication campaign significantly. However, if the call for boycott is repeated in future it might have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine s which are being boycotted are addressed accordingly.", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott of the 2015 polio vaccination program did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have a significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.", "Question: Did the call for vaccine boycott by the Catholic bishops affect polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott of the vaccine by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could have a negative implication to polio eradication. It is important to ensure that any vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott by the Catholic bishops negatively affect polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not negatively impact the campaign significantly. However, if the call for boycott is repeated in future it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety concerns are addressed accordingly.", "Question: Did the call for boycott by the Catholic health authority affect the vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in Kenya it could have some significant negative implication to polio eradication. It is therefore important to ensure that any vaccine safety issues are addressed accordingly.", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is sustained in future it could have some significant negative implication to the campaign. It is therefore important to ensure that any vaccine safety issues are addressed accordingly."], "original_ll": -0.0007669889706417105, "sampled_ll": -0.004567648483840001, "all_perturbed_sampled_ll": [-0.003814283068240125, -0.005104831406699079, -0.010028817114417792, -0.0052217738226446, -0.005444659080331585, -0.0016383044840314472, -0.0026013832529697403, -0.006306135304484267, -0.003401677115320909, -0.0015151339283824999], "all_perturbed_original_ll": [-0.0009375395417628, -0.0008191615003845453, -0.0007661656930263292, -0.0032521608485977377, -0.00036430822041270586, -0.0009262575200094669, -0.00038507018151480514, -0.0013399201036602597, -0.0005824423578850666, -0.0007637327147504054], "perturbed_sampled_ll": -0.004507699857752204, "perturbed_original_ll": -0.0010136758682004123, "perturbed_sampled_ll_std": 0.002408080208746182, "perturbed_original_ll_std": 0.00079341310262957}, {"original": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "sampled": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Factors such as the intensity of pain,", "perturbed_sampled": ["Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Despite neck pain being reported as a type of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain report decreased ability to perform daily activities, reduced overall physical health, and an impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Although several variables, such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical functioning and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life by changing conditions such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical functioning, and a negative impact on their mental health. Constant, prolonged episodes of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Factors such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and a negative impact on mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. In this study, we examined variables such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and an impact on their mental health. The persistence of neck pain often can lead to chronic conditions, exacerbating the decline in health-related quality of life. Factors such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions that have further impacts on the decline in quality of life. Factors such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical health, and negative impact on psychological health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the physical health concerns and decreasing quality of life. Factors such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals experiencing neck pain often report decreased ability to perform daily activities, reduced overall physical functioning, and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Neck pain, such as the intensity of pain,", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer:Yes, neck pain is associated with worse health-related quality of life 6 months later. Individuals with neck pain often report decreased ability to perform daily activities, diminished physical health, and a negative impact on their mental health. The persistence of neck pain over time can lead to chronic conditions, exacerbating the decline in quality of life. Factors such as the intensity of pain,"], "perturbed_original": ["Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. This suggests that neck pain may be a contributor of lower physical HRQoL in the future. An awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life (HRQoL) 6 months later? Answer: We found that neck pain was negatively associated with physical HRQoL but not mental HRQoL. Our study suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with future physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL may be important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the potential future effects of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the future management of neck pain in populations.", "with physical HRQoL? Is neck pain associated with physical but not mental health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in populations. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was associated with worse physical, but not mental HRQoL. Our analysis suggests that neck pain may be a contributor to poor physical HRQoL in the future. Raising awareness of the possible future impact of neck pain on physical and mental health is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life (HRQoL) 6 months later? Answer: Our study found that neck pain was negatively associated with physical but not mental HRQoL. Our findings suggest that neck pain may be a contributor of future physical HRQoL in the study population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a significant contributor of impaired physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers when it comes to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Our results indicate that neck pain was associated with worse physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for clinicians and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with reduced health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our results suggest that neck pain may be an independent predictor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in diverse populations."], "original_ll": -0.0001758533768327835, "sampled_ll": -0.0050700506985487375, "all_perturbed_sampled_ll": [-0.005233235409503163, -0.004996385681525834, -0.010602636874077706, -0.005716699632475979, -0.0091924944179073, -0.004988774137087684, -0.005414770199647629, -0.005227111493304063, -0.0002601286174442105, -0.005354554232183192], "all_perturbed_original_ll": [-0.00016647495335595747, -0.00016311253191, -0.0002375670609472727, -0.00025883624649408163, -0.0007549551745214425, -0.00010700119293864581, -0.00044174370249240385, -0.0001508573330956123, -0.00013606052166937498, -0.00010576948850000001], "perturbed_sampled_ll": -0.005698679069515676, "perturbed_original_ll": -0.00025223782059247916, "perturbed_sampled_ll_std": 0.0025974780950671467, "perturbed_original_ll_std": 0.00019248802364217347}, {"original": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "sampled": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond adequately to medical therapy.", "perturbed_sampled": ["Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond to medical therapy.", "is decompressive surgery effective for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond to conventional medical therapy.", "Question: Is decompressive accompanied with for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis who do compressive cervical myelopathy, particularly in patients a viable treatment option not respond adequately to medical therapy.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond adequately to medical therapy.", "Question: Is surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond adequately to medical therapy.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in cases that do not respond adequately to medical therapy.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer:Decompressive surgery can be an effective treatment option sarcoidosis accompanied cord compressive cervical by Question: myelopathy, particularly in patients who do not respond adequately to medical therapy.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical with compressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied do not cervical myelopathy, particularly in patients who with compressive respond adequately to medical therapy.", "Question: Is decompressive surgery Yes. Decompressive surgery spinal cord an effective treatment option for with compressive cervical myelopathy? Decompressive surgery can be an effective treatment option for spinal cord sarcoidosis accompanied by compressive cervical myelopathy, particularly in patients who do not respond adequately to medical therapy.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? for can be an effective treatment cervical myelopathy, spinal cord sarcoidosis accompanied by compressive Decompressive surgery particularly in patients who do not respond adequately to medical therapy."], "perturbed_original": ["Question: Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy is not evident. Early diagnosis for sarcoidosis from other organ and steroid treatment may be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompressive surgery for spinal cord sarcoidosis with compressive myelopathy is not evident. Early diagnosis with correlations from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: The effect of surgery on spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other causes and early steroid therapy should be needed.", "Question: Is cervical decompressive surgery effective for spinal cord sarcoidosis accompanied by cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other clinical sources and supportive care with steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. As for sarcoidosis from other organ s, drug therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive myelopathy? Answer: The effect of decompressive surgery for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy are needed.", "Question: Is decompressive surgery effective in spinal cord sarcoidosis accompanied with compressive myelopathy? Answer: The effect of decompressive surgery for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompression effective for spinal cord sarcoidosis accompanied with compressive myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was studied. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive accompanied with compressive Answer: The effect of decompression for spinal cord sarcoidosis were myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy . needed.", "Question: Is decompression surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis is needed and early organ and steroid therapy should be needed."], "original_ll": -0.0004141017035655738, "sampled_ll": -0.0017522409407815002, "all_perturbed_sampled_ll": [-0.0023083547436862713, -0.012540112305703245, -0.004595874522463871, -0.0022302111403169995, -0.0013433385943929824, -0.001380803060769661, -0.0066216660205471655, -0.0010163334969863639, -0.0017862220621354837, -0.02036895144457082], "all_perturbed_original_ll": [-0.00048019966031499995, -0.0006534158291754999, -0.000158390207187, -0.00028161300994656246, -0.004203170518045084, -0.0007168435352148333, -0.0005649235041688526, -0.0008712423985975863, -0.007083616529415087, -0.00041661998614793644], "perturbed_sampled_ll": -0.005419186739157286, "perturbed_original_ll": -0.0015430035178213442, "perturbed_sampled_ll_std": 0.00601396970414317, "perturbed_original_ll_std": 0.0021578517797494093}, {"original": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "sampled": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "perturbed_sampled": ["Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:"], "perturbed_original": ["Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer:"], "original_ll": -0.0017731983223021424, "sampled_ll": -0.0011599503021785715, "all_perturbed_sampled_ll": [-0.002084481347182143, -0.0005659762741678571, -0.0005724168124385713, -0.0020527349254714287, -0.0005724168124385713, -0.0018285931804664284, -0.0013946512979749997, -0.0008960065948892856, -0.0007497376753771431, -0.0011549267138785712], "all_perturbed_original_ll": [-0.0016875223852214287, -0.0009464538335892858, -0.0013328887855357143, -0.0028796879472478575, -0.000991206019442857, -0.0009679206536428571, -0.001983137940512143, -0.0017476341457735715, -0.0014649867028607144, -0.0009016746619357141], "perturbed_sampled_ll": -0.0011871941634285, "perturbed_original_ll": -0.0014903113075762143, "perturbed_sampled_ll_std": 0.0005854681783364629, "perturbed_original_ll_std": 0.0005889013594662263}, {"original": "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "sampled": "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there can be variations depending on the specific location, resources available, and population served. These teaching sites are", "perturbed_sampled": ["Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there can be variations depending on the specific teaching site's location, resources available, and population served. These teaching sites are", "Question: Does family practice at residency teaching sites often reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there can be important variations based on the specific location, resources available, and population served. These teaching sites are", "Question: Does family practice at residency teaching sites often reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there may be variations depending on the specific location, resources available, and population served. These teaching sites are", "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there are variations depending on the specific location, teaching site, and population served. These teaching sites are", "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites should reflect community practice, though there can be variations depending on the specific location, resources , and patient population . Family practice teaching sites are", "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, though there can be variations depending on the specific location, resources available, and types of patients served. These teaching sites are", "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites reflects community practice, though there can be variations depending on the specific location, resources available, and population served. However, not all teaching sites are", "Question: Does family practice at residency teaching sites reflect community practice? Answer:Yes, family practice at residency teaching sites often reflects community practice, although there can be variations depending on the specific location, demographics, and resources available. These teaching sites are", "Question: Does family practice at residency teaching sites include community practice? Answer:Yes, family practice at residency teaching sites typically includes community practice, though there can be variations depending on the specific location, resources available, and population served. These teaching sites are", "Does family practice at residency teaching sites reflect community practice? Family practice at residency teaching sites often reflects community practice, though there may be variations depending on the specific location, resources available, and population served. These teaching sites are"], "perturbed_original": ["Question: Does family practice at residency training sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency training sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency training sites reflect community practice? Answer: The residency training sites of the Case Western Reserve Universities College of Medicine provide patient care opportunities similar to those found in a national survey of community-based general practitioners.", "Question: Do the patterns of practice at residency teaching sites reflect community practice? Answer: The residency training programs at the Northeastern Ohio Universities \u2019 Schools of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites differ from community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to the patient care that occurs in a private practice of family and general practitioners.", "Question: Does family medicine residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to the experience of individuals completing training in a national survey of family and general practitioners.", "Question: To what extent does the practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide community practice opportunities similar to those found in a national survey of family and general practitioners.", "Answer: How does family practice at residency teaching sites reflect community practice? Answer: The residency teaching sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national database of family and general practitioners.", "Question: Does family practice training in teaching sites reflect community practice? Answer: The residency training programs of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in the survey of family and general practitioners.", "Question: Does family practice at these training sites reflect community practice? Answer: The residency programs of the Family Medicine Residency Program of the Northeastern University College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners."], "original_ll": -0.00017111625418869564, "sampled_ll": -0.005015781846101399, "all_perturbed_sampled_ll": [-0.005730058060851886, -0.006861061582897691, -0.004638373350530196, -0.006158358806608367, -0.006371786068076601, -0.005058082853460385, -0.0070265780108271165, -0.005378807452180613, -0.0052259879334918, -0.0001424669986304545], "all_perturbed_original_ll": [-0.0001221192414728261, -0.00017350058762543476, -0.0007377831573310871, -0.005930656856962858, -0.00012875245941460002, -0.0001416064961077551, -0.0001842499720822449, -0.00012697579828319149, -0.00015680781334066664, -0.00011571040044470585], "perturbed_sampled_ll": -0.00525915611175551, "perturbed_original_ll": -0.000781816278306537, "perturbed_sampled_ll_std": 0.0018595662559616661, "perturbed_original_ll_std": 0.0017255243105583403}, {"original": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer:", "sampled": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer:", "perturbed_sampled": ["Question: Is duration of psychological treatment for depression ????????????????????????????????????????? return into treatment? Answer:", ": Is the duration of psychological treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment for depression related to ? treatment? Answer:", "Question: Is duration of treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment for depression ??????????????????????????????????????????? return into treatment? Answer:", "Question: Is duration in treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment for depression ?.................................... return into treatment? Answer:", "Question: Is duration of psychological treatment for depression related to  treatment? Answer:", "Question: Is duration of psychological treatment for depression related ? into treatment? Answer:", "Question: Is duration of psychological treatment for  to return into treatment? Answer:"], "perturbed_original": ["Question: Is duration of psychological treatment for depression ............................... return into treatment? Answer:", "Question: Is duration of ? for depression related to return into treatment? Answer:", ". Is duration of psychological treatment for depression related to return into treatment? Answer:", "How is the duration of psychological treatment for depression related to return into treatment? Answer:", ": How is duration of psychological treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment for depression ?................... return into treatment? Answer:", "Question: Is duration on treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment for depression related .................................................................................... into treatment? Answer:", "Is duration of psychological treatment for depression related to return into treatment? Answer:", "Question: Is duration of psychological treatment not related to return into treatment? Answer:"], "original_ll": -0.005838607887773529, "sampled_ll": -0.005830328322655883, "all_perturbed_sampled_ll": [-0.019525995432152003, -0.014938991662618748, -0.00735282877775625, -0.008189396037662503, -0.021273563575675003, -0.0030374950418500003, -0.03596278572754444, -0.013367753769113333, -0.05650572001721249, -0.3385031600785715], "all_perturbed_original_ll": [-0.019412309701100004, -0.0021304019171125, -0.021844128829702665, -0.0009331469531493334, -0.030540724604771252, -0.02708300835913889, -0.00276779297813125, -0.011402388044533333, -0.00104700862375, -0.009152993143076875], "perturbed_sampled_ll": -0.05186576901201563, "perturbed_original_ll": -0.01263139031544661, "perturbed_sampled_ll_std": 0.09671405470521251, "perturbed_original_ll_std": 0.010736231823140223}, {"original": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "sampled": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "perturbed_sampled": ["Question: Whether increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and resistance indexes early signs .................................. abnormalities in young obese males? Answer:", "Question: Is increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery flow resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and Yes, the early signs of vascular abnormalities in young obese males? Answer:", "Question: To what extent are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery vascular resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid ? and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: How much increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery - resistance indexes early signs of vascular abnormalities in young obese males? Answer:"], "perturbed_original": ["Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in in males? Answer:", "Question: Are increased carotid artery plaque resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and resistance indexes early predict vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and resistance indexes early ?????n?n??n??n???n??nn?n?n?nn?n?nn?n?n??n?n?n?n?n?n?n??n vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery sss?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and wall stress as indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and resistance indexes early markers vascular abnormalities in young obese males? Answer:", "Question: Is increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Do increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer:", "Question: Are increased carotid artery pulsatility and resistance angiographic signs of vascular abnormalities in young obese males? Answer:"], "original_ll": -0.0026181337952104005, "sampled_ll": -0.0032516591150672, "all_perturbed_sampled_ll": [-0.0032422986803043994, -0.028313850658199996, -0.0025798983998796005, -0.0015347434725152174, -0.00325585648125423, -0.001838886908426786, -0.001695490715997826, -0.0022686086813543485, -0.0022524277822473077, -0.0016103826717508692], "all_perturbed_original_ll": [-0.021992597203158694, -0.002538430746696957, -0.0064636402299575, -0.0023178420176075383, -0.013065958417489226, -0.002797873317734074, -0.014670947964468746, -0.0033909715550963994, -0.0032374726494500006, -0.0045147546646104], "perturbed_sampled_ll": -0.004859244445193059, "perturbed_original_ll": -0.007499048876626953, "perturbed_sampled_ll_std": 0.007840570968974546, "perturbed_original_ll_std": 0.006411385685384236}, {"original": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer:", "sampled": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer:", "perturbed_sampled": [". Does brainstem mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders ? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients  of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging detect in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients ? of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with  consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance ?tttt?t?t?t?t?t?t?t??t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t recovery in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging ? in patients with disorders of consciousness? Answer:", "does mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging detect in patients with disorders of consciousness? Answer:"], "perturbed_original": ["Question: Can mental imagery functional magnetic resonance imaging predict ?????????????????????????????????????????????? patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging nenenene?ne fMRI?ne fMRIne fMRIne fMRIne fMRInenenenenenenenenenenenene in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders  Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients ? of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance in recovery in patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with  consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with ? consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict  patients with disorders of consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with do consciousness? Answer:", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders ? Answer:"], "original_ll": -0.0024769790054964993, "sampled_ll": -0.0032117749643499997, "all_perturbed_sampled_ll": [-0.04206372597698556, -0.032259186420963336, -0.0032606484564777784, -0.005047305002589474, -0.007519904865311112, -0.023226848405916666, -0.0024408081393076, -0.0243984854923, -0.012341666644893752, -0.003991559016341052], "all_perturbed_original_ll": [-0.023661138506559334, -0.0011014747558822449, -0.053399639506964705, -0.008569935743327779, -0.004580871040147369, -0.019909863754922222, -0.01804796619616316, -0.005869943692505556, -0.01585169205399474, -0.029155578891966665], "perturbed_sampled_ll": -0.01565501384210863, "perturbed_original_ll": -0.018014810414243375, "perturbed_sampled_ll_std": 0.013269713853318108, "perturbed_original_ll_std": 0.014558813056252558}, {"original": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "sampled": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "perturbed_sampled": ["Question: the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope : l Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: : Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the  of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a No the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", ": Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:"], "perturbed_original": ["Question: Does the Simultaneous ?nsesss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does  Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope  Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "1. Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of . Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope and an Endoscope Increase the Incidence of Ventriculoperitoneal Shunt Infection? Answer:", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer:"], "original_ll": -0.001997739782888065, "sampled_ll": -0.000884722635007742, "all_perturbed_sampled_ll": [-0.004633917897168333, -0.00071174894076, -0.01292177641184129, -0.01309069380139333, -0.01303503531518484, -0.0037139309106499993, -0.009058870153590711, -0.0010593534739670965, -0.0049405781048424136, -0.001114535696945484], "all_perturbed_original_ll": [-0.012374643507955082, -0.005665676515187037, -0.0007045013056703227, -0.0018938647715420688, -0.015734755211982067, -0.0016913097260300002, -0.0027639009463069695, -0.0012511064727357146, -0.0006512790782897144, -0.0015776602253358067], "perturbed_sampled_ll": -0.006428044070634351, "perturbed_original_ll": -0.004430869776103478, "perturbed_sampled_ll_std": 0.004895540156929424, "perturbed_original_ll_std": 0.005055188529623064}, {"original": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "sampled": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "perturbed_sampled": ["Question: Can a Novel Surgical Approach to the Temporomandibular Joint s and Reduce Complications? Answer:", "Question: Did a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can ?:?!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can a Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can a Novel t to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Does a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can a Novel Surgical ??????????????????????????????????????????????????????????????????????????????????????????????????????????????? the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Would a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:"], "perturbed_original": ["Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can ????????????????????????????????????? Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: How Does a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can \u2019t Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and ? Answer:", "Question: Does the Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Can an Assisted Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:", "Question: Q: Does a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer:"], "original_ll": -0.0008406139224819999, "sampled_ll": -0.0014853128456395997, "all_perturbed_sampled_ll": [-0.006629676635774167, -0.0010074981359688001, -0.0016938365406440625, -0.00132360755536, -0.0055998387545329155, -0.0003780596719808, -0.004565960235128627, -0.0007407679823495999, -0.0006204824926561904, -0.0008386827789980953], "all_perturbed_original_ll": [-0.001154918706964, -0.00118042002611875, -0.0009662271771923077, -0.009081799409245599, -0.0010143140047848, -0.006260396445651999, -0.0027080391586581823, -0.0005143886661412, -0.0013373294915146154, -0.0004126773387511111], "perturbed_sampled_ll": -0.002339841078339326, "perturbed_original_ll": -0.0024630510425022564, "perturbed_sampled_ll_std": 0.0022096687953033632, "perturbed_original_ll_std": 0.002743208355963335}, {"original": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "sampled": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "perturbed_sampled": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:"], "perturbed_original": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer:"], "original_ll": -0.0011900243977665, "sampled_ll": -0.0010693998961805, "all_perturbed_sampled_ll": [-0.0009493021853765, -0.0007776490632494999, -0.0009505038492100002, -0.0010665499313065002, -0.0008548166023995, -0.0009561171513315002, -0.0006363800599625, -0.0007775542177015, -0.0009651045147599996, -0.0009550221423964998], "all_perturbed_original_ll": [-0.0011289046788865002, -0.0012628913375575, -0.0009497660716315, -0.000926351872769, -0.0012737439737915, -0.0009527747771649999, -0.0009473180483175001, -0.0009381119253525, -0.0012099388902824999, -0.0008859809638625], "perturbed_sampled_ll": -0.0008888999717693999, "perturbed_original_ll": -0.0010475782539616, "perturbed_sampled_ll_std": 0.00011975099992026732, "perturbed_original_ll_std": 0.00014556271783517372}, {"original": "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "sampled": "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cells in the dentate gyrus of the hippocampus. They project to the CA3 region of the hippocampus, where they synapse onto the dendrites of pyramidal cells and interneurons. The release", "perturbed_sampled": ["Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cells in the dentate gyrus of the hippocampus. They project to the striatum of the cerebral cortex, where they synapse onto the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory signal in the brain. Mossy fibers are axons originating from the granule cells in the dentate gyrus region of the hippocampus. They project to the CA3 region of the hippocampus, where they axon onto the dendritic spines of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cells in the dentate gyrus of the hippocampus. They project to the amygdala region of the hippocampus, where they synapse onto the dendrites of pyramidal cells and are known to release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are small fibers originating from the neurons in the middle gyrus of the hippocampus. They project to the CA3 region of the hippocampus, where they synapse onto the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are derived from the granule cells in the dentate gyrus of the hippocampus. These fibers migrate to the CA3 region of the hippocampus, where they synapse on the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cells within the dentate gyrus of the hippocampus. They project to the CA3 region of the brain where they terminate along the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cell layer of the dentate gyrus of the hippocampus. They project to the CA3 region of the hippocampus, where they synapse onto the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a primary excitatory neurotransmitter in the brain. Mossy fibers are axons originating from the granule cells in the dentate gyrus of the hippocampus. They project to the CA3 region of the hippocampus, where they synapse onto the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release glutamate, which is a major excitatory transmitter in the brain. Mossy fibers are axons originating from the granule cells in the dorsal horn of the hippocampus. They project to the CA3 region of the hippocampus, where they contact the dendrites of pyramidal cells and interneurons. The release", "Question: Do mossy fibers release GABA? Answer:No, mossy fibers do not release GABA. Instead, mossy fibers are known to release dopamine, which is a major excitatory neurotransmitter in the brain. Mossy fibers are axons that protrude from the granule cells in the dentate gyrus of the hippocampus. They project to the CA3 region of the hippocampus, where they synapse onto the axons of pyramidal cells . The release"], "perturbed_original": ["Question: Do mossy fibers release GABA? Answer: We have not found any compelling evidence that these mossy fibers release GABA, but we have discovered a mossy fiber GABAergic signal. The role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other studies have found that this signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABAergic signals? We have thus provided preliminary evidence that there is a mossy fiber GABAergic signal. The physiologic role of the mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that the mossy fiber GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its role.", "Question: Do mossy fibers release GABA? Answer: We have provided compelling evidence that there is a mossy fiber GABAergic signal. The physiological importance of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory function, but further work is needed to elucidate its actual role.", "Question: Do mossy fibers produce GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal remains elusive, but it is likely to be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, but further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Our results have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiological function of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is released after a specific stimulus to the mossy fiber. This signal could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its role.", "Question: Do mossy fibers release GABA? Answer: We have seen compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that the mossy fiber GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or neuroprotective effect, but further work is needed to elucidate its actual role.", "Question: Do mossy fibers emit GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber signal is uncertain, but may be of developmental importance. Other evidence suggests that the mossy fiber signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to determine its actual role.", "Question: Do mossy fibers release GABA? Answer: We have provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to determine its actual role.", "Question: Do mossy fibers release GABA? We have provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate the physiologic role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of the mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Our evidence suggests that this GABAergic signal is transiently upregulated during brain stimulation. This could suggest a positive inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role."], "original_ll": -0.00010563416911694736, "sampled_ll": -0.0037760188272243146, "all_perturbed_sampled_ll": [-0.0037854929699045452, -0.004334601699659327, -0.0036802966741808912, -0.00426081358485303, -0.004940946481539208, -0.003532936025902524, -0.003352229205815533, -0.0040124101701805885, -0.003881514495120927, -0.00492791003390202], "all_perturbed_original_ll": [-4.29340748570297e-05, -0.00014748620026463919, -9.845091491853935e-05, -6.82595345432653e-05, -0.00015507667873770832, -0.00012881935316391753, -0.00015309162374516487, -0.00015002460931903225, -0.00020095763355882978, -0.00017306037591092782], "perturbed_sampled_ll": -0.004070915134105859, "perturbed_original_ll": -0.00013181609990190542, "perturbed_sampled_ll_std": 0.0005173259939856082, "perturbed_original_ll_std": 4.5950096538902244e-05}, {"original": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "sampled": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "perturbed_sampled": ["Question: Reporting and interpreting red blood cell morphology: is there agreement or discrepancy between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and education between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", ": Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discrepancy between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "Question: Reporting and interpreting red blood cell (RBC) morphology. Is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discordance arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, tend to identify and report subtle variations in", "Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and interpret variations in", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? There can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in RBCs, are highly trained and experienced to identify and report subtle variations in", "reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer:Yes, there can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell morphology. This discrepancy often results from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who specialize in laboratory medicine, are trained to identify and report subtle variations in", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? There can be discordance between clinical pathologists and clinicians when it comes to reporting and interpreting red blood cell (RBC) morphology. This discrepancy often arises from differences in training, experience, and perspectives between the two groups. Clinical pathologists, who are specialists in laboratory medicine, are trained to identify and report subtle variations in"], "perturbed_original": ["Question: Reporting and interpreting red blood cell morphology: is there discordance between laboratory technicians and clinicians? Answer: Important differences in the clinical relevance of certain RBC-M terms exist between clinicians and laboratories. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the laboratory. Lab practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting changes in red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of RBC-M changes are expressed in different terms by clinicians and pathologists. The inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve understanding, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell parameters: what is the relationship between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that results are interpreted as intended by the pathologist. CP reporting practices should be examined critically to improve communication, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell molecular markers: is there discordance between pathologists and clinicians? We conclude that differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of specific interpretations on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be aligned with appropriate clinical guidelines to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting of red blood cell morphology: is there an agreement between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Interpretation practices of CBC reports should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical interpretation of certain RBC-M terms exist between clinicians and CPs. An interpretive review of the CBC reports is the only way to ensure that RBC-M changes are interpreted as intended by the reporting physician. Diagnostic reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there overlap between clinical pathologists and clinicians? Answer: Important differences about the use of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by CPs. Reporting practices must be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to demonstrate that RBC-M changes are reported as intended by the CP. An RBC-M dictionary should be developed to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there agreement between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of RBC-M terms exist between clinicians and CPs. Clinically tailored interpretive comments on CBC reports are the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be considered critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: does there exist discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive notes in CBC reports is the clearest way to ensure that RBC-M terms are consistently interpreted by clinicians and by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions."], "original_ll": -0.00026936802334829544, "sampled_ll": -0.0033390852475573044, "all_perturbed_sampled_ll": [-0.004556750188852112, -0.008215205228220118, -0.0035229236454342697, -0.004419859615483294, -0.003198377124728369, -0.004384266107591446, -0.0035373525193535234, -0.0005683365505344944, -0.0049011877776712915, -0.0005768843103648838], "all_perturbed_original_ll": [-0.0010935573444976745, -0.0002715411325538462, -0.0003456828890178823, -0.0002491433805898888, -0.00021238560709444437, -0.0001752209858115909, -0.0002867022807818604, -0.0003804701575994444, -0.0003955909298610465, -0.0006510669824130767], "perturbed_sampled_ll": -0.00378811430682338, "perturbed_original_ll": -0.0004061361690220755, "perturbed_sampled_ll_std": 0.0020819061265213113, "perturbed_original_ll_std": 0.00026169670160729674}, {"original": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "sampled": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "perturbed_sampled": ["Colon cancer in young patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from older individuals with cancer", "Question: Colorectal cancer a distinct patients: is it characteristics that clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic in older patients.???????????????????????????????????????????? differentiate it from colorectal cancer", "Question: Colorectal recognized young patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly clinical entity as a distinct ........................................... with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "entity? Colorectal cancer in young patients: is it a distinct clinical entity? colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "al cancer in young patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "Question: Colorectal cancer in young entity it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct distinctive biologic, with ..????????????????????????????????????????? clinical, and genetic characteristics that differentiate it from colorectal cancer", "Question: Colorectal COL young patients: is it a distinct clinical entity? Answer:Yes, a distinct in young patients is increasingly being recognized as COL clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in young patients is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "Question: Colorectal cancer in distinct clinical is it a is increasingly entity? Answer:Yes, colorectal cancer in young patients older patients; being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics that differentiate it from colorectal cancer", "Question: Colorectal cancer the elderly patients: is it a distinct clinical entity? Answer:Yes, colorectal cancer in that distinguish is increasingly being recognized as a distinct clinical entity, with unique epidemiological, clinical, and genetic characteristics ...!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! it from colorectal cancer"], "perturbed_original": ["Question: Colorectal cancer in young patients: is it a distinct clinical entity? studies are cancer among young patients may constitute a distinct clinical entity. Further the treatment needed to validate our findings and define . approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? be a cancer among young patients may Further research distinct clinical entity. Description: is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young is needed it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research clinical presentation and risk to validate our findings and define the is needed in this population.", "? Lung cancer in young patients: is it a distinct clinical entity? : Lung cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may and understand distinct clinical entity. Further research is needed to validate our findings risk of developing colorectal cancer the .s.s.d.b. in this population.", "Question: Colorectal cancer in distinct clinical is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a is necessary entity. Further research a to validate our findings and define the optimal approach in this population.", ". Colorectal cancer in young patients: is it a distinct clinical entity? Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and to determine the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it entity. clinical confirm these Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to . findings and define the optimal approach in this population.", "patients, could describe colorectal cancer in young patients, making it a distinct clinical entity. Conclusions Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: be a among young patients may necessary to distinct clinical entity. Further research is Colorectal cancer validate our findings and define the optimal approach in this population."], "original_ll": -9.3413408565e-05, "sampled_ll": -0.004512177248759074, "all_perturbed_sampled_ll": [-0.009607345043503461, -0.02060560971610785, -0.02159246917752289, -0.005555894156795199, -0.011746276712597599, -0.01905329995017551, -0.007532802451946153, -0.005825368581712592, -0.011625815653429818, -0.021949650596251723], "all_perturbed_original_ll": [-0.03759592852608187, -0.01892282879296468, -0.0008133352056847058, -0.011738228618301592, -0.0023426214904450006, -0.0007720284425691667, -0.0028790581381570213, -0.0036102642260538295, -0.002942301748521569, -0.008845518391953598], "perturbed_sampled_ll": -0.01350945320400428, "perturbed_original_ll": -0.009046211358073302, "perturbed_sampled_ll_std": 0.006305312801976197, "perturbed_original_ll_std": 0.010981541964948598}, {"original": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "sampled": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer:No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "perturbed_sampled": ["Question: Is discordance in TEOAE and AABR predictable in newborns? Answer:No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells of the cochlea, which", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer:No, discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not . These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "Question: Is discordance of TEOAE and AABR outcomes predictable in newborn hearing screening? The discordance of Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "Question: Is discordance in TEOAE and AABR more common in newborns? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE assesses the function of the outer hair cells in the cochlea, which", "Question: Is discordance in TEOAE and AABR outcomes predictable in hair cells discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in auditory neuralgia screening is likely to be predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "Question: Is discordance in TEOAE and AABR outcomes completely predictable for hearing screening of newborns? Answer:No, discordance between Transient Evoked Optoelectric Activity Evoked (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes for newborn hearing screening is not entirely predictable. These two tests assess different components of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "Question:Is discordance in TEOAE versus AABR outcomes predictable in newborns? Answer:No, discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automatic Auditory Brainstem Response (AABR) outcomes in newborns undergoing newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells in the cochlea, which", "Question: Is discordance in TEOAE and AABR tests predictable in newborns? Answer:No, discordance between Transient Evoked Otoacoustic Emission (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE assesses the function of the outer hair cells in the cochlea, which", "Question: Is discordance between TEOAE and AABR outcomes predictable in newborns? Answer:No, discordance between Transcutaneous Evoked Otoacoustic Emissions (TEOAE) and Auditory Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the hair cells in the cochlea, which", "newborn hearing screening: Is the discordance in TEOAE and AABR outcomes predictable in all infants? The discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborn hearing screening is not entirely predictable. These two tests assess different parts of the auditory system. TEOAE measures the function of the outer hair cells of the cochlea, which"], "perturbed_original": ["Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Regardless of the available screening technologies, discordant TEOAE and AABR may be observed for some mothers with hearing loss , even in healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes inevitable for some categories of apparently healthy newborns? Answer: Given the limitations of available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of apparently healthy newborns and also among apparently healthy newborns whose mothers received inappropriate screening. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance between TEOAE and AABR inevitable in newborns? Answer: Given the available screening methods, discordance between TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some newborns, in particular for hearing loss among apparently healthy babies whose mothers received prenatal care. The potential limitations and morbidities as well as efficacy of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR predictive of hearing loss in newborns? Answer: Given the available data, discordant TEOAE and AABR may be predictive of some categories of hearing loss among apparently healthy newborns whose mothers have received good prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance between TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns who have received prenatal assessment. The potential limitations of perinatal morbidities as basis of targeted screening in some cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available data, discordant TEOAE and AABR may be predicted for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of TEOAE or AABR as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the limitations of both technologies, discordance between TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal screening. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance between HH and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordance between HH and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The predictive value of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently normal infants whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted interventions in such infants merit further consideration."], "original_ll": -0.0009807597411113924, "sampled_ll": -0.004917530881742748, "all_perturbed_sampled_ll": [-0.004218862458623557, -0.00657746955002, -0.00029117580956056183, -0.00017186866629625, -0.0011080494556132954, -0.006098238590973685, -0.008170020559915852, -0.0041867807189071736, -0.005959942176497935, -0.0012082443811175004], "all_perturbed_original_ll": [-0.002690343733416455, -0.0005874529667317778, -0.0004455576536940506, -0.00010825040771308641, -0.0004969125319693903, -0.0004142241988340507, -0.000501238296306329, -0.00040878162387308637, -0.0005733409111585526, -0.0007677232085010389], "perturbed_sampled_ll": -0.003799065236752581, "perturbed_original_ll": -0.0006993825532197819, "perturbed_sampled_ll_std": 0.0027662733607439986, "perturbed_original_ll_std": 0.00068241448771373}, {"original": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "sampled": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "perturbed_sampled": ["Question: May student examiners be reasonable ?????????????????????s??s??cise?cise?s??s??s??s?s?s??s???? for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty in an examination on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty ?....................................... undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty in an OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitutes for faculty in an undergraduate OSCE on medical emergencies? Answer:", "and student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", ": Would medical student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", ". Question: Would student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "and student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty in an  on medical emergencies? Answer:"], "perturbed_original": ["or student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: ????????????????????? examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: s and fellow examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for at an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty in the OSCE on medical emergencies? Answer:", "Question: May student examiners ???................................ substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on . Answer:", "Question: May student examiners be reasonable substitute examiners ?................................. in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute ?ssss?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? faculty in an undergraduate OSCE on medical emergencies? Answer:", "Question: May student examiners be reasonable substitute examiners for faculty ?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s? undergraduate OSCE on medical emergencies? Answer:"], "original_ll": -0.004012678471918333, "sampled_ll": -0.0030007326048054166, "all_perturbed_sampled_ll": [-0.0016430871758582983, -0.0019438348036272723, -0.08884643727613334, -0.002543226442317392, -0.003341765786456818, -0.0013646453979113632, -0.010765549846878261, -0.010747061146420834, -0.0007850886717045453, -0.0038654769790833327], "all_perturbed_original_ll": [-0.0015958316743, -0.0046553430875459255, -0.010052501223778001, -0.00938527582755652, -0.0015430042600126086, -0.012745388956674998, -0.024649394890559097, -0.010864287110874997, -0.024074295659098337, -0.0077998988421436365], "perturbed_sampled_ll": -0.012584617352639143, "perturbed_original_ll": -0.010736522153254411, "perturbed_sampled_ll_std": 0.025657151101416076, "perturbed_original_ll_std": 0.007690821411699522}, {"original": "Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained.", "sampled": "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "perturbed_sampled": ["Question: Amblyopia: Is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually develops during infancy and early childhood. In most cases, amblyopia affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to develop normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually begins during infancy and early childhood. In most cases, amblyopia affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual condition where an eye fails to achieve adequate visual acuity, even with the use of prescription eyeglasses or contacts. The condition usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, despite the use of prescription eyeglasses or contact lenses. The condition begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", ". When is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye never develops enough to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Is the visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. The condition usually begins to manifest during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Amblyopia: is visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a condition in which visual development stops and an eye fails to achieve normal visual acuity, even with the use of prescription eyeglasses or contact lenses. Amblyopia usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "Question: Is the visual loss permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve vision at full acuity, even with the use of glasses or contact lenses. Amblyopia usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The", "onset of amblyopia at 2 years old is it permanent? Answer:Amblyopia, often referred to as \"lazy eye,\" is a visual development disorder where an eye fails to achieve normal visual acuity, even with the use of prescription glasses or contact lenses. The condition usually begins during infancy and early childhood. In most cases, it affects only one eye, but it can manifest in both.\n\nAnswer: The"], "perturbed_original": ["Question: Amblyopia: Is the vision loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This return of visual function often occurs in the wake of visual loss in the fellow eye , and the improvement appears to be sustained.", "Question: Is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the normal eye over a period of time. This recovery in visual function in the normal eye can occur in the wake of vision loss in the fellow eye and the improvement appears to be sustained.", "Question: Amblyopia: is visual function permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyotic eye over a period of time. This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained.", "Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience a partial recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function in the amblyopic eye often leads to visual loss in the fellow eye and the visual loss is thought to be sustained.", "Question: Amblyopia: is it permanent? Answer: Patients with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the absence of visual loss in the fellow eye and the amblyopia appears to be sustained.", "Question: Amblyopia: is visual loss permanent? Answer: Children with a history of amblyopia who develop visual loss in the previously amblyopic eye can experience recovery of visual function in the amblyopic eye over a period of time. This improvement of visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be long-term and sustained.", "Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can typically recover some degree of visual function in the amblyopic eye over a short period of time. This recovery in visual function occurs in the wake of visual loss in the previously normal eye, and the improvement appears to be sustained.", "Question: Amblyopia: is visual loss permanent? Answer: Older people with no history of amblyopia who have experienced visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained.", "Question: Amblyopia: is visual loss permanent? Answer: Older people with the condition of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the fellow amblyopic eye over an extended period of time. This recovery in visual function occurs in the absence of visual loss in the fellow eye and the improvement appears to be sustained.", "Question: Amblyopia: is visual loss . Older people with a history of amblyopia who develop visual loss in the previously normal eye can show improvement of visual function in the amblyopic eye over a period . This recovery in visual function occurs in the wake of visual loss in the fellow eye and the improvement appears to be sustained."], "original_ll": -0.0001384387562130137, "sampled_ll": -0.007471456325507532, "all_perturbed_sampled_ll": [-0.007245310665417471, -0.005766737845281567, -0.007883152160342152, -0.009890904317112151, -0.008789508483371851, -0.010201998502295128, -0.014204131549953732, -0.008058967633643648, -0.01001396673820039, -0.020948119996553008], "all_perturbed_original_ll": [-0.0007707634342778947, -8.702994164388889e-05, -0.00018960264850520543, -5.551448622234569e-05, -8.705415932794522e-05, -9.966218827051948e-05, -4.6491383325384624e-05, -8.715842199851351e-05, -5.7707961924133325e-05, -0.005048016336662501], "perturbed_sampled_ll": -0.010300279789217109, "perturbed_original_ll": -0.0006529000962158331, "perturbed_sampled_ll_std": 0.004146203532134156, "perturbed_original_ll_std": 0.001479559539533085}, {"original": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "sampled": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "perturbed_sampled": ["Question: Does ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate ?ts?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict ? patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate s outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate ?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for patients ? radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for patients treated with surgery prostatectomy? Answer:", "Question: Does prior benign prostate ?t????????????????????? a b c? d c? e?? e? e e e??? e?????? outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for patients ? radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate .....?..?.?..?.?..?.??.?.?.?.?.?.?.????.?.?.???? outcome for patients treated with radical perineal prostatectomy? Answer:"], "perturbed_original": ["Question: Does prior benign prostate n outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: ????????????????????????.\u2019\u201d??.???.??.???.?.?.?.??.??? benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for patients treated  perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy  for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate biopsy predict outcome for  with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate ?s outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior ????????????????????????????s?\u2019??s?s??s??s??s??s???? biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Does prior benign prostate n outcome for patients treated with radical perineal prostatectomy? Answer:", "Question: Can prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer:"], "original_ll": -0.001328853035066087, "sampled_ll": -0.0021741144769273917, "all_perturbed_sampled_ll": [-0.00782488559662264, -0.004517307002783001, -0.003704874747186364, -0.013692262446011367, -0.00667792608988091, -0.06548934796740181, -0.0012678088162485, -0.0005304580189014894, -0.03569111883586363, -0.0010785499513163636], "all_perturbed_original_ll": [-0.007877232635192273, -0.0016612897461288371, -0.0015496180137982607, -0.006389858127610478, -0.06020896827800002, -0.006640328969418095, -0.004913344814456521, -0.001064246809934286, -0.008042839579404545, -0.001632810949815217], "perturbed_sampled_ll": -0.014047453947221608, "perturbed_original_ll": -0.009998053792375852, "perturbed_sampled_ll_std": 0.019798703931475526, "perturbed_original_ll_std": 0.01694187779644328}, {"original": "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "sampled": "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "perturbed_sampled": ["Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:"], "perturbed_original": ["Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:", "Question: Does minimal access major surgery in the newborn hurt less? Answer:"], "original_ll": -0.0022496076370799997, "sampled_ll": -0.003700176140173333, "all_perturbed_sampled_ll": [-0.0020193583520933334, -0.0037665115046293324, -0.00169162721836, -0.004381978240048668, -0.0023206863105199997, -0.0024785684718866665, -0.0016901890752533334, -0.004368753606959335, -0.0024616650810133337, -0.0022523576884866665], "all_perturbed_original_ll": [-0.0031250890612533333, -0.0023227957876, -0.004422092683116666, -0.0032930771193533334, -0.0018725947679066666, -0.0017757453815199999, -0.0016737654857133335, -0.00268760074042, -0.0017759375722560004, -0.003255065691413333], "perturbed_sampled_ll": -0.002743169554925067, "perturbed_original_ll": -0.002620376429055267, "perturbed_sampled_ll_std": 0.0009839971990920286, "perturbed_original_ll_std": 0.0008562169471620318}, {"original": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "sampled": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "perturbed_sampled": ["Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the specific goals of treatment. Gallbladder cancer is the second most common cancer diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the specific type of treatment. Gallbladder cancer is rare and is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the disease, the patient's overall health condition, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, your overall health condition, and the specific goals of your treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the specific goals of treatment. Gallbladder cancer is usually diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's health condition, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the disease, the patient's overall health, and the specific goals of treatment. Gallbladder cancer is often diagnosed", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer:Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma depends on several factors, including the stage of the cancer, the patient's overall health condition, and the type of treatment. Gallbladder cancer is often diagnosed"], "perturbed_original": ["Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe alternative method of palliative management of patients. However, further studies are necessary to determine the role of radiotherapy in palliative patients treatment of gallbladder carcinoma.", "Question: Is external radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy has been reported to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", ". Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, more clinical trials are needed to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external radiotherapy in the palliative management of gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective treatment for palliative management of gallbladder carcinoma. However, further studies are necessary to determine the actual utility of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma safe and effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in the adjuvant treatment of gallbladder carcinoma.", "Question: Is palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be safe and effective method of palliative management of gallbladder carcinoma. However, more clinical studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are needed to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy of gallbladder carcinoma is effective. External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of external radiation therapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: What is the role of palliative radiotherapy for gallbladder carcinoma? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma."], "original_ll": -8.111090070076923e-05, "sampled_ll": -0.002308323392452699, "all_perturbed_sampled_ll": [-0.0021476642616512697, -0.002059298061890645, -0.002121673052221492, -0.0027519273860866665, -0.001792356272832857, -0.002078978456424677, -0.0023040193497790478, -0.0025308965073101613, -0.0031485350552366126, -0.0029106343297566136], "all_perturbed_original_ll": [-0.0005973399319958621, -9.947010792307692e-05, -0.000351272019604394, -8.980764541147058e-05, -4.707005332292308e-05, -7.93536073663077e-05, -0.000581720660315, -5.776717859123078e-05, -0.006632827931875693, -7.392574735791044e-05], "perturbed_sampled_ll": -0.002384598273319004, "perturbed_original_ll": -0.0008610554883763869, "perturbed_sampled_ll_std": 0.0004121142848363016, "perturbed_original_ll_std": 0.0019347899407817315}, {"original": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "sampled": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "perturbed_sampled": ["Question: The use of audit to identify maternal mortality in different any evidence of the use of audit?tttt?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t??t??t?t it just a difference between the rich and the poor? Answer:", "Question: Use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of technology to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is there just a difference between the rich and the poor? Answer:", "The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it ??????????????\u00bb????????????????????????????????????????????????????????????????????????????? difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it just a of the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it It will.::.?:.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! difference between the rich and the poor? Answer:", "Question: ?!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:"], "perturbed_original": ["Question: The use = to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it just audit?????????????????????? \u00e0?r??????????????\u201d???. between the rich and the poor? Answer:", "Question: The use of audit to : mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: What is the cost-effectiveness of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify costs in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: ?r?n???n???n??n??n??n?n?n?n?n?n??n?n?n?n?n?n?n?n?n?n?n?n?n?n?n?n?n?n just a difference between the rich and the poor? Answer:", "Question: The : audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The ?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer:", "Question: The use of audit to identify maternal mortality in different settings: is it just a : the rich and the poor? Answer:"], "original_ll": -0.0021005137524117853, "sampled_ll": -0.0017424993332996424, "all_perturbed_sampled_ll": [-0.0020037611329200003, -0.0011325114014722223, -0.0012488889952267854, -0.0016165100871828573, -4.009867835208334e-05, -0.0023853333076586276, -0.002825868499446785, -0.005516562252307408, -0.0010007241677184211, -0.0006545964379266666], "all_perturbed_original_ll": [-0.0010328327339437038, -0.0008999547116962962, -0.001014766712871163, -0.010004552276986297, -0.0007780757370153124, -0.0020630511722766667, -0.003189066009036512, -0.007085196902207777, -0.0026792218618931656, -0.0105416629126], "perturbed_sampled_ll": -0.0018424854960211855, "perturbed_original_ll": -0.00392883810305269, "perturbed_sampled_ll_std": 0.0014512856856913258, "perturbed_original_ll_std": 0.003635607475746933}, {"original": "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "sampled": "Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "perturbed_sampled": ["Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure ? the removal of", ":Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: :. Question:: splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? : splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, gastric vein.s that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? : splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it possible? Answer:Transgastric endoscopic splenectomy: is it question Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is : Answer:Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of", "Question: Transgastric endoscopic splenectomy: is it : endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy, a procedure that involves the removal of"], "perturbed_original": ["Question: Transgastric : is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model  feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival studies are being planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model is feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: : splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric Question: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term : are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model is technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model is technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric Answer: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned."], "original_ll": -0.00017096332465, "sampled_ll": -0.23441745399899136, "all_perturbed_sampled_ll": [-0.021224786714345203, -0.1968009551556842, -0.020207124914879596, -0.009288740151067499, -0.014237922093093268, -0.010945187284457496, -0.034905127497884235, -0.011469088312820624, -0.02113626791931857, -0.011150057465836818], "all_perturbed_original_ll": [-0.0005221382898795, -0.008966570656082326, -0.00013158516516326087, -0.0002231053865229545, -0.014758424783319252, -0.00018882777728073172, -0.015752973913935226, -0.00012577549625466665, -0.00011057753193111109, -0.0006335524737763414], "perturbed_sampled_ll": -0.035136525750938744, "perturbed_original_ll": -0.004141353147414538, "perturbed_sampled_ll_std": 0.05438147732395214, "perturbed_original_ll_std": 0.006129138848386462}, {"original": "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "sampled": "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "perturbed_sampled": ["Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors development. Though important in the development and progression of primary systemic are the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors considered important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors considered important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors considered important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions is still unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental Despite considered important in the development and progression of primary systemic is the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and cause primary systemic vasculitis. While the genesis of these conditions remains largely unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors are important in the development and progression of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors are considered important in the development and maintenance of primary systemic vasculitis. While the exact cause of these conditions remains largely unknown, a", "Question: Are environmental factors important in primary systemic vasculitis? Answer:Yes, environmental factors cause of important in the development and progression of primary systemic vasculitis. While the exact . these conditions remains largely unknown, a"], "perturbed_original": ["Question: Are environmental factors important in the pathogenesis of peripheral systemic vasculitis? Answer: A significant association between farming and PSV was identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A relationship between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV was identified for the first time. Results also confirmed reported associations with silica, solvents, and allergy.", "Question: Are environmental factors involved in primary systemic vasculitis? Answer: A new association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been reported in the literature, but this study has provided evidence for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors an important factor in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with gluten and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and vasculitis has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in the pathogenesis of pauci- systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV is identified for the first time. Results also support previously reported associations between PSV and occupational exposure, solvents, and allergy."], "original_ll": -0.0002583516021652174, "sampled_ll": -0.007900579355753695, "all_perturbed_sampled_ll": [-0.023417479001309305, -0.006436145069619129, -0.007964487480676597, -0.008900776378896807, -0.008164860046182129, -0.03245529520618696, -0.020027022711256216, -0.006771993797303778, -0.006916554175720216, -0.014447394680468887], "all_perturbed_original_ll": [-0.00018479305927408162, -0.00021998410138533334, -0.0001745565808836957, -0.0002577915827068182, -0.0001392432541941304, -0.00013925937215642856, -0.00013027631718636365, -0.00019441434552659576, -0.0006427101374975003, -0.0001811471166559184], "perturbed_sampled_ll": -0.013550200854762004, "perturbed_original_ll": -0.00022641758674668658, "perturbed_sampled_ll_std": 0.008484682286027494, "perturbed_original_ll_std": 0.00014361756704299965}, {"original": "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "sampled": "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been a topic of", "perturbed_sampled": ["Question:How well does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or undergoing intensive care unit (ICU) intervention, has been a topic of", "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been a topic of", "Question: Does the central venous pressure predict fluid the relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill responsiveness? The surgical intervention, has been a topic of", "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been a topic of", "Question: Does ant venous pressure predict fluid responsiveness? central between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been a topic of", "Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under ventilatory control, has been a topic of", "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been the topic of", "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who ? ill . surgical intervention, has been a topic of", "Question: Does the central venous pressure predict fluid the relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill responsiveness? The surgical intervention, has been a topic of", "Question: Does the central venous pressure predict fluid responsiveness? Answer:The relationship between central venous pressure (CVP) and fluid responsiveness in patients, particularly those who are critically ill or under surgical intervention, has been a topic of"], "perturbed_original": ["Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread . using central practice of to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure as a predictor of responsiveness to fluid therapy. This approach to fluid therapy should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid output? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure influence fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure correlate with fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This method of fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There guide fluid data to support the widespread practice of using central venous pressure to the therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict the need for fluid therapy? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data that support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no reliable data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned."], "original_ll": -0.0003776976627102221, "sampled_ll": -0.011643855358654259, "all_perturbed_sampled_ll": [-0.004348352101935092, -0.011063121842073618, -0.0007458526451786365, -0.009344114861061278, -0.007412661856722325, -0.013497486553354343, -0.007674559141924254, -0.03506573405834468, -0.000946995571566591, -0.010348164070181276], "all_perturbed_original_ll": [-0.013622092679771332, -0.00021509171855574463, -7.171067038511628e-05, -0.00017443538551733335, -0.0002110892091648889, -0.0002692194395910869, -0.0030537947834781824, -0.00020254213771255317, -0.0002593022451991111, -0.0002038869664602174], "perturbed_sampled_ll": -0.010044704270234208, "perturbed_original_ll": -0.0018283165235835567, "perturbed_sampled_ll_std": 0.00924026153961496, "perturbed_original_ll_std": 0.0040225410085049105}, {"original": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "sampled": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "perturbed_sampled": ["Does administration of preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass surgery? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "reduce stroke risk? Answer:Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do preoperative statins reduce atrial fibrillation after coronary bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do preoperative statins reduce atrial artery coronary artery bypass grafting? Answer:Yes, preoperative statins have been reported to reduce the incidence of atrial fibrillation after coronary", "Question: Do statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Can statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer:Yes, preoperative statins have been shown to reduce the incidence of atrial fibrillation after coronary", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass . Post preoperative statins have been shown to reduce the incidence of atrial ? Yes, coronary"], "perturbed_original": ["Question: Do preoperative anticoagulant agents reduce the incidence of atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that the use of ACE inhibitor therapy seems to reduce AF development after CABG.", "Question: Do statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin s appear to reduce AF development after CABG.", "Question: Does use of preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF after CABG.", "Question: Do preoperative anticoagulations reduce the risk of atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative anticoagulation seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: AF indicated that preoperative statin A recent study to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin treatment seems to reduce AF development after CABG.", "Question: Do statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our data suggest that preoperative statin therapy seems to reduce AF development after CABG.", "Does use of preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Results from this study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study found that preoperative statin therapy seems to reduce AF development after CABG."], "original_ll": -0.00018396903435615385, "sampled_ll": -0.006778441764096829, "all_perturbed_sampled_ll": [-0.00014179527361027024, -0.007239986958700001, -0.004941496113086889, -0.005665711802588, -0.008688519274138917, -0.010032504630960767, -0.007122909312840001, -0.008715180917719998, -0.006189065602368292, -0.03092649119116805], "all_perturbed_original_ll": [-0.00019760251650239127, -0.009475103237333332, -0.00028505622132275, -0.00022141868176799997, -0.00021658475263384614, -0.0010014629211487181, -0.00015557116125897437, -0.00022019084817351348, -3.2921325191025636e-05, -0.00013154628604027026], "perturbed_sampled_ll": -0.008966366107718119, "perturbed_original_ll": -0.0011937457951372822, "perturbed_sampled_ll_std": 0.007762622634353161, "perturbed_original_ll_std": 0.002771958382315493}, {"original": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "sampled": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "perturbed_sampled": ["Answer: In the case of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness l'il it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness : Will it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness -  inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress ??????????????????????????????\u201d??? disease? Answer:", "Question: Prognosis of  deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to ? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress ???????????????????????????????????? disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably ....................????????????????? Meniere's disease? Answer:", "Answer: A short episode of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:"], "perturbed_original": ["Question: \"It is related to low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably develop into Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness ?rh it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does ? progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress ???????????????????????????????? disease? Answer:", "Question: Early episode of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: A severe case of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: The cause of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden de does it inevitably progress to Meniere's disease? Answer:", "Question: Prognosis of low-tone sudden deafness s it inevitably progress to Meniere's disease? Answer:"], "original_ll": -0.0032453788697712504, "sampled_ll": -0.0020191948897729166, "all_perturbed_sampled_ll": [-0.0006245496299154167, -0.014731528933370418, -0.025310463490853325, -0.010426539379947274, -0.005794062884455173, -0.006232746416361905, -0.0025149523017475007, -0.010915111487370692, -0.01594114217405125, -0.00027836419093125005], "all_perturbed_original_ll": [-0.002101691908122, -0.004063525959808333, -0.03147947130640833, -0.011580294185543911, -0.015167913394553574, -0.012444924024243482, -0.0010646752108145834, -0.0026668111174217393, -0.005127433822172727, -0.009841988763906087], "perturbed_sampled_ll": -0.009276946088900421, "perturbed_original_ll": -0.009553872969299477, "perturbed_sampled_ll_std": 0.007471301372935759, "perturbed_original_ll_std": 0.008657755240859662}, {"original": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "sampled": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "perturbed_sampled": ["Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:"], "perturbed_original": ["Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer:"], "original_ll": -0.004024242607620588, "sampled_ll": -0.0016248791470605882, "all_perturbed_sampled_ll": [-0.002572321655474706, -0.0019311184229629408, -0.004208181292317647, -0.004726048171452353, -0.001898284553313529, -0.0019372322310435295, -0.003037677681472353, -0.0025279933878264702, -0.0028999117381482355, -0.005434372692719411], "all_perturbed_original_ll": [-0.0019624413797264704, -0.003037677681472353, -0.002205366048281176, -0.0020468325136411766, -0.0019173028814129407, -0.003524018425988236, -0.002422370624055882, -0.0019275367519958823, -0.0028703303035205884, -0.002555385348098235], "perturbed_sampled_ll": -0.003117314182673117, "perturbed_original_ll": -0.002446926195819294, "perturbed_sampled_ll_std": 0.0011887129559257895, "perturbed_original_ll_std": 0.0005200163880367201}, {"original": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "sampled": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "perturbed_sampled": ["Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it a insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a ? tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile ? patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in .n:nnn?n?n?n?n?nn?nn?nn?nn?nn?nn?nn?nn?n?nn?nn?nn?nn?nn?n?tn??nn?n choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely ???????????????.?.?.?.?.?.????.?.???.?.???.? clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in acute choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the bile duct in patients with choledocholithiasis-induced cholangitis? Answer:"], "perturbed_original": ["Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of a bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube ?????????s??s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?? endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile . patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage device after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance duct? Question:???????????\u00bb Question:?s question??s -?s?n?s question??s answer?s question?s answer?s?s?s?s answer?s?s answer?s?s.s common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after  of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:", "is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer:"], "original_ll": -0.0011174971508730767, "sampled_ll": -0.0008465447778479488, "all_perturbed_sampled_ll": [-0.0007029194860943591, -0.002714528784830263, -0.0069912230023921615, -0.0005225847689997223, -0.019594055358930263, -0.005563568475940811, -0.000856776536845091, -0.0008741809865792308, -0.0007949402024086842, -0.0006270074238097367], "all_perturbed_original_ll": [-0.0008619341199415789, -0.011112556714619404, -0.010476503082403844, -0.001593596573664359, -0.00047893601147578935, -0.00024701961499128204, -0.013298986532971895, -0.0042912370917716665, -0.000817559413566154, -0.009337942524158], "perturbed_sampled_ll": -0.003924178502683032, "perturbed_original_ll": -0.005251627167956398, "perturbed_sampled_ll_std": 0.0056606087419109235, "perturbed_original_ll_std": 0.004941319316541074}, {"original": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "sampled": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "perturbed_sampled": ["Question: Does birth center care during a woman's first pregnancy ? impact on her future reproduction? Answer:", "Question: Does early birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does unpreparedness for birthing center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center care a woman's first pregnancy have any impact on her future reproduction? Answer:", ": Can birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center ????????????????????..?.?????????? a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy have any impact on ? reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy have any impact ..............................???? future reproduction? Answer:", "Question: Does birth center care during a woman's ? have any impact on her future reproduction? Answer:", "Question: Does a high-risk pregnancy center care during a woman's first pregnancy have any impact on her future reproduction? Answer:"], "perturbed_original": ["Question: Does birth ??????????????????????????????????? during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy .eseseseseses.es.eseseses.eseseses.esesesesesesesesesese impact on her future reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy have future?:.................................. on her future reproduction? Answer:", "Question: Does not.:?????????????????????????????????????????????? care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does .sssssss.ss.ss.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.ss care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy have any effects on her future reproduction? Answer:", "Question: Does birth center care during a woman's first pregnancy have any impact  future reproduction? Answer:", "Question: Does the pregnancy center care during a woman's first pregnancy have any impact on her future reproduction? Answer:", "Question: Does birth center care during a woman's first ?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?? any impact on her future reproduction? Answer:", "Question: Does birth center care during her first pregnancy have any impact on her future reproduction? Answer:"], "original_ll": -0.006330380265086821, "sampled_ll": -0.00875506325723818, "all_perturbed_sampled_ll": [-0.01417895081192, -0.002689353399440435, -0.00203729441393074, -0.006631361058880953, -0.011931670075680556, -0.0016160125277616666, -0.023742564763372002, -0.012048665645770833, -0.0019767955591690474, -0.0037574237062056], "all_perturbed_original_ll": [-0.0023576485854137925, -0.03292300808377, -0.0047141906796000005, -0.0008829328036041176, -0.006606070329305918, -0.006916845102271818, -0.026448694228314275, -0.002582718140499565, -0.005256479684146521, -0.0020158533599400003], "perturbed_sampled_ll": -0.008061009196213184, "perturbed_original_ll": -0.009070444099686601, "perturbed_sampled_ll_std": 0.006917253931321602, "perturbed_original_ll_std": 0.010578929930571978}, {"original": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer:", "sampled": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer:", "perturbed_sampled": ["Question: Are UK \" with the training and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are pediatric radiologists satisfied with the training and support received in suspected child abuse? Answer:", "Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received from child abuse? Answer:", "Question: Are radiologists satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are you satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received in reducing risk of abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received in relation to patient abuse? Answer:", "Question: Are UK C with the training and support received in suspected child abuse? Answer:"], "perturbed_original": ["Question: Are UK radiologists satisfied with the training and support received ??????????? child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support  suspected child abuse? Answer:", "Question: Are UK radiologists about the training and support received in suspected child abuse? Answer:", "Question: Are forensic radiologists satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with care and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with the training they have received in suspected child abuse? Answer:", "Question: Are UK professionals satisfied with the training and support received in suspected child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received ?:.?????????.?.?.???????? child abuse? Answer:", "Question: Are UK radiologists satisfied with the training and support received in relation to disclosures of sexual abuse? Answer:", "Question: Are UK radiologists having the training and support received in suspected child abuse? Answer:"], "original_ll": -0.004788218321977, "sampled_ll": -0.0057051656796465, "all_perturbed_sampled_ll": [-0.0056550256561688885, -0.0021174584498525003, -0.0025451927747434998, -0.0006107995183493748, -0.00841669013456, -0.006628018422342104, -0.008333512036868891, -0.006707715221188094, -0.0015440560188747618, -0.031131006056649993], "all_perturbed_original_ll": [-0.156184324328524, -0.023600353521772224, -0.01866630484736474, -0.0019234561438015, -0.002525779571578947, -0.0032265988284685, -0.007150160709606841, -0.023550187946525563, -0.0014324687983091303, -0.00817664799366842], "perturbed_sampled_ll": -0.007368947428959811, "perturbed_original_ll": -0.024643628268961985, "perturbed_sampled_ll_std": 0.00837278914184021, "perturbed_original_ll_std": 0.044632950296970855}, {"original": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "sampled": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased", "perturbed_sampled": ["Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impacts red blood cells\u2019 ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, or a lower than normal number of red blood cells, impacts the body's ability to carry oxygen throughout the body, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, which is characterized by a lower than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal quantity of red blood cells, impacts the body's ability to carry oxygen, leading to decreased", "Question:Does preoperative anemia affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impairs the body's ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, affects the body's ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased", "is preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as having a less than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer:Yes, preoperative anemia does adversely affect colon and rectal surgery outcomes. Anemia, defined as a lower than normal number of red blood cells, impacts the body's ability to carry oxygen efficiently, leading to decreased"], "perturbed_original": ["Question: How much does preoperative anemia adversely affect colon and GI surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Can anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe, moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild anemia is an independent risk factor for perioperative mortality and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia influence colon and rectal surgery outcomes? A large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon bypass surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon or rectal surgery outcomes? Answer: This large multicenter database study showed that the presence of severe , moderate, and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter study suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the combined effect of severe and moderate and even mild preoperative anemia is a risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia . colon and rectal surgery is an This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia affect independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon ic surgery outcomes? Answer: This large multicenter database has demonstrated that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery."], "original_ll": -0.0007226515848072729, "sampled_ll": -0.006313030881211936, "all_perturbed_sampled_ll": [-0.007276138000237935, -0.00714993557364127, -0.0053232647031487505, -0.006920159680526066, -0.004946665149879839, -0.007301519226899032, -0.008046894606825807, -0.017539847896247667, -0.006768671142561428, -0.007546605067023709], "all_perturbed_original_ll": [-0.00015909692917910715, -0.0007557367854660378, -0.0004349252301614544, -0.0005691660821015386, -0.0003349495441047169, -0.0014480069407105359, -0.00038309664302574076, -0.00043819961525654543, -0.003298946458643725, -0.012751096641054905], "perturbed_sampled_ll": -0.00788197010469915, "perturbed_original_ll": -0.0020573220869704303, "perturbed_sampled_ll_std": 0.0033463652809015594, "perturbed_original_ll_std": 0.0036715804326738232}, {"original": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "sampled": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", "perturbed_sampled": ["Question: Can septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", "Q: Can septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? A: No, but it can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change ????????????????????.???.?.????.??.?.?.?.?.?.???.?????? of compensatory hypertrophy of the middle turbinate. When a deviated septum is dimensions septoplasty,", "Question: Does septoplasty change the dimensions of compensatory hypertrophy middle turbinate. middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the . Question: When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially the middle dimensions of compensatory hypertrophy of ????????????????????????????????????????? turbinate. When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions and hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions and hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", ". Question:Can septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer:Yes, septoplasty can potentially hypertrophy dimensions of ..?.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! of the middle turbinate. When a deviated septum is corrected through septoplasty,", "Question: Does septoplasty change the dimensions of the middle of .?????????????????????????????????? turbinate? Answer:Yes, septoplasty can potentially change the dimensions of compensatory hypertrophy of the middle turbinate. When a deviated septum is corrected through septoplasty,"], "perturbed_original": ["Question: Does septoplasty change the dimensions of the base of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not produced after septoplasty, even after one year.", "after septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: of the study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that the dimensions of compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate was not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle that compensationatory The present study findings suggest turbinate? hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the degree of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty alter the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is still not affected by septoplasty, even after one year.", "Question: Does septoplasty change the amount of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not influenced by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle septoplasty not affected by  after one year."], "original_ll": -0.00017112237208199998, "sampled_ll": -0.0067592330445810705, "all_perturbed_sampled_ll": [-0.007176716165154287, -0.0009814628583743636, -0.015884811717783925, -0.016169368204487194, -0.016857838369535357, -0.006628913264495893, -0.0055236755506157705, -0.013059724554956317, -0.015925980109553574, -0.014291216966855803], "all_perturbed_original_ll": [-0.0001824586235216667, -0.0028753823677082142, -0.0093541838514492, -0.0002575554334645283, -0.000171128459903, -0.0032622269882147913, -0.0002050803847504, -0.00017106913585941173, -0.0001544999704728, -0.009320460640317113], "perturbed_sampled_ll": -0.01124997077618125, "perturbed_original_ll": -0.002595404585566113, "perturbed_sampled_ll_std": 0.005363749980144411, "perturbed_original_ll_std": 0.0035516833316685784}, {"original": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "sampled": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its effectiveness and impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "perturbed_sampled": ["Question: Upstream solutions: does the supplemental security income (SSI) program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is one of the most pressing challenges in understanding its effectiveness and impact. The program, established to provide financial support to individuals with limited income and assets who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "Question: Upstream solutions: does the supplemental security income (SSI) program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its effectiveness and impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 or older, plays a significant role in the social welfare of the", "Question: Upstream solutions: does the supplemental security income program reduce disability among the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability among the elderly is crucial in understanding its effectiveness and impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its effectiveness . The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, has played a significant role in the social safety net of the", ". Home \u00bb health solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its social impact. The SSI program, which is designed to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "Disability in the elderly: challenges and solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its role and impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its effectiveness and impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a crucial role in the social safety net of the", ", and solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial to understanding its effectiveness and impact. The SSI program, established to provide financial support to individuals with limited income s who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is a key element to understanding its full impact. The SSI program, established to provide financial support to individuals with limited income and resources who are disabled or aged 65 and older, plays a significant role in the social safety net of the", "Question: Upstream Research Question: Does the supplemental security income program reduce disability in the elderly? Answer:The question of whether the Supplemental Security Income (SSI) program reduces disability in the elderly is crucial in understanding its effectiveness and impact. The SSI program, established to provide support to individuals with limited income and resources who are disabled, blind, or aged 65 and older, plays a significant role in the social safety net of the"], "perturbed_original": ["Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of the older population. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic factors affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Income support policy is a significant new lever for improving health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support programs as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially among lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research would be a useful approach to explore whether health is improved by a variety of income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce smoking in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to assess their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of fiscal and policy policy policies affect health.", "and solutions: does the supplemental security income program reduce disability in the elderly? Income support policy may provide a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future studies should examine a variety of different income support policies, as well as whether a broader range of social protection policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may provide a significant new lever for improving health, especially that of lower-income persons. Even though the findings are robust, more studies are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of government social and economic policies affect health.", "Question: Upstream solutions: does the supplemental nutrition program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Given that the findings are from only one sample, additional analyses and replications are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: How can the supplemental security income program reduce disability in the elderly? This research suggests that income support policy may be a significant new lever for improving population health, particularly that of lower-income groups. But though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as how a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce mortality in the elderly? This study indicates that a broadly defined income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to assess their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income communities. Results from the current study are encouraging, though the findings are preliminary and additional analyses are needed to confirm their reliability. Future research should examine a variety of different kinds of income support policies, as well as whether a broader range of social and economic policies affect health."], "original_ll": -6.671654510738095e-05, "sampled_ll": -0.007912398298586818, "all_perturbed_sampled_ll": [-0.004813941818795959, -0.0037442897854858886, -0.006080252030217159, -0.0025602438084024706, -0.008179997934019204, -0.003361525360029456, -0.006029022932735341, -0.015018911260835831, -0.006297459653856393, -0.0064922676825945455], "all_perturbed_original_ll": [-5.7688940789880956e-05, -5.378244973898734e-05, -3.892176381097826e-05, -0.005701016702959177, -0.0001468906354730769, -4.562931022773809e-05, -7.884821633303372e-05, -4.822194851471265e-05, -6.622299593112361e-05, -8.032221118032257e-05], "perturbed_sampled_ll": -0.006257791226697225, "perturbed_original_ll": -0.000631754517495903, "perturbed_sampled_ll_std": 0.003332493274681619, "perturbed_original_ll_std": 0.001690006735081853}, {"original": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "sampled": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "perturbed_sampled": [". Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity after major infection factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: .?????????????????????????????????????????? migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "and neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity in response to trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: ??????????????????????????????????????????????????????????????????????? migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "recruitment in a mouse model. Airway neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil e levels after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "function? Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil ia after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:"], "perturbed_original": ["Question: ...........\u201d............................... migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil ia after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity after major trauma: a factor in ????????????s??s??s??s??s??s??s?s??s?\u2019?'?s??s???s??s??&?s???s??'\u2019??s??? of acute respiratory distress syndrome? Answer:", "Question: Increased ?tiontiontiontiontiontion?tiontiontion?version?question?tiontion?version?tion?version?tion?version?tion?tion!version!version!?tion!tion!tion!tion!tion!tion!tion!tion!tion!tion!tion!tion!tion!tion!tion activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil <unk> after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity after major trauma: a factor the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil migratory activity after major ?????????????????????????????????????????????????????????????????????????????????????????????????????????????? factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased neutrophil ic inflammation after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:", "Question: Increased ? activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer:"], "original_ll": -0.0027439605545381486, "sampled_ll": -0.0040402040041829625, "all_perturbed_sampled_ll": [-0.007525940983740003, -0.004816402884553201, -0.002569009175508857, -0.0021411133935478263, -0.0028715935600914294, -0.0008778422245307317, -0.0005947981322619354, -0.010794994533649198, -0.017074470069826205, -0.0176088343963125], "all_perturbed_original_ll": [-0.012009610153905, -0.014500628916039584, -0.0016872353195238462, -0.0015600375692814772, -0.0027191326228233332, -0.006060892221562308, -0.0034606902834503706, -0.002109598174688077, -0.013008563232330768, -0.002527771636662609], "perturbed_sampled_ll": -0.006687499935402188, "perturbed_original_ll": -0.005964416013026737, "perturbed_sampled_ll_std": 0.006093488906958318, "perturbed_original_ll_std": 0.00490106209653742}, {"original": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "sampled": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, can lead to tethered cord syndrome due to the abnormal attachments that develop and limit the movement", "perturbed_sampled": ["Question: In patients with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, can lead to tethered cord s due to the abnormal attachments that develop and limit the movement", "Question: A patient questions: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, may lead to tethered scoliosis due to the abnormal attachments that develop and limit the movement", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, is a condition that can lead to tethered cord syndrome , where the abnormal ly thick fibers between nerve roots develop and limit the movement", "Question: A patient has myelomeningocele, is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, can lead to chronic cord syndrome due to the abnormal attachments that develop and limit the movement", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, may lead to tethered cord syndrome due to the abnormal placement of the membrane lining the spinal cord which may develop and limit the movement", "Question: A patient asks a surgeon, is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of infection, can lead to tethered cord syndrome due to the abnormal attachments that develop on the movement", ": In patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a form of spina bifida, can lead to tethered cord syndrome due to the abnormal attachments that develop and limit the movement", ": a patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, typically leads to tethered cord syndrome due to the abnormal attachments that may limit the movement", "Question: A typical complication of myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. Myelomeningocele, a type of spina bifida, can cause tethered cord syndrome due to the abnormal attachments which can irritate the spinal cord and limit the movement", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer:Yes, untethering is often considered a necessary procedure prior to scoliosis correction in patients with myelomeningocele. This type of tumor can lead to tethered scoliosis due to the abnormal attachments that develop and limit the movement"], "perturbed_original": ["Question: A patient with spinal cord untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with scoliosis who are undergoing corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", ": Scoliosis patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are scheduled for corrective surgery and do not present with clinical symptoms of a tethered cord, even if it is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to ? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients (1) who are undergoing scoliosis corrective surgery and do not present with (2) of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient 's question: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that surgical untethering may be unnecessary in children with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: For patients with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: A study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical evidence of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient may have a tethered cord \u2013 is untethering necessary prior to correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms associated with a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered spinal cord, even though tethering has been demonstrated.", "Question: A patient with myelomeningocele: is diagnosis corrected prior to scoliosis correction? Answer: The study also demonstrated that spinal cord untethering may be necessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with MM is not experiencing pain. Is spinal cord untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and who do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with MM has tethered cord. Is cord untethering necessary prior to scoliosis correction? Answer: The study results suggested that cord untethering may be unnecessary in patients with MM who undergo scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated."], "original_ll": -0.00027312743325575345, "sampled_ll": -0.00342682113259721, "all_perturbed_sampled_ll": [-0.0078046800145706976, -0.01346047868425683, -0.008801654043173894, -0.008231290599006236, -0.00935242483673085, -0.008961029499688607, -0.011050400594773527, -0.008901004609457109, -0.008332711532342827, -0.006778194739156233], "all_perturbed_original_ll": [-0.00015617914709121212, -0.00034993807277399993, -0.00018741185127239433, -0.009299496284189853, -0.0002799973338849315, -0.00012829021613557144, -0.0001995519944561644, -0.00031598191190366197, -0.00013336599505973332, -0.0003468285654019718], "perturbed_sampled_ll": -0.00916738691531568, "perturbed_original_ll": -0.0011397041372169495, "perturbed_sampled_ll_std": 0.0017718941445772, "perturbed_original_ll_std": 0.002721138488107954}, {"original": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer:", "sampled": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer:", "perturbed_sampled": ["Question: Body perception: do parents, their children, and have different beliefs?tt?tt?tt?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t physicians perceive body image differently? Answer:", "Question: Body perception: 's children?.??? ','.? ', '.'.????? ', '.?'.?', '.??','.''''''''?''''' their children, and their children's physicians perceive body image differently? Answer:", "Question: ! do parents, their children, and their children's physicians perceive body image differently? Answer:", "Image perception: do parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: do they perceive body image differently???????????????????????????????????????? children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: do parents, their children, and ?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?t?nt?t?t?t?t?t?t?t?t?t?t physicians perceive body image differently? Answer:", "Question: Body perception: do parents, children and their children's physicians perceive body image differently? Answer:", "Question: How do parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: do parents, their children, and their children's physicians  image differently? Answer:", "Question: Body perception: do parents, their 's physicians?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s their children's physicians perceive body image differently? Answer:"], "perturbed_original": [", and the media. Body image perception: do parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body , their parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: do parents, Yes, all and their children's physicians perceive body image differently? Answer:", "Question: Body , their parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: ????????'?''?''?'' ''?''?? ''???'' ''''?''''''''?''''?''?''''' their children, and their children's physicians perceive body image differently? Answer:", "Question: Body , parents, their children, and their children's physicians perceive body image differently? Answer:", "Question: Body perception: do parents, their children, and their children's physicians perceive body ? Answer:", "Question: Body perception: do parents, their children, and their children's children body image differently? Answer:", "Question: Body perception: do parents, their children, and their perception of body image?ssssss?sss?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s perceive body image differently? Answer:", "in perception: do parents, their children, and their children's physicians perceive body image differently? Answer:"], "original_ll": -0.001986638077398261, "sampled_ll": -0.002207437700990435, "all_perturbed_sampled_ll": [-0.010937005883602363, -0.0010844806257546808, -0.0025836006995542853, -0.0009579053676042107, -0.010588519159394289, -0.027856282434596497, -0.007660729102576188, -0.003947243384532857, -0.006578388099287143, -0.017041539676326316], "all_perturbed_original_ll": [-0.029487034716159256, -0.01833036409438636, -0.001682230225821739, -0.022574926027645457, -0.006759844822095688, -0.04168823906520952, -0.02314514664753476, -0.012432264568452272, -0.012965275162998547, -0.01560244133098842], "perturbed_sampled_ll": -0.008923569443322881, "perturbed_original_ll": -0.018466776666129205, "perturbed_sampled_ll_std": 0.007925476827326326, "perturbed_original_ll_std": 0.010923024183146826}, {"original": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.", "sampled": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "perturbed_sampled": ["Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "Question: The presence of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The presence of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated to be a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "the insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The ATP carboxylase enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the regulation of sodium-water balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in maintaining the body's fluid balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been proposed as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the regulation of the fluid balance", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism has been speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that is involved in the body's fluid balance", ". A candidate gene for insulin resistance? Question:The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer:The insertion allele of the ACE gene I/D polymorphism is speculated as a candidate gene for insulin resistance. The angiotensin-converting enzyme (ACE) gene produces an enzyme that aids in the body's fluid balance"], "perturbed_original": ["Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated by insulin resistance or by increased inhibition of oxidative processes involved in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.", "Question: The insertion allele of the ACE gene polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype may be mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in the liver of subjects with the ACE DD genotype.", "Question: The insertion allele of the ACE -1 polymorphism. A candidate gene for insulin resistance? We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in glucose utilization. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.", "Question: -The C allele of the ACE I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.", "Question: The insertion allele of the ABCB2 gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in insulin sensitivity. Conversely, we report an increased sensitivity in NIDDM subjects with the DD genotype.", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that the increased coagulation risk of the DD genotype is not mediated through a prothrombin-mediated cascade or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the DD genotype.", "Question: The insertion allele of the ACE I/D polymorphism. A candidate gene for insulin resistance? We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in insulin production with the ACE DD genotype.", "Question: The insertion allele of the ACE 1 polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated by glucose resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the DD genotype.", "Question: DD allele of the ACE gene I/D polymorphism. A risk factor for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in glucose tolerance, and we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance but through increase in fibrinolysis. Conversely, we report an increased cardiovascular risk in NIDDM subjects with the ACE DD genotype."], "original_ll": -0.00030282199948215377, "sampled_ll": -0.0063874312378468115, "all_perturbed_sampled_ll": [-0.010768909577363428, -0.0031650092506573134, -0.003826504349757428, -0.009982348645568696, -0.012968638867657041, -0.012958363716475633, -0.004474934061993623, -0.004047459240715286, -0.00441374668436942, -0.01611760346239813], "all_perturbed_original_ll": [-0.0002100883313156338, -0.0002996980676090476, -0.00020541845298616663, -0.0003906456591310937, -0.00018045469994687501, -0.00017222877806291669, -0.00016219674200466667, -0.0003047667640774603, -0.00017604006683737702, -0.000938726024128209], "perturbed_sampled_ll": -0.0082723517856956, "perturbed_original_ll": -0.00030402635860994463, "perturbed_sampled_ll_std": 0.004557720077155614, "perturbed_original_ll_std": 0.00022317043062407586}, {"original": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "sampled": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "perturbed_sampled": ["Question: The role of bile duct sludge: is it different from bile duct stones? Answer:The role of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct stones are often", "Question: What is the clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the management of gastrointestinal health. Bile duct sludge, often", "Question: The clinical significance of bile duct sludge: is it the same as bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question: What is the clinical significance of bile duct sludge and how is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question: The topic of bile duct sludge: is it different from bile duct stones? Answer:The subject of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question: What is the clinical significance of bile duct sludge: is it different from bile duct stones? Understanding the clinical significance of bile duct sludge and how it differs from bile duct stones is an important task for those in the realm of gastrointestinal health. Bile duct sludge, often", "The clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is a very confusing topic in the realm of gastrointestinal health. Bile duct sludge, often", "Question:The clinical significance of bile duct sludge: is it different from bile duct stones? Answer:The clinical significance of bile duct sludge and how it differs from bile duct stones is an important topic in the realm of gastrointestinal health. Bile duct stones are often"], "perturbed_original": ["and clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic bile duct sludge is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct stones are believed to be an important cause of choledocholithiasis.", "Question: The clinical significance of symptomatic bile duct sludge: is it different from that of CBD stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from that of stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to sludge is likely CBD stones. Bile duct CBD to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from the clinical significance of CBD stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings suggest that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical presentations of bile duct sludge. Is it different from bile duct stones? Answer: The findings indicate that the clinical appearance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "and clinical significance of bile duct sludge: is it different from bile duct stones? The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge and is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD . Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical characteristics of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical profile of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis."], "original_ll": -0.000149876221709661, "sampled_ll": -0.008575055331313274, "all_perturbed_sampled_ll": [-0.007903655044758493, -0.009266410290078334, -0.008508637862243686, -0.0080326226117875, -0.007570513975652413, -0.008299593240282729, -0.008419100679931697, -0.00346097896554138, -0.0059694828962499995, -0.006504565518587591], "all_perturbed_original_ll": [-0.0004077471539676666, -0.00019200002975406779, -0.0002898407627753226, -0.00034983160975983046, -0.00016392108090274192, -0.00013458861766864406, -0.0001906210711984746, -7.813193404436362e-05, -0.0066924277273151716, -0.0001391695628594915], "perturbed_sampled_ll": -0.007393556108511383, "perturbed_original_ll": -0.0008638279550245775, "perturbed_sampled_ll_std": 0.0016002189797154128, "perturbed_original_ll_std": 0.001945325332132501}, {"original": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "sampled": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "perturbed_sampled": ["improved diagnosis and staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases of colorectal : PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. ???????????????????????????????????????? really add something to multidetector CT? Answer:", "Question: Preoperative staging of ????????????????????????????????????????? liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to ?s Answer:", "Question: Preoperative staging of patients with advanced stage of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging in patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver cancer..?????????\u00bb????????????????????????????????????????????????. colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver .s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s.s colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging in patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:"], "perturbed_original": ["Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does ?????????????????????????????????????????. add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something new over CT? Answer:", "Question: Preoperative assessment of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: PET/CT of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of . liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases due to carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients and metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Question: Study of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases ?.!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!. carcinoma. Does PET/CT really add something to multidetector CT? Answer:", "Question: Preoperative staging of patients with liver metastases ??????????.?.?..?????.???.?.?.?.?.?.?????? carcinoma. Does PET/CT really add something to multidetector CT? Answer:"], "original_ll": -0.000704623921482258, "sampled_ll": -0.0010147380144709679, "all_perturbed_sampled_ll": [-0.022691806193654827, -0.023810906926337937, -0.013131830211702162, -0.013053912114922413, -0.0105950537518475, -0.0017930488725633336, -0.0011289728341387097, -0.0005055133605102126, -0.009693027599222932, -0.0004896741639754839], "all_perturbed_original_ll": [-0.0006748039723757894, -0.001307683444322414, -0.000810050163267742, -0.0012921601135748386, -0.004099106056274828, -0.0009172918095673333, -0.002188769156082334, -0.00752586012758793, -0.0014207570669133335, -0.0016922833123946665], "perturbed_sampled_ll": -0.00968937460288755, "perturbed_original_ll": -0.002192876522236121, "perturbed_sampled_ll_std": 0.008349143774994936, "perturbed_original_ll_std": 0.0020089781048031902}, {"original": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:", "sampled": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:", "perturbed_sampled": ["Question: Does the .?!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!& health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya ????????????????????????????????????????????? principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the definition of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya ?sss?s?s?ss?s?s?s?s?s?s?s?ss?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s?s principles of universal coverage? Answer:", "Question: Does the country\u2019s health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the principles . coverage? Answer:", "Question: Does the public health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care ?s Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet .t of universal coverage? Answer:"], "perturbed_original": ["Question: Does ?........................................ of health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya ?s principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the principles ?.??????????????????????????????????????????????? coverage? Answer:", "does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet ? of universal coverage? Answer:", "Question: Does the current system of health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health ? in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the principles of ? Answer:", "How well does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer:"], "original_ll": -0.0027224810064714997, "sampled_ll": -0.0010102631585049999, "all_perturbed_sampled_ll": [-0.0013024858456624998, -0.014384505348277243, -0.0008184451196525, -0.0020664831157385, -0.0034415700930996223, -0.0030723085281365, -0.009125672183673684, -0.0022925005965315787, -0.02052004291437527, -0.036984246696285], "all_perturbed_original_ll": [-0.011354302862442859, -0.0190720268684625, -0.01120020284258516, -0.0056531206058112494, -0.006406617620943685, -0.005936293084356191, -0.016414872490705265, -0.0068843171568, -0.0007711816065083334, -0.0009400059720804999], "perturbed_sampled_ll": -0.00940082604414324, "perturbed_original_ll": -0.008463294111069575, "perturbed_sampled_ll_std": 0.011083857479858206, "perturbed_original_ll_std": 0.005730582565336033}, {"original": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.", "sampled": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as working memory, attention, and processing speed, tend to", "perturbed_sampled": ["Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as verbal memory, attention, and processing speed, tend to", "Question: Does cognitive function predict frequency- compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in memory-related cognitive abilities such as working memory and processing speed, tend to", "Question: Can executive function predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, executive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with enhanced executive capabilities, particularly in areas such as working memory, attention, and processing speed, tend to", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with better cognitive capabilities, particularly in areas such as working memory, attention, and processing speed, tend to", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as memory, attention, and processing speed, are able to", "Question: Does cognitive function predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as memory, attention, and processing speed, tend to", "and cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals who have higher cognitive capabilities, particularly in areas such as working memory, verbal ability, and processing speed, tend to", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as working memory, visual processing , and attention to", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function does predict frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as working memory, attention, and processing speed, tend to", "Question: Does cognitive function affect high frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer:Yes, cognitive function impacts high frequency-compressed speech recognition in listeners with normal hearing and normal cognition. Studies have shown that individuals with higher cognitive capabilities, particularly in areas such as memory, attention, and processing speed, tend to"], "perturbed_original": ["Question: Does cognitive function predict frequency compressed sound recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed sounds was not examined in the present study. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? The study showed that there was a significant relationship between cognitive function and recognition of frequency compressed speech-in-noise . However, this relationship was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relation between cognitive function and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in people with normal hearing and normal memory function? The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to adjust to the frequency-compressed conditions.", "Question: Does cognitive function affect frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not found. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided prior knowledge and/or time to 'acclimatize' to frequency-compressed conditions.", "Question: Does the magnitude of cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The results may have been different if the participants had been provided with additional training and/or time to 'acclimatize' to the frequency-compressed conditions.", "and cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal /normally functioning cognitive function. The relationship between cognitive functioning and recognition of frequency compressed speech was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in normal adults with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to practice the frequency-compressed conditions.", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency -compressed speech was not statistically significant. The findings may have been different if the participants had been provided with training and/or time to 'acclimatize' to the frequency-compressed conditions."], "original_ll": -0.0003349776480439437, "sampled_ll": -0.010559870565377612, "all_perturbed_sampled_ll": [-0.007514838259483182, -0.013479788282172058, -0.007172483859197206, -0.010702991358778807, -0.007652617964436061, -0.005989851869069252, -0.23690768866951692, -0.005491388717567076, -0.009444396150954775, -0.009027470814058955], "all_perturbed_original_ll": [-0.0004259709528985915, -0.0005551887421496157, -0.00015075415455732396, -8.18518444916923e-05, -0.00022437729599214282, -0.00018333202428314285, -0.00028873717608759997, -0.0007719034197636767, -0.00039885734625348483, -0.003768816116431159], "perturbed_sampled_ll": -0.03133835159452343, "perturbed_original_ll": -0.000684978907290843, "perturbed_sampled_ll_std": 0.06855931319972017, "perturbed_original_ll_std": 0.0010465836444291702}, {"original": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "sampled": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "perturbed_sampled": ["Question: Preoperative platelet count in squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: ? count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count in renal cell carcinoma: is it a prognostic factor? Answer:", "? Low platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count and squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count s:?s:?s:?s:?sssssss?s:?ss?s?s?s?s?s?s?s?s?s?s?s?s? squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal transitional carcinoma: is it a prognostic factor? Answer:", ". Plasma platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "! The platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a  Answer:"], "perturbed_original": ["in a clinical practice. The platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal squamous cell of it a prognostic factor? Answer:", "Question: Preoperative platelet ??????????????????????????????????????????????????????????????????????????? esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "and platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal squamous  is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal squamous cell carcinoma? Is it a prognostic factor? Answer:", "Question: Preoperative platelet count in esophageal squamous cell is it a prognostic factor? Answer:", "count in esophageal. High platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "versus platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:", "count is a prognostic factor? Low platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer:"], "original_ll": -0.0010797162234796151, "sampled_ll": -0.000915297397516923, "all_perturbed_sampled_ll": [-0.002181110566395652, -0.0023253616126478267, -0.0014413324634904544, -0.04829228933172333, -0.002032741993592174, -0.0012881301547363268, -0.0011653785543854168, -0.0019653653130931818, -0.010291417810517274, -0.012238879444386364], "all_perturbed_original_ll": [-0.021608951136033217, -0.012331103068095416, -0.0031153723848713942, -0.0009218206330209522, -0.0028134287662130437, -0.0036167812006319233, -0.004762955098502083, -0.009520926301477408, -0.002219613085602727, -0.007928905175963332], "perturbed_sampled_ll": -0.008322200724496801, "perturbed_original_ll": -0.006883985685041149, "perturbed_sampled_ll_std": 0.013851037820377575, "perturbed_original_ll_std": 0.005981555545644787}, {"original": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "sampled": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "perturbed_sampled": ["Question: Long-term significance of postictal psychotic episodes II. Are they predictive of  episodes? Answer:", "Question: ??????????????????????????????????????????????? of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive ?????????????????? &??????.??.?.?.?.?.?.?.?.?.?.?.??.? psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are ? of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of ??????????????????????????????????????????????????????????????????????????????????? episodes? Answer:", "Question:  of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic ? Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are ? of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal . Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal  Answer:"], "perturbed_original": ["Question: Long-term significance of postictal psychotic ? Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal  II. Are they predictive of interictal psychotic episodes? Answer:", "I. What is the significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II.  predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. ??????????????.??.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?.?? predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal  Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal ? Answer:", "Question: Long-term significance of postictal psychotic episodes II.  predictive of interictal psychotic episodes? Answer:", "I. What is the significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer:", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of subsequent episodes? Answer:"], "original_ll": -0.0022882557304552, "sampled_ll": -0.0019640034454699996, "all_perturbed_sampled_ll": [-0.03133783708620952, -0.0014381421550702942, -0.004666583815075555, -0.004253064160535, -0.0021114468383892854, -0.003885060646321818, -0.024620561255178263, -0.004573708284166666, -0.011620034716, -0.03607311231221818], "all_perturbed_original_ll": [-0.026666971184789126, -0.0063864862924130445, -0.013270894089204165, -0.008763947655460872, -0.00043101167194938776, -0.0005717577456319999, -0.01806651686129565, -0.00723653962305435, -0.013479139305814583, -0.0019325758997472723], "perturbed_sampled_ll": -0.012457955126916456, "perturbed_original_ll": -0.009680584032936045, "perturbed_sampled_ll_std": 0.012469662275180694, "perturbed_original_ll_std": 0.007952371701644262}, {"original": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "sampled": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "perturbed_sampled": ["Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry  Postmenopausal Women? Answer:", ": Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", ": Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", ": Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 ? Answer:", "Question: Are Serum Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 ? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Activity in 370 Postmenopausal Women? Answer:", ": Are the Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry ? Postmenopausal Women? Answer:"], "perturbed_original": ["Question: Were Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are The Serum Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone  370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in Healthy Women? Answer:", "Question: Are the Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone ? 370 Postmenopausal Women? Answer:", "Question: Are Biochemical Markers of Bone Turnover Representative of Risk in 370 Postmenopausal Women? Answer:", ": Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Question: Are Bone Mapping Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:", "Answer: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer:"], "original_ll": -0.002319785736113103, "sampled_ll": -0.0020137775367527586, "all_perturbed_sampled_ll": [-0.02398179996010667, -0.0016082065197513791, -0.0026053372493008, -0.0025117559491220002, -0.00703689187234, -0.0014864180162942858, -0.00668052341182, -0.0009854006872115383, -0.02969477361358679, -0.05226397447364445], "all_perturbed_original_ll": [-0.005145999000848147, -0.0017358454621979307, -0.023665258292025, -0.0020177845388929167, -0.0015503139179643337, -0.00954112213911, -0.0011867951310864, -0.004466747497816399, -0.0012342398405565521, -0.00017301011109586205], "perturbed_sampled_ll": -0.012885508175317788, "perturbed_original_ll": -0.005071711593159354, "perturbed_sampled_ll_std": 0.01625139024625832, "perturbed_original_ll_std": 0.006728579836115296}, {"original": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "sampled": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "perturbed_sampled": ["Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Is percutaneous lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine ? Answer:", "Question: Is the technique for drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage from cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal ? after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid after spine surgery effective? Answer:", "Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after ? effective? Answer:"], "perturbed_original": ["Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal  after spine surgery effective? Answer:", "Question: Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is balloon drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after less effective? Answer:", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Question: Is a drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:", "Q: Is primary lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer:"], "original_ll": -0.0024661092592647826, "sampled_ll": -0.0019597002131717394, "all_perturbed_sampled_ll": [-0.0019836007875147824, -0.03737411625790238, -0.011679126349726253, -0.0417414728829143, -0.0010213845478729167, -0.003436410143022857, -0.012466546931800002, -0.0025404480526733334, -0.0027144936067323815, -0.007951798658018181], "all_perturbed_original_ll": [-0.002747512930213333, -0.002747512930213333, -0.011848861460616499, -0.013485274096569046, -0.0015714146852749999, -0.0033551132933147825, -0.019887400684759093, -0.0015130061377978262, -0.0029781528386090914, -0.025862478821674584], "perturbed_sampled_ll": -0.012290939821817738, "perturbed_original_ll": -0.008599672787904258, "perturbed_sampled_ll_std": 0.014192111044701488, "perturbed_original_ll_std": 0.008288928141868377}, {"original": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "sampled": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of health systems. These programs play a crucial role in building a workforce equipped with the necessary knowledge, skills, and competencies to tackle the unique health challenges faced by these countries. Through comprehensive education and", "perturbed_sampled": ["Question: Impact of public health programs on contributing to health system reform in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the sustainability and improvement of health systems. These programs play a crucial role in building a workforce equipped with the necessary knowledge, skills, and values to tackle the unique health challenges faced by these populations through comprehensive education and", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of health systems. These programs play a crucial role in building a pool of professionals with the necessary knowledge, skills, and competencies to face the unique health challenges faced by these countries. The impact of MPH education and", "Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of health systems. These programs play a crucial role in building human capital that is equipped with the knowledge, skills, and competencies to tackle the specific public health challenges faced by these countries. Through comprehensive education and", "Question: Impact of MPH programs to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of health systems. These programs play a crucial role in building a workforce with the necessary knowledge, skills, and competencies to tackle the unique health challenges faced by these countries. They also help bridge the gap between formal education and", "Question: Impact of MPH s on public health workforce and contribution to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant and contributes to the strengthening of health systems. These programs play a crucial role in building a workforce with the necessary knowledge, skills, and competencies to meet the unique health challenges faced by these countries. Through comprehensive education and", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to strengthening of health systems. These programs play a crucial role in building a workforce equipped with necessary knowledge, skills, and competencies to address the unique challenges faced by these countries. Their relevance to public health education and", "Question: Impact of MPH programs: How do they contribute to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of national health systems. These programs play a crucial role in building a workforce equipped with the necessary knowledge, skills, and competencies to tackle the unique health challenges faced by these countries. Through comprehensive education and", "Question: Impact of MPH programs: contributing to health system strengthening, particularly in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries (LMICs), is significant in contributing to the strengthening of health systems. These programs play a crucial role in building a workforce equipped with the necessary knowledge, skills, and attitudes to tackle the unique health challenges of these countries. Through comprehensive education and", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer:Answer: The impact of Master of Public Health programs, particularly in low- and middle-income countries, is significant in contributing to the strengthening of health systems. These programs play an important role in building a workforce equipped with the necessary knowledge, skills, and competencies to tackle the unique health challenges faced by these countries. Through comprehensive education and", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries. Answer:Answer: The impact of Master of Public Health (MPH) programs, particularly in low- and middle-income countries, is significant and contributes to the strengthening of health systems. These programs play a crucial role in developing a workforce equipped with the necessary knowledge, skills, and competencies to tackle the unique health challenges faced by these countries. Through comprehensive education and"], "perturbed_original": ["Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of graduate-level health education in contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to bring considerable value to their workplaces and often had influence at the national level. Much of the impact described was in line with the health educational aims. The qualitative method study revealed more in-depth understanding of the drivers of impact as well as their potential influence on career pathways.", "Question: Impact of MPH programs: What is their role in health system strengthening in low- and middle-income countries? Answer: There was considerable evidence of graduates' impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at management level. Much of the impact described was directly connected with public health educational aims. The qualitative method study revealed more detail on aspects of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and /or to influence at national level. Much of the impact described was in line with public health educational aims. The qualitative method used was appropriate as it allowed more in-depth understanding of graduates' impact as described through their career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to have been able to bring expertise to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of public health education in contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact on many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational expectations. A qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to governance strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels. Graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth details of graduates' impact as well as their career pathways.", "Question: Global MPH programs: contributing to health system strengthening in low- and middle-income countries? There was considerable impact at many levels. Graduates were perceived to be able to contribute significantly to their workplaces and to exert influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to health system development in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and exert influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as possible career pathways.", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: The study found that MPH programs had a considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways."], "original_ll": -0.0003218099038688234, "sampled_ll": -0.006868447716165274, "all_perturbed_sampled_ll": [-0.0023062530175729347, -0.004025479186663086, -0.2789343109161903, -0.0047887866382098935, -0.006712492982624149, -0.007520697093655496, -0.003552561406321368, -0.004780134261315685, -0.00470897592753046, -0.002917535941719999], "all_perturbed_original_ll": [-0.00023150555934202383, -0.00037217384764021746, -0.0003326278232171429, -0.0016105913528673033, -0.000259284074162093, -0.00026977349905151155, -0.00039135509277741175, -0.00013886915338397592, -0.0003210362541657143, -0.0005195068489694443], "perturbed_sampled_ll": -0.032024722737180336, "perturbed_original_ll": -0.00044467235055768386, "perturbed_sampled_ll_std": 0.08231691940218747, "perturbed_original_ll_std": 0.00040060205229150263}, {"original": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "sampled": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "perturbed_sampled": ["Question: Locoregional opening of the rodent brain for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional crosslinking of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for pulsed Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", ". Enhanced opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant ? Answer:", "induced opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain : paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional ? the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Transparency of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: What if...adjuvant opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:"], "perturbed_original": [". Preparative opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Interruption of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Inhibition of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Question: Enhancement of transmembrane diffusion of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Is it a problem of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG ????nn?nn?n?n?n??n?n?n-en!n?n?n?n?nn?n?n?nn?nn?n??n? n??n?????? therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel ?:::::.:..:::?:?:!:!:!!:!:!:!!!!!!!!!!!!!!!!!!!!!!! laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel ?:??????????\u00ab\u00bb??<unk>??????<unk>?????????????????????????????????????????????????????? laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: n?:::????:?:?::??::??:??:??:??:?:?:????:???????? concept of adjuvant glioma therapy? Answer:", "et al. Ablation or direct opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer:"], "original_ll": -0.004960276201265454, "sampled_ll": -0.0022829744740786363, "all_perturbed_sampled_ll": [-0.003742149228946829, -0.0033510606925682604, -0.0019370181322285, -0.002589725581041052, -0.014428864886469757, -0.0017351510777873684, -0.006130025712729536, -0.0020791988198672093, -0.00254533082366575, -0.0008055047330419566], "all_perturbed_original_ll": [-0.0013779186542246153, -0.0005209884884314286, -0.001560412254132683, -0.007471620767699112, -0.0011461148046369768, -0.002023380282923563, -0.0006793291874751724, -0.002508359239735588, -0.00019544732126985074, -0.0008250138318502271], "perturbed_sampled_ll": -0.003934402968834622, "perturbed_original_ll": -0.0018308584832379218, "perturbed_sampled_ll_std": 0.003756693496384579, "perturbed_original_ll_std": 0.001994730881067567}, {"original": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "sampled": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "perturbed_sampled": ["Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:"], "perturbed_original": ["Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer:"], "original_ll": -0.0029032091951376473, "sampled_ll": -0.002648008099110588, "all_perturbed_sampled_ll": [-0.0020785816786000003, -0.001848564604664706, -0.002091176930697059, -0.0024272931632735293, -0.002496033516217647, -0.0014760954245941176, -0.0029808517057076473, -0.0020072901359605884, -0.0048927481055841176, -0.0016163006426311766], "all_perturbed_original_ll": [-0.004865279252658824, -0.002189556193211765, -0.0029265125563988238, -0.0013755725523941175, -0.004865279252658824, -0.0029331571659117653, -0.002072525484482353, -0.00249024184012353, -0.0022891476913841184, -0.0010442124104076472], "perturbed_sampled_ll": -0.0023914935907930587, "perturbed_original_ll": -0.002705148439963177, "perturbed_sampled_ll_std": 0.0009319438497110912, "perturbed_original_ll_std": 0.0012184042629740557}, {"original": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "sampled": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "perturbed_sampled": ["Question: Visceral adipose tissue area measurement at a single level: can  visceral adipose tissue volume? Answer:", "Question: Reducing tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Abdominal visceral tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single site: How well, if at all, can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Abdominal tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:"], "perturbed_original": ["1. Question:1. Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single level: can it ?.??.????.?.?.?.?.?.?.?.?.?.?.?.?.?.???.?.?.?.?.??.??? adipose tissue volume? Answer:", "Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Abdominal tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a single level: can ?????????????????????????????????????????????? visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at surface level: can it represent visceral adipose tissue volume? Answer:", "Question: Visceral adipose tissue area measurement at a  can it represent visceral adipose tissue volume? Answer:"], "original_ll": -0.002554857813492308, "sampled_ll": -0.0032078226626073075, "all_perturbed_sampled_ll": [-0.008902750370073334, -0.0020378659142969565, -0.0016462988223432, -0.0020105240185924246, -0.002658162497132308, -0.0014659455264495833, -0.002884484317221538, -0.0006258250833036364, -0.0018203957391929166, -0.0005467816959877273], "all_perturbed_original_ll": [-0.004181296003977, -0.0016318207520083332, -0.022044439535051176, -0.0005854824578431818, -0.0020364783125576924, -0.000937234203075, -0.0012678828366158334, -0.07409839786289185, -0.0019300811638980004, -0.0028454776702847824], "perturbed_sampled_ll": -0.002459903398459363, "perturbed_original_ll": -0.011155859079820285, "perturbed_sampled_ll_std": 0.0022625795634621743, "perturbed_original_ll_std": 0.021842486036047954}, {"original": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "sampled": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "perturbed_sampled": ["Question: ! age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the differences in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference  for Australian aborigines and whites? Answer:", "Can gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference in between Australian aborigines and whites? Answer:", "Question: Can gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational  explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference ? for Australian aborigines and whites? Answer:", "Question: Can gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age explain the difference in birthweights for Australian aborigines and whites? Answer:"], "perturbed_original": ["Question: Does gestational age misclassification cause a difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does ?....?.????????????\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019\u2019 misclassification explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference in ?::????????????????????????????????????? Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference in between Australian aborigines and whites? Answer:", "Question: Does gestational age explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational length explain the difference in birthweights for Australian aborigines and whites? Answer:", "Question: Does gestational age misclassification explain the difference in birthweights for Australian  whites? Answer:", "Question: Does gestational age misclassification explain the difference in birthweights for Australian ? whites? Answer:", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines ? Answer:", "Question: Does gestational age misclassification explain the difference in birthweights for Australian s whites? Answer:"], "original_ll": -0.0011503488335125002, "sampled_ll": -0.0013244092218575004, "all_perturbed_sampled_ll": [-0.0031185309061063636, -0.001242933586575, -0.0025750083454904762, -0.0014771354009225001, -0.004401694128502273, -0.0017389691169875001, -0.007843041042714285, -0.03377309932155228, -0.0016442753005995834, -0.0013916833239336365], "all_perturbed_original_ll": [-0.001007386599164167, -0.008403565518666811, -0.0040947621285857575, -0.005933230471222728, -0.0016309396243627274, -0.0014995015668136365, -0.0032939823517999997, -0.0088272295939925, -0.01976864689915227, -0.03005851951275429], "perturbed_sampled_ll": -0.005920637047338389, "perturbed_original_ll": -0.00845177642665149, "perturbed_sampled_ll_std": 0.009480074707152696, "perturbed_original_ll_std": 0.008929012043939925}, {"original": "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "sampled": "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "perturbed_sampled": ["Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:"], "perturbed_original": ["Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:", "Question: Is there a correlation between androgens and sexual desire in women? Answer:"], "original_ll": -0.013804242037649999, "sampled_ll": -0.007371608891496666, "all_perturbed_sampled_ll": [-0.0054981072922466664, -0.010361560441672224, -0.012746503337977777, -0.007853275742357778, -0.007796715812505557, -0.017824902984263334, -0.008391501111477778, -0.007460102714980554, -0.007781918937718889, -0.0179754742001], "all_perturbed_original_ll": [-0.007626264475191112, -0.01008898311095, -0.017900061321715004, -0.010032711627616665, -0.007383624863741112, -0.011298466765616112, -0.013754487769235555, -0.008096128764744446, -0.009978578857968332, -0.01427928904503889], "perturbed_sampled_ll": -0.010369006257530056, "perturbed_original_ll": -0.011043859660181723, "perturbed_sampled_ll_std": 0.004181361028183857, "perturbed_original_ll_std": 0.0031894084067864022}, {"original": "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "sampled": "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "perturbed_sampled": ["Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:"], "perturbed_original": ["Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:", "Question: Is there a role for fondaparinux in perioperative bridging? Answer:"], "original_ll": -0.0022925283319410526, "sampled_ll": -0.0023113065669226316, "all_perturbed_sampled_ll": [-0.0033120680192915784, -0.0024211058408378948, -0.0023364302977678954, -0.002196055405078947, -0.003954509929142106, -0.002478044374663158, -0.002264883652684211, -0.002683378910028947, -0.004118731821044738, -0.0023912682496368422], "all_perturbed_original_ll": [-0.0024607080257226317, -0.002295091408120526, -0.0033120680192915784, -0.003503376526394737, -0.0022683009886784213, -0.0023912682496368422, -0.0023912682496368422, -0.0035282728724394734, -0.0029601548962342105, -0.0026240924855073684], "perturbed_sampled_ll": -0.002815647650017632, "perturbed_original_ll": -0.002773460172166263, "perturbed_sampled_ll_std": 0.0006801165883754645, "perturbed_original_ll_std": 0.0004820541304601428}, {"original": "Question: Do African American women require fewer calories to maintain weight? Answer:", "sampled": "Question: Do African American women require fewer calories to maintain weight? Answer:", "perturbed_sampled": ["Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:"], "perturbed_original": ["Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:", "Question: Do African American women require fewer calories to maintain weight? Answer:"], "original_ll": -0.007409934553962666, "sampled_ll": -0.004667318450277999, "all_perturbed_sampled_ll": [-0.004657097327768666, -0.0038703496324046668, -0.004503543606793333, -0.0077981344898259974, -0.00427903793779, -0.0047552342105333335, -0.004074011983757999, -0.004759250745808666, -0.004904080057975334, -0.004786956206908667], "all_perturbed_original_ll": [-0.004786956206908667, -0.007201485716538667, -0.004579491092028667, -0.004786024039642, -0.00462726748334, -0.003183900802619334, -0.008722709702826669, -0.004179803470973333, -0.003161930999483334, -0.006969235866846001], "perturbed_sampled_ll": -0.004838769619956666, "perturbed_original_ll": -0.0052198805381206675, "perturbed_sampled_ll_std": 0.001037278376529735, "perturbed_original_ll_std": 0.0017278856794398524}, {"original": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "sampled": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "perturbed_sampled": ["Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:"], "perturbed_original": ["Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer:"], "original_ll": -0.000949770310975, "sampled_ll": -0.0011093248442187499, "all_perturbed_sampled_ll": [-0.0019565297022143746, -0.0012708375176175, -0.000928929882834375, -0.00121700262698375, -0.000921225950586875, -0.0013549279383325, -0.001450882135815625, -0.0023772800692875, -0.0011093248442187499, -0.001386124231540625], "all_perturbed_original_ll": [-0.0014803098406874998, -0.00089885495821875, -0.0019225240909343752, -0.0023794394959250004, -0.00098222179552375, -0.00201854474945, -0.0008728229332, -0.001247121295090625, -0.001206302150058125, -0.001463085714878125], "perturbed_sampled_ll": -0.0013973064899431877, "perturbed_original_ll": -0.0014471227023966251, "perturbed_sampled_ll_std": 0.0004307362058151121, "perturbed_original_ll_std": 0.00048658464240686417}, {"original": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "sampled": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively preserved and the body's", "perturbed_sampled": ["Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower fasting plasma glucose levels indicate that the disease has been detected at an earlier stage, pancreatic function is relatively preserved and the body's", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively intact and can better regulate the body's", "Question: Are lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where the treatment is more effective, and the body's", "Question: Are lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels suggest that the disease has been detected at an earlier stage, where pancreatic function is relatively preserved and the body's", "diabetes have an improved outcome. Question:Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively preserved and the body's", "Question: Is fasting plasma glucose (FPG) level at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been diagnosed at an earlier stage, where pancreatic function is relatively preserved and the body's", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with better outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively preserved and the body's", "Question: Are lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively more effective in maintaining the body's", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with better outcomes. This association is primarily because lower glucose levels indicate that the disease has been detected at an earlier stage, where pancreatic function is relatively preserved and the body's", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer:Yes, lower fasting plasma glucose levels at the time of diagnosis of type 2 diabetes are associated with improved outcomes. This is primarily because lower glucose levels at diagnosis of type 2 diabetes usually mean that the disease has been detected at an earlier stage, where insulin-producing pancreatic function is relatively preserved and the body's"], "perturbed_original": ["Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: The authors found that those with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, targeted early case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial fasting plasma glucose levels at diagnosis and who may be earlier in the course of their disease had improved clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be helpful to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with worse clinical outcomes? Answer: Those with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic , active case detection programs would be required to identify them.", "Question: Are lower fasting blood sugar levels at diagnosis of type 2 diabetes associated with better outcomes? Answer: People presenting with type 2 diabetes and low initial glycemia who may be earlier in the course of the disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? surveillance presenting with type 2 diabetes with lower initial glycemia who may require treatment early in the course of the disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active and efficient prevention programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of the disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would help to identify them.", "Question: Are lower fasting blood glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Researchers found that patients presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of the disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of the disease had fewer adverse clinical outcomes despite a delayed disease progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "? Q. Are lower fasting blood glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since some of these people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of the disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs may be required to identify them."], "original_ll": -0.0002162575775244737, "sampled_ll": -0.0037730948098176, "all_perturbed_sampled_ll": [-0.005912078844812859, -0.0036057750822875646, -0.005524471284807721, -0.0050032688890857685, -0.004945903793546584, -0.0030913097837762826, -0.0045234018252696, -0.005541812409523375, -0.00043223544590301373, -0.004687373536975953], "all_perturbed_original_ll": [-9.792438237025316e-05, -0.00016475959585625003, -0.0007615537027255405, -0.00021669721069434212, -0.0014519948456273683, -0.0001605722748861333, -6.0432044891298707e-05, -0.00014659400150000002, -0.00021847990003576921, -0.00012776145664216215], "perturbed_sampled_ll": -0.0043267630895988726, "perturbed_original_ll": -0.00034067694152291176, "perturbed_sampled_ll_std": 0.001537767601253941, "perturbed_original_ll_std": 0.00041549002689980315}], "metrics": {"roc_auc": 0.5575555555555556, "fpr": [0.0, 0.0, 0.0, 0.006666666666666667, 0.006666666666666667, 0.013333333333333334, 0.013333333333333334, 0.02666666666666667, 0.02666666666666667, 0.03333333333333333, 0.03333333333333333, 0.04, 0.04, 0.04666666666666667, 0.04666666666666667, 0.05333333333333334, 0.05333333333333334, 0.06666666666666667, 0.06666666666666667, 0.07333333333333333, 0.07333333333333333, 0.08, 0.08, 0.09333333333333334, 0.09333333333333334, 0.1, 0.1, 0.10666666666666667, 0.10666666666666667, 0.12666666666666668, 0.12666666666666668, 0.15333333333333332, 0.15333333333333332, 0.16, 0.16, 0.17333333333333334, 0.17333333333333334, 0.18, 0.18, 0.19333333333333333, 0.19333333333333333, 0.2, 0.2, 0.23333333333333334, 0.23333333333333334, 0.24, 0.24, 0.24666666666666667, 0.24666666666666667, 0.25333333333333335, 0.25333333333333335, 0.26666666666666666, 0.26666666666666666, 0.2866666666666667, 0.2866666666666667, 0.30666666666666664, 0.30666666666666664, 0.31333333333333335, 0.31333333333333335, 0.32666666666666666, 0.32666666666666666, 0.3333333333333333, 0.3333333333333333, 0.3466666666666667, 0.3466666666666667, 0.36, 0.36, 0.36666666666666664, 0.36666666666666664, 0.38, 0.38, 0.43333333333333335, 0.43333333333333335, 0.4666666666666667, 0.4666666666666667, 0.4866666666666667, 0.4866666666666667, 0.49333333333333335, 0.49333333333333335, 0.5133333333333333, 0.5133333333333333, 0.5266666666666666, 0.5266666666666666, 0.5333333333333333, 0.5333333333333333, 0.5466666666666666, 0.5466666666666666, 0.5733333333333334, 0.5733333333333334, 0.58, 0.58, 0.5933333333333334, 0.5933333333333334, 0.6066666666666667, 0.6066666666666667, 0.6333333333333333, 0.6333333333333333, 0.6466666666666666, 0.6466666666666666, 0.6666666666666666, 0.6666666666666666, 0.6733333333333333, 0.6733333333333333, 0.6933333333333334, 0.6933333333333334, 0.7, 0.7, 0.7533333333333333, 0.7533333333333333, 0.76, 0.76, 0.78, 0.78, 0.7933333333333333, 0.7933333333333333, 0.8, 0.8, 0.8266666666666667, 0.8266666666666667, 0.8466666666666667, 0.8466666666666667, 0.8533333333333334, 0.8533333333333334, 0.8733333333333333, 0.8733333333333333, 0.8866666666666667, 0.8866666666666667, 0.9133333333333333, 0.9133333333333333, 0.92, 0.92, 0.9333333333333333, 0.9333333333333333, 0.94, 0.94, 0.9466666666666667, 0.9466666666666667, 0.9533333333333334, 0.9533333333333334, 0.9666666666666667, 0.9666666666666667, 0.9733333333333334, 0.9733333333333334, 1.0, 1.0], "tpr": [0.0, 0.006666666666666667, 0.013333333333333334, 0.013333333333333334, 0.06666666666666667, 0.06666666666666667, 0.07333333333333333, 0.07333333333333333, 0.08, 0.08, 0.08666666666666667, 0.08666666666666667, 0.14666666666666667, 0.14666666666666667, 0.16, 0.16, 0.16666666666666666, 0.16666666666666666, 0.17333333333333334, 0.17333333333333334, 0.2, 0.2, 0.21333333333333335, 0.21333333333333335, 0.22, 0.22, 0.22666666666666666, 0.22666666666666666, 0.23333333333333334, 0.23333333333333334, 0.24666666666666667, 0.24666666666666667, 0.25333333333333335, 0.25333333333333335, 0.26, 0.26, 0.26666666666666666, 0.26666666666666666, 0.2866666666666667, 0.2866666666666667, 0.30666666666666664, 0.30666666666666664, 0.34, 0.34, 0.3466666666666667, 0.3466666666666667, 0.35333333333333333, 0.35333333333333333, 0.37333333333333335, 0.37333333333333335, 0.38666666666666666, 0.38666666666666666, 0.4, 0.4, 0.43333333333333335, 0.43333333333333335, 0.44, 0.44, 0.4666666666666667, 0.4666666666666667, 0.47333333333333333, 0.47333333333333333, 0.4866666666666667, 0.4866666666666667, 0.5, 0.5, 0.5133333333333333, 0.5133333333333333, 0.5333333333333333, 0.5333333333333333, 0.54, 0.54, 0.5466666666666666, 0.5466666666666666, 0.5533333333333333, 0.5533333333333333, 0.5733333333333334, 0.5733333333333334, 0.5866666666666667, 0.5866666666666667, 0.5933333333333334, 0.5933333333333334, 0.6066666666666667, 0.6066666666666667, 0.62, 0.62, 0.6266666666666667, 0.6266666666666667, 0.6333333333333333, 0.6333333333333333, 0.6466666666666666, 0.6466666666666666, 0.6666666666666666, 0.6666666666666666, 0.6733333333333333, 0.6733333333333333, 0.68, 0.68, 0.6933333333333334, 0.6933333333333334, 0.7, 0.7, 0.7066666666666667, 0.7066666666666667, 0.7133333333333334, 0.7133333333333334, 0.7266666666666667, 0.7266666666666667, 0.7333333333333333, 0.7333333333333333, 0.74, 0.74, 0.7466666666666667, 0.7466666666666667, 0.76, 0.76, 0.7666666666666667, 0.7666666666666667, 0.7933333333333333, 0.7933333333333333, 0.8, 0.8, 0.8133333333333334, 0.8133333333333334, 0.8266666666666667, 0.8266666666666667, 0.84, 0.84, 0.8466666666666667, 0.8466666666666667, 0.8666666666666667, 0.8666666666666667, 0.92, 0.92, 0.9266666666666666, 0.9266666666666666, 0.9333333333333333, 0.9333333333333333, 0.94, 0.94, 0.96, 0.96, 0.9666666666666667, 0.9666666666666667, 1.0]}, "pr_metrics": {"pr_auc": 0.596507203681842, "precision": [0.5, 0.4983277591973244, 0.4966442953020134, 0.494949494949495, 0.49324324324324326, 0.4915254237288136, 0.4931972789115646, 0.4948805460750853, 0.4965753424657534, 0.49828178694158076, 0.496551724137931, 0.4982698961937716, 0.4965277777777778, 0.49477351916376305, 0.493006993006993, 0.49473684210526314, 0.4964788732394366, 0.49469964664310956, 0.49645390070921985, 0.49466192170818507, 0.49642857142857144, 0.4946236559139785, 0.49640287769784175, 0.49458483754512633, 0.4927536231884058, 0.4909090909090909, 0.48905109489051096, 0.48717948717948717, 0.4852941176470588, 0.4833948339483395, 0.48148148148148145, 0.483271375464684, 0.48507462686567165, 0.48314606741573035, 0.48120300751879697, 0.47924528301886793, 0.4810606060606061, 0.4790874524714829, 0.48091603053435117, 0.4827586206896552, 0.4846153846153846, 0.4864864864864865, 0.4844961240310077, 0.48249027237354086, 0.484375, 0.48627450980392156, 0.484251968503937, 0.48221343873517786, 0.48412698412698413, 0.4860557768924303, 0.488, 0.4859437751004016, 0.4838709677419355, 0.48582995951417, 0.483739837398374, 0.4857142857142857, 0.48770491803278687, 0.4897119341563786, 0.48760330578512395, 0.4854771784232365, 0.48333333333333334, 0.4811715481171548, 0.4831932773109244, 0.48523206751054854, 0.4872881355932203, 0.48936170212765956, 0.48717948717948717, 0.4892703862660944, 0.4870689655172414, 0.48484848484848486, 0.48695652173913045, 0.4890829694323144, 0.4868421052631579, 0.4889867841409692, 0.4911504424778761, 0.49333333333333335, 0.49107142857142855, 0.49327354260089684, 0.49099099099099097, 0.49321266968325794, 0.4954545454545455, 0.4977168949771689, 0.5, 0.5023041474654378, 0.5046296296296297, 0.5069767441860465, 0.5093457943925234, 0.5070422535211268, 0.5047169811320755, 0.5071090047393365, 0.5047619047619047, 0.507177033492823, 0.5096153846153846, 0.5120772946859904, 0.5097087378640777, 0.5121951219512195, 0.5098039215686274, 0.5123152709359606, 0.5148514851485149, 0.5174129353233831, 0.515, 0.5125628140703518, 0.5151515151515151, 0.5177664974619289, 0.5153061224489796, 0.517948717948718, 0.520618556701031, 0.5233160621761658, 0.5260416666666666, 0.5235602094240838, 0.5263157894736842, 0.5291005291005291, 0.526595744680851, 0.5240641711229946, 0.521505376344086, 0.5243243243243243, 0.5271739130434783, 0.5245901639344263, 0.521978021978022, 0.5248618784530387, 0.5222222222222223, 0.5251396648044693, 0.5280898876404494, 0.5310734463276836, 0.5340909090909091, 0.5314285714285715, 0.5344827586206896, 0.5375722543352601, 0.5348837209302325, 0.5321637426900585, 0.5352941176470588, 0.5325443786982249, 0.5297619047619048, 0.5329341317365269, 0.536144578313253, 0.5333333333333333, 0.5365853658536586, 0.5398773006134969, 0.5432098765432098, 0.5403726708074534, 0.5375, 0.5408805031446541, 0.5379746835443038, 0.535031847133758, 0.532051282051282, 0.535483870967742, 0.538961038961039, 0.5424836601307189, 0.5394736842105263, 0.543046357615894, 0.5466666666666666, 0.5503355704697986, 0.5540540540540541, 0.5578231292517006, 0.5547945205479452, 0.5586206896551724, 0.5625, 0.5664335664335665, 0.5704225352112676, 0.574468085106383, 0.5785714285714286, 0.5827338129496403, 0.5869565217391305, 0.583941605839416, 0.5882352941176471, 0.5925925925925926, 0.5895522388059702, 0.5864661654135338, 0.5833333333333334, 0.5877862595419847, 0.5846153846153846, 0.5813953488372093, 0.5859375, 0.5905511811023622, 0.5873015873015873, 0.584, 0.5887096774193549, 0.5934959349593496, 0.5901639344262295, 0.5867768595041323, 0.5916666666666667, 0.5882352941176471, 0.5932203389830508, 0.5982905982905983, 0.5948275862068966, 0.591304347826087, 0.5877192982456141, 0.584070796460177, 0.5892857142857143, 0.5855855855855856, 0.5909090909090909, 0.5963302752293578, 0.6018518518518519, 0.5981308411214953, 0.5943396226415094, 0.5904761904761905, 0.5865384615384616, 0.5825242718446602, 0.5882352941176471, 0.594059405940594, 0.6, 0.5959595959595959, 0.5918367346938775, 0.5979381443298969, 0.6041666666666666, 0.6, 0.5957446808510638, 0.6021505376344086, 0.5978260869565217, 0.5934065934065934, 0.5888888888888889, 0.5955056179775281, 0.5909090909090909, 0.5977011494252874, 0.5930232558139535, 0.6, 0.6071428571428571, 0.6144578313253012, 0.6219512195121951, 0.6296296296296297, 0.625, 0.620253164556962, 0.6153846153846154, 0.6103896103896104, 0.6052631578947368, 0.6133333333333333, 0.6081081081081081, 0.6027397260273972, 0.5972222222222222, 0.6056338028169014, 0.6142857142857143, 0.6086956521739131, 0.6029411764705882, 0.5970149253731343, 0.6060606060606061, 0.6, 0.609375, 0.6190476190476191, 0.6129032258064516, 0.6229508196721312, 0.6166666666666667, 0.6271186440677966, 0.6379310344827587, 0.6491228070175439, 0.6607142857142857, 0.6545454545454545, 0.6481481481481481, 0.660377358490566, 0.6730769230769231, 0.6862745098039216, 0.68, 0.6938775510204082, 0.6875, 0.7021276595744681, 0.6956521739130435, 0.7111111111111111, 0.7272727272727273, 0.7209302325581395, 0.7142857142857143, 0.7317073170731707, 0.725, 0.717948717948718, 0.7105263157894737, 0.7027027027027027, 0.7222222222222222, 0.7142857142857143, 0.7352941176470589, 0.7575757575757576, 0.75, 0.7741935483870968, 0.7666666666666667, 0.7586206896551724, 0.7857142857142857, 0.7777777777777778, 0.7692307692307693, 0.76, 0.75, 0.7391304347826086, 0.7272727272727273, 0.7142857142857143, 0.7, 0.6842105263157895, 0.7222222222222222, 0.7058823529411765, 0.75, 0.7333333333333333, 0.7857142857142857, 0.8461538461538461, 0.8333333333333334, 0.9090909090909091, 0.9, 0.8888888888888888, 0.875, 0.8571428571428571, 0.8333333333333334, 0.8, 0.75, 0.6666666666666666, 1.0, 1.0, 1.0], "recall": [1.0, 0.9933333333333333, 0.9866666666666667, 0.98, 0.9733333333333334, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.96, 0.96, 0.9533333333333334, 0.9466666666666667, 0.94, 0.94, 0.94, 0.9333333333333333, 0.9333333333333333, 0.9266666666666666, 0.9266666666666666, 0.92, 0.92, 0.9133333333333333, 0.9066666666666666, 0.9, 0.8933333333333333, 0.8866666666666667, 0.88, 0.8733333333333333, 0.8666666666666667, 0.8666666666666667, 0.8666666666666667, 0.86, 0.8533333333333334, 0.8466666666666667, 0.8466666666666667, 0.84, 0.84, 0.84, 0.84, 0.84, 0.8333333333333334, 0.8266666666666667, 0.8266666666666667, 0.8266666666666667, 0.82, 0.8133333333333334, 0.8133333333333334, 0.8133333333333334, 0.8133333333333334, 0.8066666666666666, 0.8, 0.8, 0.7933333333333333, 0.7933333333333333, 0.7933333333333333, 0.7933333333333333, 0.7866666666666666, 0.78, 0.7733333333333333, 0.7666666666666667, 0.7666666666666667, 0.7666666666666667, 0.7666666666666667, 0.7666666666666667, 0.76, 0.76, 0.7533333333333333, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.74, 0.74, 0.74, 0.74, 0.7333333333333333, 0.7333333333333333, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.7266666666666667, 0.72, 0.7133333333333334, 0.7133333333333334, 0.7066666666666667, 0.7066666666666667, 0.7066666666666667, 0.7066666666666667, 0.7, 0.7, 0.6933333333333334, 0.6933333333333334, 0.6933333333333334, 0.6933333333333334, 0.6866666666666666, 0.68, 0.68, 0.68, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6733333333333333, 0.6666666666666666, 0.6666666666666666, 0.6666666666666666, 0.66, 0.6533333333333333, 0.6466666666666666, 0.6466666666666666, 0.6466666666666666, 0.64, 0.6333333333333333, 0.6333333333333333, 0.6266666666666667, 0.6266666666666667, 0.6266666666666667, 0.6266666666666667, 0.6266666666666667, 0.62, 0.62, 0.62, 0.6133333333333333, 0.6066666666666667, 0.6066666666666667, 0.6, 0.5933333333333334, 0.5933333333333334, 0.5933333333333334, 0.5866666666666667, 0.5866666666666667, 0.5866666666666667, 0.5866666666666667, 0.58, 0.5733333333333334, 0.5733333333333334, 0.5666666666666667, 0.56, 0.5533333333333333, 0.5533333333333333, 0.5533333333333333, 0.5533333333333333, 0.5466666666666666, 0.5466666666666666, 0.5466666666666666, 0.5466666666666666, 0.5466666666666666, 0.5466666666666666, 0.54, 0.54, 0.54, 0.54, 0.54, 0.54, 0.54, 0.54, 0.54, 0.5333333333333333, 0.5333333333333333, 0.5333333333333333, 0.5266666666666666, 0.52, 0.5133333333333333, 0.5133333333333333, 0.5066666666666667, 0.5, 0.5, 0.5, 0.49333333333333335, 0.4866666666666667, 0.4866666666666667, 0.4866666666666667, 0.48, 0.47333333333333333, 0.47333333333333333, 0.4666666666666667, 0.4666666666666667, 0.4666666666666667, 0.46, 0.4533333333333333, 0.44666666666666666, 0.44, 0.44, 0.43333333333333335, 0.43333333333333335, 0.43333333333333335, 0.43333333333333335, 0.4266666666666667, 0.42, 0.41333333333333333, 0.4066666666666667, 0.4, 0.4, 0.4, 0.4, 0.3933333333333333, 0.38666666666666666, 0.38666666666666666, 0.38666666666666666, 0.38, 0.37333333333333335, 0.37333333333333335, 0.36666666666666664, 0.36, 0.35333333333333333, 0.35333333333333333, 0.3466666666666667, 0.3466666666666667, 0.34, 0.34, 0.34, 0.34, 0.34, 0.34, 0.3333333333333333, 0.32666666666666666, 0.32, 0.31333333333333335, 0.30666666666666664, 0.30666666666666664, 0.3, 0.29333333333333333, 0.2866666666666667, 0.2866666666666667, 0.2866666666666667, 0.28, 0.2733333333333333, 0.26666666666666666, 0.26666666666666666, 0.26, 0.26, 0.26, 0.25333333333333335, 0.25333333333333335, 0.24666666666666667, 0.24666666666666667, 0.24666666666666667, 0.24666666666666667, 0.24666666666666667, 0.24, 0.23333333333333334, 0.23333333333333334, 0.23333333333333334, 0.23333333333333334, 0.22666666666666666, 0.22666666666666666, 0.22, 0.22, 0.21333333333333335, 0.21333333333333335, 0.21333333333333335, 0.20666666666666667, 0.2, 0.2, 0.19333333333333333, 0.18666666666666668, 0.18, 0.17333333333333334, 0.17333333333333334, 0.16666666666666666, 0.16666666666666666, 0.16666666666666666, 0.16, 0.16, 0.15333333333333332, 0.14666666666666667, 0.14666666666666667, 0.14, 0.13333333333333333, 0.12666666666666668, 0.12, 0.11333333333333333, 0.10666666666666667, 0.1, 0.09333333333333334, 0.08666666666666667, 0.08666666666666667, 0.08, 0.08, 0.07333333333333333, 0.07333333333333333, 0.07333333333333333, 0.06666666666666667, 0.06666666666666667, 0.06, 0.05333333333333334, 0.04666666666666667, 0.04, 0.03333333333333333, 0.02666666666666667, 0.02, 0.013333333333333334, 0.013333333333333334, 0.006666666666666667, 0.0]}, "loss": 0.40349279631815804}